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Abstract……
Enterohemorrhagic Escherichia coli (EHEC) is a virulent pathotype of E. coli that is
associated with major outbreaks of hemorrhagic colitis and the life-threatening kidney disease
hemolytic uremic syndrome. For successful host colonization and attachment to the intestinal
mucosa, EHEC requires the locus of enterocyte effacement (LEE) pathogenicity island, which
encodes a type III secretion system (TTSS) responsible for secreting and translocating effector
proteins into host colonocytes. Regulation of the LEE is primarily directed through the first
operon, LEE1, encoding the locus encoded regulator (Ler), and occurs through the direct and
indirect action of several regulators. The 2006 U.S. spinach outbreak of E. coli O157:H7,
characterized by unusually severe disease, has been attributed to a strain (TW14359) with
enhanced pathogenic potential including elevated virulence gene expression, robust adherence,
and the presence of novel virulence factors.
Aim 1 of this dissertation proposes a mechanism for the unique virulence expression and
adherence phenotype of this strain, and further expands the role for regulator RcsB in control of
the E. coli locus of enterocyte effacement (LEE) pathogenicity island. Proteomic analysis of
TW14359 revealed a virulence proteome consistent with previous transcriptome studies that
included elevated levels of the LEE regulatory protein Ler and type III secretion system (T3SS)
proteins, secreted T3SS effectors, and Shiga toxin 2. Basal levels of the LEE activator and Rcs
phosphorelay response regulator, RcsB, were increased in strain TW14359 relative to O157:H7
strain Sakai. Deletion of rcsB eliminated inherent differences between these strains in ler
expression, and in T3SS-dependent adherence. A reciprocating regulatory pathway involving
RcsB and LEE-encoded activator GrlA was identified and predicted to coordinate LEE activation
vii

with repression of the flhDC flagellar regulator and motility. Overexpression of grlA was shown
to increase RcsB levels, but did not alter expression from promoters driving rcsB transcription.
Expression of rcsDB and RcsB was determined to increase in response to physiologic levels of
bicarbonate, and bicarbonate-dependent stimulation of the LEE was shown to be dependent on
an intact Rcs system and ler activator grvA. The results of this aim significantly broaden the role
for RcsB in EHEC virulence regulation.
The bicarbonate ion (HCO3-) has been shown to stimulate LEE gene transcription through
the LEE1 promoter, and is predicted to serve as a physiologic signal for EHEC colonization.
Results from the previous aim demonstrated that bicarbonate induction of the LEE is mediated
through the Rcs phosphorelay, and is dependent upon an intact global regulator of virulence grvA
gene. However, the direct mechanism through which RcsB-GrvA regulates ler, and the
contribution of GrvA to the virulence of EHEC is unknown. In Aim 2, the RcsB-GrvA regulon
of EHEC was determined by RNA sequencing, and the contributions of each to virulence and
stress fitness was explored. A significant increase in transcription of the gad genes for extreme
acid resistance was observed for both EHEC strains TW14359∆grvA and TW14359∆rcsB∆grvA
compared to TW14359, and corresponded with a significant increase in acid survival for
TW14359∆grvA during exponential growth. Therefore, a model by which RcsB-GrvA
coordinate LEE expression with acid resistance through GadE was proposed.

Finally, the

temporal regulation of both rcsDB and grvAB operons in response to bicarbonate was defined
using single copy luxE chromosomal reporter fusions. Taken together, these results demonstrate
the role of RcsB and GrvA to EHEC virulence, and reveal a novel role for GrvA in of extreme
acid resistance and LEE gene expression and in EHEC.

viii

Finally, production of the ECP pilus has been demonstrated in enterohemorrhagic
Escherichia coli O157:H7 (EHEC), and has been shown to be required for efficient adherence to
epithelial cells during colonization. The first gene of the ecpRABCDE operon encodes a
transcriptional regulator (EcpR) that positively regulates its own transcription, and promotes
transcription and production of the downstream gene, ecpA, encoding the major ECP subunit
EcpA. However, the distance between the ecpR and ecpA genes suggests the presence of
regulatory elements that control ecpA directly. Therefore, it was hypothesized that an additional
promoter was able to direct transcription of ecpA, independent of the promoter upstream of ecpR.
To test this, promoter-lacZ transcriptional reporter fusions were created using the regions
upstream of ecpR and ecpA to test for promoter activity, coupled with western blot analysis to
detect EcpA in both wild-type and ecpR promoter mutant strains. In Aim 3, we showed that an
additional promotable element, downstream of the EHEC O157:H7 strain TW14359 ecpR
translational start site, is capable of driving transcription of ecpA, and that its activity is
independent of an intact ecpR promoter. In addition, site-directed mutagenesis was used to
characterize a TW14359 specific single nucleotide polymorphism within the predicted ecpA
promoter region. Overproduction of EcpR was observed to increase cytosolic RcsB and Tir,
indicating that ecp production is able to stimulate the LEE, and that the ecpA promoter
polymorphism may contribute to intrinsically increased rcsB transcription in TW14359. Taken
together, the results, and those obtained in Aims 1 and 2, expand the model for regulation of the
ecp operon in EHEC O157:H7 strain TW14359, and broaden the model for EcpR and RcsB in
the coordinate regulation of E. coli common pilus and type III secretion.
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Chapter 1: Introduction
1.1 Enterohemorrhagic Escherichia coli (EHEC)
Escherichia coli is a facultatively anaerobic gram negative bacteria of the family
Enterobacteriaceae, and is commonly found as a component of the normal mammalian lower
intestinal flora (Giangrossi et al., 2005). And though it is found in the gut, E. coli can survive for
extended periods of time in terrestrial and aquatic habitats (van Elsas et al., 2011). Since its
discovery, E. coli has become an integral part of modern molecular biology as a model organism
and has been intensively studied. Though the average genome size of E. coli is roughly 4.7
Megabases (Mb), there exists a highly diverse subset of E. coli strains and pathotypes with
unique properties and ecological niches (Touchon et al., 2009). The core genome of E. coli is
composed of roughly 2,000 genes, while the pan genome contains roughly 18,000 orthologous
genes (Touchon et al., 2009). This extensive repertoire of genes provides E. coli with an
enormous set of tools to adapt and respond to various environments, including those found in the
human host. While some E. coli strains are non-pathogenic, a subset of important E. coli
pathotypes exist which can cause overt disease in humans. These include enteropathogenic E.
coli (EPEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), enterotoxigenic
E. coli (ETEC), extra-intestinal pathogenic E. coli (ExPEC), uropathogenic E. coli (UPEC), and
enterohemorrhagic E. coli (EHEC) (Lim et al., 2011; Nataro and Kaper, 1998).
Enterohemorrhagic Escherichia coli is a zoonotic pathogen capable of causing severe
diarrheagenic illness, as well as life-threatening kidney disease, in humans. There are an
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Figure 1 - Model depicting the pathway for enterohemorrhagic E. coli host colonization
The model for E. coli colonization of the human host, following ingestion of bacteria in contaminated
water or food, involves passage through the gastric barrier and successful competitive colonization of the
intestinal mucosa.

2

estimated 77,000 EHEC infections each year, resulting in 2,000 hospitalizations and 60 deaths,
with an estimated annual cost of $405 million (Frenzen et al., 2005). An infection caused by
EHEC typically presents with frankly bloody diarrhea (hemorrhagic colitis), and may progress to
a toxin-associated illness known as hemolytic uremic syndrome, which is characterized by
thrombocytopenia, and microangiopathic hemolytic anemia (Nataro and Kaper, 1998).
The primary reservoir of EHEC is domestic and wild ungulates, however colonized
calves and adult cattle typically remain asymptomatic (Cray and Moon, 1995). Transmission
generally occurs indirectly through the fecal-oral route (Fig. 1), with outbreaks originating from
contaminated food (Nataro and Kaper, 1998). Other sources of infection include direct contact
with infected persons or domestic animals, and tainted water (drinking and recreational) (Rangel
et al., 2005). The low oral infectious dose of EHEC (<100 bacteria) is determined by its ability to
successfully survive passage through the stomachs gastric acid barrier, and by competitive
colonization of the host intestine (Kaper et al., 2004). As antibiotic use is contraindicated for
EHEC infections, due to complications associated with Shiga toxin production and HUS, there
are very few strategies in use for infection treatment and prevention (Jaeger and Acheson, 2000).
This fact underscores the importance of further understanding the mechanisms which determine
the virulence of this pathogen.

1.2 Virulence determinants of EHEC and the mechanisms by which they cause disease
1.2.1 Shiga Toxin..........
The virulence of EHEC is largely dictated by production of Shiga toxin 2 (Stx2) (Boerlin
et al., 1999; O'Brien et al., 1983). Stx2 is an AB5 toxin, comprised of Stx2A and five Stx2B
subunits. The genes which encode the toxin (stx2AB) are contained within a temperate lambdoid
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prophage (Johannes and Romer, 2010; Unkmeir and Schmidt, 2000). The toxin can enter the host
cell through binding of cell surface expressed glycolipids, specifically globotriaosylceramide
(Gb3), leading to clathrin mediated endocytosis and retrograde transport of the toxin through the
endoplasmic reticulum (Johannes and Romer, 2010). There, the A-subunit is released into the
cytoplasm where it cleaves a single adenine base from the eurkaryotic 28S ribosomal RNA
leading to an inhibition of protein synthesis, and cell death (Endo et al., 1988). It has been shown
that cattle lack the vascular receptors for Stx2 binding, which can explain why they are
asymptomatic carriers for stx2 positive EHEC serotypes (Pruimboom-Brees et al., 2000).
Recently, it was shown that EHEC strain EDL933 carrying a non-inducible variant of Stx2 was
able to colonize a mouse host, but was not able to produce any pathological changes without
Stx2 production, underscoring the significant role of Stx2 in EHEC pathogenesis following
colonization (Tyler et al., 2013).

1.2.2 The Locus of Enterocyte Effacement (LEE)
Successful competitive colonization of the host intestine requires a 36 kb pathogenicity
island termed the locus of enterocyte effacement (LEE), which contains five operons encoding
structural, auxiliary and regulatory components of a contact-dependent type III secretion system
(T3SS) (McDaniel et al., 1995; Moon et al., 1983) (Fig. 3A). The LEE contains genes necessary
for production of the T3SS, regulation of the LEE, and effectors required for intimate attachment
to host cells (Deng et al., 2004; McDaniel et al., 1995; Perna et al., 1998). Intimate attachment is
dependent on the interaction of the TTSS translocated effector Tir, localized to the apical region
of the host intestinal cell, with the EHEC-encoded adhesin, intimin (Kenny et al., 1997b).
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Pedestal structures (attaching and effacing lesions) are a consequence of actin condensation
below the attached bacterium (Campellone, 2010; Cheng et al., 2008; Garmendia et al., 2004;
Knutton et al., 1989). Previous studies have identified the conditions which stimulate T3SS
production and subsequently enhance EHEC gut adherence, this includes growth at 37°C,
physiologic osmolarity, and the presence of sodium bicarbonate (Kenny et al., 1997a;
Rosenshine et al., 1996). Abe et al. observed maximum expression of LEE genes in EHEC when
grown in the presence of 44 mM sodium bicarbonate under nutrient-rich conditions, which has
been proposed to be a similar environment to that of the intestinal ileum (Abe et al., 2002;
Fordtran and Locklear, 1966). Currently, no mechanism for bicarbonate stimulation of the LEE
has been identified in EHEC or EPEC (Yang et al., 2008).
The ATPase EscN is localized to the base of the inner membrane T3SS ring and
hydrolyzes ATP to provide the energy for effector translocation (Sorg et al., 2005; Tree et al.,
2009; Winnen et al., 2008; Yip et al., 2005; Zarivach et al., 2007). The type III secretion process
in EHEC can be divided into two general modes of activity, (i) production and secretion of the
filamentous translocon apparatus prior to contact and (ii) reduced secretion of translocon proteins
following contact and intimate adherence with increased secretion of effector proteins (Tree et
al., 2009) (Fig. 2). The T3SS itself is composed of a multi-ring basal apparatus spanning the
inner and outer membranes, composed of EscD, EscQ, EscR, EscS, EscT, EscU, and EscV
(Efromovich et al., 2008; Gauthier et al., 2003; Ogino et al., 2006; Partridge et al., 2009). The
protein EscF forms the needle complex, a structure which spans the inner and outer membranes,
onto which the EHEC translocon apparatus assembles. In this regard, the T3SS of EHEC and
EPEC is different from that of Yesinia pestis, where type III secretion is independent of a
filament structure and relies solely on the needle complex for secretion (composed of YscF)
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(Torruellas et al., 2005). The translocon apparatus is composed of three proteins to form a
filament and pore complex. The filament structure is composed of multimeric EspA subunits
extending outward from the needle complex, with a diameter of 120 Å and central channel
diameter of 25 Å (Keller et al., 2002). Each EspA filament is capped with a complex composed
of two proteins, EspB and EspD, which serves to form a pore roughly 3-5 nm in diameter within
the membrane of the host cell (Kresse et al., 1999; Mitra et al., 2012). Together, the T3SS
filament and pore complex, formed by EspA and EspB/D, function to create a hollow conduit
between the bacterial and host cell cytosol through which effector proteins are translocated.
Effector proteins that are encoded within the LEE, and those that are non-LEE-encoded,
serve diverse functions in the infection process. The effector protein Tir (translocated intimin
receptor) is preferentially secreted into the host cytoplasm, where it localizes to the host cell
cytoplasmic membrane (DeVinney et al., 1999). There, it serves as a receptor for the EHEC
outer membrane protein intimin. Binding of the host cell localized Tir with intimin facilitates
intimate attachment of the bacterium, and is followed by the production of a pedestal structure
formed by the condensation of actin below the bacterium (Garmendia et al., 2004; Kaper et al.,
2004; Knutton et al., 1989; Knutton et al., 1987). Some effectors, such as NleE, NleC, and
NleH, have been shown to modulate the host cell immune response (Hemrajani et al., 2008; Yen
et al., 2010). Others, such as Map and EspF, are able to disrupt tight-junctions and promote
apoptosis, respectively (Crane et al., 2001; Dean and Kenny, 2009). The switch between
secretion of translocators (i.e. structural proteins which constitute the filament and pore complex)
and effectors is complex, and the proper timing/regulation of their secretion is vital for
successful attachment. It has been shown that the LEE-encoded chaperone CesT serves to

6

Figure 2 - Model for type III secretion in hemorrhagic Escherichia coli (EHEC)
(Left)The type III secretion system (T3SS) of EHEC is composed of the needle complex (Esc proteins)
and the secreted translocon apparatus (Esp proteins). The EscF protein forms the minimal structure
through which proteins can be secreted in a type III dependent manner. However the translocon apparatus
proteins EspA, EspB, and EspD are required for pore complex formation and intimate adherence.
(Middle) Loss of the ATPase EscN results in loss of ATP hydrolysis required for protein translocation
through the T3SS. (Right) Secretion hierarchy of the T3SS is dictated by the SepD/SepL complex, and
mutation of either results in hypersecretion of non-translocon effector proteins into the extracellular
milieu.
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localize effectors to the TTSS by association with the SepL/SepD complex, and that Tir is
preferentially localized to the complex for secretion (Deng et al., 2005; Thomas et al., 2005; Yip
et al., 2005). Secretion of both LEE- and non-LEE-encoded effectors is thought to occur in a
rank order manner (Mills et al., 2008). Due to preferential binding of Tir-bound-CesT to the
SepD/L complex, other effectors are effectively blocked from being secreted (Thomas et al.,
2005). Prior to attachment to a host cell, the proteins composing the translocon filament (EspA,
EspB, and EspD) are preferentially secreted, along with Tir. Following attachment and
translocation of Tir, CesT is able to stabilize other effectors prior to proteolytic degradation and
direct them to be secreted (Leverton and Kaper, 2005; Mills et al., 2008; Winnen et al., 2008).

1.2.3 Regulation of type III secretion in EHEC
The control and expression of the TTSS is tightly controlled and coordinated by factors
which are both LEE- and non-LEE encoded (Fig. 3B). All of the genes required for formation of
the TTSS are encoded within the 5 major operons of the LEE, LEE1-LEE5 (Elliott et al., 1999).
The master LEE regulator Ler, encoded as the first gene of the LEE1 operon, positively
stimulates LEE gene transcription by relieving H-NS mediated repression while negatively
regulating its own transcription (Bingle et al., 2014; Elliott et al., 2000). It has been proposed
that the antagonistic effect on H-NS repression by Ler is due to the formation of toroidal-protein
DNA complexes, wherein Ler has a higher affinity for host DNA (Mellies et al., 2011).
However, the precise mechanism of binding specificity remains unclear. Ler is also able to
stimulate production of other LEE encoded regulators including GrlA and GrlR, which activate
and repress ler transcription, respectively (Berdichevsky et al., 2005; Deng et al., 2004; Elliott et
al., 2000; Haack et al., 2003; Islam et al., 2011; Sperandio et al., 2000). The genes grlA and grlR
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are encoded as a discistron from an H-NS/Ler regulated promoter (Barba et al., 2005), and GrlA
binds directly to the LEE1 promoter region (Huang and Syu, 2008). Activation of LEE1
transcription by GrlA, through the specific interaction with a region between the -10 and -35
sites of the LEE1 P1 promoter, is dependent on its helix-turn-helix (HTH) motif, and is not
required following deletion of H-NS, supporting its role in anti-silencing the ler promoter (Islam
et al., 2011; Jimenez et al., 2010). The regulator GrlA has two functional domains, including a
transcriptional domain and a domain involved in specific interaction with GrlR (Jimenez et al.,
2010), a protein that binds directly with GrlA to inhibit its anti-silencing activity at the LEE1
promoter (Iyoda et al., 2006). It was recently shown that the specific interaction of GrlR with
GrlA inhibits the activity of GrlA by out-competing target DNA for its helix-turn-helix motif
(Padavannil et al., 2013).
Further regulation of LEE gene transcription is mediated through numerous factors
encoded outside of the LEE including RpoS, RpoN, EivF, EtrA, PchC, GrvA, Hfq, RgdR, QseA,
and RcsB (Dong et al., 2009; Flockhart et al., 2012; Hansen and Kaper, 2009; Hengge, 2009;
Iyoda and Watanabe, 2004; Kendall et al., 2010; Laaberki et al., 2006; Navarro Llorens et al.,
2010; Riordan et al., 2010; Russell et al., 2007; Sharp and Sperandio, 2007; Tobe et al., 2005;
Zhang et al., 2004). Transcription of LEE genes in EHEC, and subsequent type III secretion, is
maximal during exponential growth, with LEE gene transcription collapsing during stationary
phase (Bergholz et al., 2007b; Mitra et al., 2012). Stationary phase regulation by sigma factor
RpoS is partially dependent on the protease ClpXP, which is also able to promote the stability of
the LEE gene repressor GrlR, and the accumulation of RpoS leads to activation of the LEE
repressing acid resistance regulators (Dong and Schellhorn, 2009; Iyoda and Watanabe, 2005).
The regulators EivF and EtrA are two LEE regulatory proteins encoded within a defunct type III
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Figure 3 - Model for LEE gene regulation in EHEC
Shown above is (A) the schematic organization of the 36-kb LEE pathogenicity island, and (B) a
regulatory model for LEE gene regulation through the known RcsB-GrvA pathway, including the master
motility regulatory flhDC. The LEE1 operon encodes Ler, a positive regulator of the remaining LEE2LEE5 operons. Ler is also able to stimulate transcription of the LEE encoded grlRA operon, producing
the LEE1 activator GrlA and the GrlA inhibiting protein GrlR. The Rcs phosphorelay response regulator
RcsB directly represses motility, a phenotype also observed for GrlA, and stimulates transcription of the
grvAB operon. Finally, in a direct or indirect manner, the GrvA transcriptional regulator positively affects
LEE gene transcription through the LEE1 promoter.
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secretion system, termed ETT2, found in both pathogenic and non-pathogenic strains of E. coli
(Zhang et al., 2004). The cross-talk between the LEE and EivF/EtrA has not yet been shown to
be direct, since only repression of LEE gene transcription was demonstrated following their
overproduction. These regulators are particularly notable in that they are the regulatory remnants
of a defunct T3SS exerting influence over an extant PAI (the LEE), a phenomena that has been
described as the “Cheshire cat effect” (Zhang et al., 2004). Another notable non-LEE encoded
regulator of the LEE is actually a class of regulators, termed PerC homologs (Pch), which is
derived from their homology to the EPEC specific LEE regulator, PerC (Iyoda and Watanabe,
2004). In some EPEC strains, the pEAF plasmid contains the perC gene which encodes a direct
transcriptional activator of the LEE1 operon (Mellies et al., 1999). However, as this plasmid is
not found in EHEC, a search for other prophage encoded LEE regulators revealed a number of
PerC homologs. These included PchA, PchB, PchC, PchD, and PchD; however, only PchA,
PchB, and PchC had measurable effects on LEE1 promoter activity in EHEC and EPEC strains
(Iyoda and Watanabe, 2004; Porter et al., 2005). The Per and Pch regulators likely function in
concert with other nucleoid associated proteins, such as IHF, to de-repress the LEE1 promoter
(Porter et al., 2005).
EHEC contains a number of horizontally acquired, multi-genic, elements termed Oislands that contribute roughly 1.3 Mb of genomic content that is not present in K-12 (Hayashi et
al., 2001). The genes contained within O-islands are diverse in function, and play a significant
role in EHEC virulence and pathogenesis. Adherence modulation, specifically through regulation
of the LEE, has been demonstrated through mutational analysis of O-islands in EDL933. For
example, the transcriptional regulator RgdR, located within O-island 51, was shown to activate
transcription of LEE1, and promote type III secretion in a Ler dependent manner (Flockhart et
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al., 2012). Moreover, two other transcriptional regulators were identified within O-islands 50 and
57, termed PsrA and PsrB, respectively (Tree et al., 2011). These regulators are of particular
interest as their LEE regulatory effects are directed through the gadE P3 promoter, increasing
production of the acid fitness regulator GadE, a direct repressor at the LEE1 promoter (Kailasan
Vanaja et al., 2009; Tree et al., 2011). Indeed, the acid fitness island (AFI) of E. coli contains
numerous regulators which coordinate transcription of gadE, along with RcsB, to properly time
its production. Loss of the Psr regulators was shown to significantly activate T3S during
stationary growth, and they are believed to be involved in fine-tuning the activation of glutamate
dependent acid resistance genes, and subsequently repress transcription of the LEE, to promote
survival during gastric passage prior to colonization (Tree et al., 2011). Likewise, an additional
prophage island encoded AraC type regulator, termed PatE, was shown to stimulate acid
resistance through transcriptional regulation of the acid stress chaperone hdeA, and repress LEE
gene transcription, which was hypothesized to occur through a pathway similar to that of PsrA/B
(Bender et al., 2012).
Various host derived factors have been shown to directly and indirectly influence
expression of EHEC virulence genes, and LEE gene transcription is enhanced during growth in
media and conditions which are similar to those found in the gastrointestinal tract (Kenny et al.,
1997a). Following gastric passage, LEE gene transcription is stimulated by the bicarbonate ion
(Abe et al., 2002) produced by the pancreas to neutralize the stomachs acid (Feldman, 1983;
Fordtran and Locklear, 1966). Further, the QseBC two-component system is directly involved in
sensing host derived epinephrine, norepinephrine and AI-3 (Alam et al., 2010; Russell et al.,
2007; Sharp and Sperandio, 2007; Sperandio et al., 2002). Phosphorylated QseB promotes
transcription of the QseEFG phosphorelay system that senses epinephrine, sulfate, and phosphate
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to activate transcription of LEE genes (Njoroge and Sperandio, 2012; Reading et al., 2010).
Importantly, the regulator QseE has been shown to indirectly regulate the LEE through direct
transcriptional repression of rcsB (Njoroge and Sperandio, 2012). The QseBC and QseEFG
mutli-component phosphorelay systems provide a great example of the complex nature of
bacterial interkingdom virulence gene regulation. Furthermore, EHEC has recently been shown
to respond to host derived ethanolamine (EA) through the metabolic sensing of EA and
production of the eut operon regulator EutR; direct transcriptional regulation of the LEE1 operon
by EutR occurs through direct binding at the ler promoter (Kendall et al., 2012; Luzader et al.,
2013). Beyond factors which are produced directly by the host, products of native microflora are
capable of modulating LEE gene transcription and type III secretion mediated adherence. For
example, fucose is released from host intestinal mucin in the gut by Bacteroides
thetaiotaomicron produced fucosidases (Xu et al., 2003), and its FusSK dependent metabolism
by EHEC leads to repression of the LEE (Pacheco et al., 2012). Likewise, the products of
fermentative metabolic processes (such as acetate, propionate, and butyrate) from native bacteria
can stimulate LEE gene transcription through activation of the leucine-responsive regulatory
protein (Lrp) and the LEE1 transcriptional activator PchA (Nakanishi et al., 2009; Tobe et al.,
2011).

1.2.4 The E. coli common pilus (ECP)
EHEC adherence to epithelial cells, and subsequent host colonization, is enhanced by a
common pilus structure seen almost ubiquitously across E. coli strains, termed the E. coli
common pilus (ECP) (Rendon et al., 2007). The E. coli common pilus is a chaperone-usher
fimbrial adhesin, composed of a 21-kDa subunit encoded by the gene ecpA, and its production
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plays a role in early-stage biofilm development for commensal and pathogenic E. coli and
Klebsiella pneumonia strains (Alcantar-Curiel et al., 2013; Garnett et al., 2012; Lehti et al., 2010;
Wurpel et al., 2013).

1.3 Variation in virulence among EHEC O157:H7 strains
Although there are hundreds of O:H serotypes of EHEC, the O157:H7 serotype is most
frequently associated with humans disease (Nataro and Kaper, 1998). Strains of O157:H7 belong
to a clonal complex which has been recently organized by phylogenetic analysis into eight
discrete clades (Manning et al., 2008). Belonging to clade 8, strain TW14359 has been associated
with high incidents of HUS (15%) and hospitalization (51%), as compared to strain Sakai HUS
(~1.5%) and hospitalization (~4%) (Clade 1, 1996 Sakai city outbreak) (Manning et al., 2008).
Clade 8 strains have demonstrated increased association with epithelial cells, along with
increased expression of LEE and other virulence factors, including Shiga toxin 2 (Stx2) (Abu-Ali
et al., 2010a; Manning et al., 2008; Neupane et al., 2011). A comparative analysis of O157:H7
strains Sakai and TW14359 revealed increased attachment to MAC-T epithelial cells
corresponding to increased levels of LEE gene expression in TW14359, whereas Sakai showed
higher expression levels for genes associated with motility (Abu-Ali et al., 2010b).

1.4 The RcsCDB phosphorelay system
Formation of extracellular capsular polysaccharide has been shown to have a role in
bacterial adherence, protection from desiccation, and resistance to both specific and non-specific
host immunity (Horwitz and Silverstein, 1980; Ophir and Gutnick, 1994; Roberts, 1996). The
capsules of E. coli are surface enveloping structures composed of high-molecular weight
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polysaccharides, and consist of 4 major groups, including colonic acid (Whitfield, 2006). While
typical capsules produced by E. coli form a surface layer associated with the bacteria, a large
quantity of colonic acid produced is ultimately secreted into the growth medium as
expolysaccharide (Whitfield and Paiment, 2003), resulting in a mucoidy phenotype. Indeed, up
to 30% of the total dry weight of some K-12 strains has been observed to be colonic acid and
slime (Ophir and Gutnick, 1994). However, there can be substantial variation in the types and
quantity of colonic acid produced among E. coli strains. The group 1 and 4 capsules are related
to O-antigen LPS, and are found among EPEC, ETEC, and EHEC strains (Whitfield, 2006).
The regulation of capsular polysaccharide (CPS) was initially shown to be dependent on
Lon, an ATP hydrolysis and temperature dependent protease (Chung and Goldberg, 1981), that is
active at 37°C but not at 30°C (Phillips et al., 1984; Trisler and Gottesman, 1984). Identification
of the three key regulatory elements (RcsB, RcsC, and RcsA) involved in colonic acid synthesis,
using a lon mutant K-12 strain, suggested that one of the three genes was regulated indirectly by
the Lon protease (Gottesman et al., 1985). RcsA was further shown to be a target of ATPdependent Lon proteolysis, with a half-life of 5 minutes in wild type E. coli and 20 minutes in a
lon defective E. coli. Temperature dependent CPS production is therefore dependent on the
availability of RcsA for transcriptional activation of cps genes (Torres-Cabassa and Gottesman,
1987).
The components of the Rcs phosphorelay system include a membrane bound sensor
histidine kinase, RcsC, that transfers a phosphate to the histidine phospho-transferase RcsD,
which transfers the phosphate to the response regulator RcsB (Fig. 4) (Clarke, 2010). The rcsBrcsC gene cluster was first identified as being required for CPS production. RcsC contains
homology with known membrane bound sensor kinases, and was shown to act as a sensor
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Figure 4 - The RcsCDB phosphorelay and regulation of type III secretion in EHEC
The Rcs phosphorelay system indirectly promotes transcription of the LEE PAI through the OI-47
encoded regulator GrvA. The Rcs relay is composed of 3 major components, including the sensory kinase
(RcsC), the histidine phosphotransferase (RcsD), and the response regulator (RcsB). Signal transduction
to RcsC occurs through different mechanisms, including activation by the outer-membrane lipoprotein
RcsF.
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activating the regulator RcsB (Brill et al., 1988; Stout and Gottesman, 1990). The sensor kinase
RcsC is able to communicate membrane perturbations to RcsB caused by osmotic shock,
membrane damaging agents, and growth on solid media; importantly, RcsC is required for
normal biofilm formation (Ferrieres and Clarke, 2003). The response regulator RcsB binds to
specific DNA sequences (RcsB box) at promoters to activate or repress transcription. In its
phosphorylated state, RcsB can bind as a homodimer (RcsB2) or as a heterodimer (RcsB/X) with
other regulatory proteins, such as RcsA (Majdalani and Gottesman, 2005). In its activated state,
RcsB/RcsA can repress transcription of flagellar genes (Francez-Charlot et al., 2003) and
simultaneously activate genes involved in capsule synthesis during growth at low temperatures
(Torres-Cabassa and Gottesman, 1987). While the regulatory capacity of RcsB is broadly
dictated through activation by RcsC, binding with other non-RcsA regulatory proteins has been
reported (Torres-Cabassa and Gottesman, 1987) (Fig. 5). For example, RcsB forms a
heterodimer with BglJ relieving HN-S mediated repression of the bgl operon, and is thus
involved in the uptake and utilization of beta-glucosides (Venkatesh et al., 2010). Finally, and
importantly, RcsB can form a heterodimer with the central regulator of glutamate dependent acid
resistance (GDAR), GadE, to facilitate transcription of acid fitness genes (Castanie-Cornet et al.,
2010). As such, RcsB is required for wild-type levels of acid resistance, a factor that directly
contributes to the low infectious dose of EHEC.
The RcsB response regulator is activated by the phosphorylation of an aspartic acid
residue within the RcsB receiver domain through interaction with the membrane bound histidine
phosphotransferase RcsD (Gupte et al., 1997), rather than by interaction with the cognate sensor
kinase RcsC (Huang et al., 2006). In a typical two-component regulatory system, sensor kinase
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Figure 5 - Homo- and hetero-dimerization of RcsB in E. coli
The known heterodimerization proteins of RcsB in E. coli are listed with a brief description of their
regulatory function. In E. coli, RcsB can form a homodimer with itself to regulate transcription at
promoters containing an RcsB consensus sequence. Alternatively, RcsB can heterodimerize with RcsA,
GadE, or BglJ to regulate transcription of motility, acid resistance, or the uptake and utilization of aryl
beta-glucosides, respectively.
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autophosphorylation is either enhanced or inhibited through the sensing of its specific signal, and
the phosphate is typically transferred from a histidine residue on the sensor kinase to an aspartic
acid residue within the cognate response regulator receiver domain (Stock et al., 1989). For
example, this model of regulation is observed for a number of E. coli TCS, including
CpxA/CpxR and EnvZ/OmpR (Danese and Silhavy, 1997; Egger et al., 1997), where the former
is an example of a TCS sensor kinase that actively dephosphorylates its cognate response
regulator in the absence of stimuli (Dorel et al., 2006). The multi-component RcsCDB
phosphorelay utilizes a different method of activation, wherein the RcsD membrane bound
histidine phospho-transferase acts as an adapter protein between RcsC and RcsB (Huang et al.,
2006). Activated RcsC autophosphorylates at the His479 residue within its histidine-containing
phosphotransmitter (Hpt) domain and transfers the phosphate to its phospho-acceping Asp875
residue within its receiver domain (Fig. 6). The phosphate is then transferred to the His842
residue on the RcsD Hpt domain (Takeda et al., 2001). Recent work has shown that the RcsDABL (α-β-Loop) domain interacts directly with RcsB effector domain, while the RcsD Hpt
domain interacts with the phosphor-accepting receiver domain, suggesting that RcsD and RcsB
function together in a very limited orientation (Schmoe et al., 2011). Interestingly, in Salmonella
enterica serovar Typhimurium, overexpression of truncated RcsC or RcsD cytoplasmic domains
results in phosphorylation of RcsB and subsequent activation of Rcs regulated genes, revealing a
potentially complex activation pathway hitherto unknown (Pescaretti Mde et al., 2013).
However, this finding has not yet been replicated in E. coli.
An additional, alternative, mechanism for Rcs activation exists in E. coli that couples
carbon metabolism and the accumulation of acetyl phosphate with phosphorylation of the
response regulator RcsB. In two specific signal transduction systems with sensor kinases that
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Figure 6 - Functional domains of the Rcs components in E. coli
The Rcs phosphorelay is composed of a sensory kinase (RcsC), a histidine phosphotransferase (RcsD),
and a response regulator (RcsB). The RcsC sensor kinase is bound to the inner membrane, and has both a
periplasmic input domain and a cytosolic histidine kinase and receiver domain for autophosphorylation
and phosphotransfer to RcsD. The histidine phosphotransferase RcsD is an adapter protein which
functions as an additional control for regulation phosphorylation of the response regulator RcsB. To
receive the phosphate from RcsC, the RcsB response regulator must bind at the RcsD-ABL domain.
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favor phosphatase activity, CpxA and RcsC, the cognate response regulator can be
phosphorylated by, and respond to levels of, acetyl phosphate (Aiso et al., 2011; Batchelor et al.,
2005). When excess carbon is present, particularly glucose, cells can accumulate acetyl
phosphate. Similar levels of acetyl phosphate accumulation are observed following the mutation
of ackA, the product of which is key in the Pta-AckA cycle for acetyl-coA and acetogenesis. In
this reversible pathway, Pta synthesizes acetyl phosphate and coenzyme A (CoA) from acetylCoA, and AckA generates ATP and acetate from acetyl phosphate (Wolfe, 2005). Therefore,
mutations or growth conditions which favor the accumulation of acetyl phosphate promote the
promiscuous phosphorylation of RcsB, and can directly affect motility and virulence gene
regulation in E. coli (Aiso et al., 2011; Wolfe, 2010). Beyond phosphorylation, the presence of a
lysine acetylation domain was recently reported for RcsB which serves to regulate its activity at
the rprA promoter, and is dependent on the lysine de-acetylase CobB (Hu et al., 2013; Stelzer et
al., 2006).
While the RcsCDB mutli-component signal transduction pathway contains a sensor
histidine kinase, activation and autophosphorylation requires the function of two membranetethered proteins, specifically DjiA and RcsF (Clarke et al., 1997; Majdalani et al., 2005) (Fig.
7). The overproduction of the membrane anchored DnaJ-like protein DjiA has been shown to
significantly increase capsular polysaccharide production, dependent on GrpE and DnaK (Kelley
and Georgopoulos, 1997). In the cytoplasmic membrane, the transmembrane domain of DjiA
facilitates the formation of a DjiA-homodimer. However, while the transmembrane domain is
required for DjiA-dependent activation of CPS production, dimerization alone is not sufficient to
activate the Rcs phosphorelay (Clarke et al., 1997; Toutain et al., 2003). The specific factors
which stimulate the dimerization of DjiA and subsequent activation of CPS production have not

21

yet been elucidated. Constitutively high production of DjiA is ultimately toxic to the cell. Not
surprisingly, the production of DjiA is tightly regulated and transcription is dependent on the
extracytoplasmic-function sigma factor, RpoE (Kelley and Georgopoulos, 1997). Similarly,
overproduction of RcsF has been shown to induce CPS production in an RcsC dependent manner
(Gervais and Drapeau, 1992; Majdalani et al., 2005).
RcsF is a ~14-kDa outer-membrane bound lipoprotein which orients towards the
periplasm and its activation has been demonstrated for mutations that affect the proper folding of
periplasmic proteins, as well as those which disrupt the proper synthesis and localization of
lipopolysaccharides and lipoproteins (Castanie-Cornet et al., 2006; Tao et al., 2012). The activity
of RcsF is dependent on the formation of nonconsecutive dislufides and requires an unstructured
proline rich region to properly convey signals to the sensor kinase RcsC for Rcs phosphorelay
activation (Leverrier et al., 2011; Umekawa et al., 2013). Among enteric gram-negative bacteria
that contain RcsF, the C-terminus contains high levels of amino acid sequence similarity, while
the membrane anchored N-terminal domain is less conserved (Rogov et al., 2011). While the
current model of RcsF-RcsC activation is believed to be through direct interaction of the
periplasmic domains of both proteins, experiments performed to validate this hypothesis have
been unable to confirm specific interaction (Rogov et al., 2011). Therefore, it remains a
possibility that some other factor mediates signal transduction between RcsF and RcsC. Similar
to RcsF, overproduction of the putative lipoprotein YpdI is also able to activate the Rcs
phosphorelay in an RcsF-independent and RcsA-dependent manner, however little is known
about its specific function or role in E. coli (Rendon et al., 2007). Both DjiA and RcsF therefore
fit within a model previously described for the outer membrane lipoprotein NlpE, which serves
as an activator of the CpxAR stress response two-component system (Hirano et al., 2007; Snyder
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et al., 1995). Interestingly, the lipoprotein-specific molecular chaperone LolA is required for
efficient localization and trafficking of membrane bound lipoproteins, and lolA mutant or
overexpression derivative E. coli strains result in Rcs activation directed through RcsF (Tao et
al., 2012), a finding that supports the role for RcsF activation by misfolded/mislocalized
periplasmic proteins.
The genes encoding RcsD, RcsB, and RcsC are organized into two distinct operons, with
rcsDB and rcsC oriented and transcribed divergently. The rcsB and rcsC ORFs were identified
prior to that of rcsD, and early work suggested that their independent transcription might reflect
a need to control the transcription of each gene alone (Stout and Gottesman, 1990).

For

example, transcription of rcsB was suggested to be under the control of LexA and the alternative
sigma factor RpoN, however direct experimental evidence for the latter has been contradictory
(Gervais et al., 1992). In one case, loss of rpoN resulted in decreased rcsB transcription, while
another group independently reported no significant impact on rcsB following mutation of rpoN
(Gervais et al., 1992; Stout and Gottesman, 1990). A putative sigma-54 (RpoN) binding site was
identified upstream of rcsB, within the rcsD ORF (Stout and Gottesman, 1990), but further work
is required to determine if RpoN plays a significant direct role in the regulation of rcsB. In E.
coli strain K-12, the rcsDB operon is transcribed from a sigma-70 promoter upstream of rcsDB,
and the rcsB gene is independently transcribed from at least two sigma-70 promoters
intracistronic to rcsD, rcsBP1 and rcsBP2 (Krin et al., 2010). Importantly, transcription from the
rcsD promoter, but not the rcsB promoters, is actively repressed through direct binding of H-NS
(Krin et al., 2010). This model of regulation suggests a control scheme wherein the histidine
phospho-transferase RcsD is a rate limiting step in the phosphorelay, preventing RcsB
phosphorylation through the canonical RcsC-RcsD-RcsB route. While the Rcs component genes
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Figure 7 - RcsF and DjiA activation of the Rcs phosphorelay
The current model for Rcs phosphorelay activation includes the components of the relay itself (RcsCDB),
but also includes inner- and outer-membrane lipoproteins DjiA and RcsF. Overproduction of DjiA or
RcsF has been shown to facilitate signal transduction, through an unknown mechanism, to the sensor
kinase RcsC. The functional domains of DjiA are not well described, however the functional domains
RcsF lipoprotein have been explored. RcsF contains a disordered proline rich region and a disulfide bond
that is required for
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are typically conserved in different gram-negative bacteria, their regulatory patterns can be
divergent. For example, an analysis of rcsB regulation in the enteric pathogen Salmonella
enterica serovar Typhimurium identified an additional stationary phase inducible rcsB promoter,
and revealed a model of RcsB negative auto-regulation at the rcsD promoter to modulate
swarming behavior (Pescaretti Mde et al., 2010; Pescaretti Mde et al., 2009); however, no such
model of Rcs auto-regulation has been reported for E. coli. More recently, epinephrine sensing
histidine sensor kinase QseE was shown to negatively regulate transcription of rcsB in EHEC,
and therefore negatively affect virulence gene transcription (Deng et al., 2010).
The Rcs phosphorelay plays an important role during conditions which cause damage to
the host membrane integrity, such as osmotic shock from high glucose or sodium chloride
concentrations, and can protect the cell from desiccation (Sledjeski and Gottesman, 1996).
Additionally, the loss of tolA, encoding a membrane spanning protein involved in cell envelope
integrity, has been shown to activate the Rcs system through stimulation of the sensor kinase
RcsC (Clavel et al., 1996). Mutation of tolA leads to highly mucoid colonies and decreased
adherence in E. coli strain MG1655, a phenotype that is completely dependent on the membrane
bound lipoprotein RcsF (Vianney et al., 2005). Further examination into activation of Rcs in
response to different stimuli reveals that it plays a dynamic role in gene activation relative to
growth phase and conditions. Specifically, the co-regulator of colonic acid synthesis RcsA binds
with RcsB following phosphorylation at low temperatures, owing to temperature dependent Lon
protease activity (Torres-Cabassa and Gottesman, 1987). Independent of RcsA, activation in the
presence of ZnCl2, Fe3+ and low Mg2+ leads to induction of ugd under specific conditions and is
dependent on the regulator PhoP (Hagiwara et al., 2003; Mouslim et al., 2003). Beyond cell
envelope stress, the Rcs response regulator RcsB is required for survival following exposure to
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low acidic conditions, such as those present during gastric passage (Castanie-Cornet et al., 2007).
This dependence is due to the heterodimerization of RcsB with the acid fitness island (AFI)
regulator GadE, which is required for transcription of several key AFI encoded genes (Johnson et
al., 2011; Krin et al., 2010). Interestingly, the de novo generation of cell shape following
lysozyme treatment was recently shown to require RcsB, revealing a specific role in the recovery
from insults to the outer membrane, suggesting that the Rcs phosphorelay might play a role in
survival following exposure to host immune responses leading to membrane perturbation (Ranjit
and Young, 2013). Likewise, following exposure to human serum, extraintestinal pathogenic E.
coli (ExPEC) activates the Rcs phosphorelay, along with other envelope stress regulators, as a
protective measure in response to cell wall damage (Mellies et al., 2012). Furthermore, the Rcs
components were required for survival during exposure to antibiotics that inhibit peptidoglycan
synthesis, including the β-lactamases cefsulodin and amdinocillin, independent of RcsA, and
more recently the exposure to antimicrobial peptides was observed to activate the Rcs
phosphorelay through the membrane bound lipoprotein RcsF (Laubacher and Ades, 2008;
Tucker et al., 2010).
While the Rcs phosphorelay has a distinct role in survival during specific stress
conditions, it has also been shown to regulate the expression of virulence factors in E. coli and
other enteric pathogens. Virulence and motility gene regulation has been shown to occur through
the RcsC-RcsD-RcsB His-Asp phosphorelay system in E. coli (Francez-Charlot et al., 2003; Krin
et al., 2010; Tobe et al., 2005). Importantly, overexpression of RcsB has been observed to
increase LEE gene activity and attachment to HeLa cells (Tobe et al., 2005). RcsB was shown to
positively regulate transcription of the LEE regulator ler by positively regulating grvA, an
activator of ler (Tobe et al., 2005). The role for RcsB in TW14359 virulence, and the mechanism
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by which RcsB contributes to the LEE overexpression and adhesion phenotype, is unknown. In
Salmonella enterica serovar Typhimurium, RcsB binds and represses transcription from the
flhDC promoter in an RcsA dependent manner, and subsequently impairs swarming motility and
swimming (Chaand and Dziejman, 2013). However, unlike EHEC, virulence is significantly
attenuated in Salmonella following Rcs activation. Specifically, a constitutively active RcsC
allelic variant significantly decreases the expression of genes involved in macrophage survival
and the invasion of non-phagocytic cells (Krogh et al., 2001). Conversely, virulence of
enteropathogenic Yersinia pseudotuberculosis requires an intact Rcs phosphorelay (Sayed and
Foster, 2009). In contrast to enteropathogenic Yersinia, the gene encoding RcsD has undergone
mutational attrition in Yersinia pestis; this fact is important in light of a study demonstrating that
RcsB negatively regulates biofilm formation in Yersinia pestis, indicating that rcsD was
evolutionarily deselected to decrease RcsB phosphorylation (Sun et al., 2012). Beyond virulence
in animal hosts, RcsB regulation of virulence in gram-negative pathogenic bacteria has also been
reported. For the rosaceous plant pathogen Erwinia amylovoran, RcsB is required for the
production of the exopolysaccharide amylovoran and directly contributes to bacterial survival
and the disease symptom formation (Bereswill and Geider, 1997; Kelm et al., 1997; Santander et
al., 2014). Ultimately, RcsB plays a broad role in the regulation of genes involved in survival and
virulence gene regulation for a diverse population of gram-negative bacterial pathogens.

1.5 The G. mellonella virulence model
Galleria mellonella, the greater wax worm, has been used as a virulence model in several
important human pathogenic gram-negative bacteria, such as Pseudomonas, Listeria, Yersinia,
Campylobacter, Klebsiella, and Legionella (Champion et al., 2009; Harding et al., 2012; Insua et
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al., 2013; Miyata et al., 2003; Mukherjee et al., 2010; Senior et al., 2011). Importantly, the G.
mellonella model has shown a positive correlation of virulence patterns in mice for major
virulence determinants in gram-negative human pathogens, such as Pseudomonas aeruginosa
and enteropathogenic Escherichia coli (EPEC) (Jander et al., 2000; Leuko and Raivio, 2012).
Infection of larvae with bacteria results in a robust host immune response characterized by the
formation of melanotic nodules, recruitment of hemocytes (Jiang et al., 2010), and the
production of both antimicrobial peptides and inhibitors of microbial proteinases (Vogel et al.,
2011). The G. mellonella model has not yet been used to explore the virulence properties of
EHEC or, more specifically, factors which are unique to the O157:H7 serotype. However, at
least in EPEC, loss of the T3SS resulted in attenuated virulence, suggesting that the G.
mellonella model could be used to explore the contribution of GrvA to the overall virulence of
EHEC, and specifically strain TW14359.

1.6 Project aim
Variation in virulence has been described between distantly related EHEC strains, specifically
with higher levels of LEE gene transcription and subsequent adherence in strains which have
been characterized with a high incidence of HUS. More specifically, the 2006 U.S spinach
outbreak strain TW14359 possess increased adherence and Stx2 production when compared with
the less virulent EHEC strain Sakai. Transcriptomic studies for TW14359 revealed markedly
higher levels of LEE gene transcription and decreased transcription of motility associated genes,
likely contributing to the increased adherence phenotype.

However, the specific genetic

mechanism underlying differential virulence had not yet been described. The recently published
genome of TW14359 identified numerous factors which were unique to TW14359, and further
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revealed polymorphisms which have not been observed in other EHEC strains to-date. It is
hypothesized that the hypervirulence of this strain, and closely allied clade 8 strains, is due to the
increased expression of virulence factors common to all O157:H7 strains, as well as novel strainspecific factors. Accordingly, the aim of this project is to identify the specific factor(s) which
direct increased adherence in TW14359 and to further explore polymorphisms unique to
TW14359 which contribute to altered virulence gene regulation. Overall, identifying factors
which contribute to differential virulence will provide insight into the evolution of virulence in
enterohemorrhagic E. coli.
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Chapter 2: RcsB determines the locus of enterocyte effacement (LEE) expression and
adherence phenotype of Escherichia coli O157:H7 spinach outbreak strain TW14359 and
coordinates bicarbonate-dependent LEE activation with repression of motility

Note to Reader. Portions of these results have been previously published (Morgan et al., 2013)
and are utilized with permission of the publisher (Appendix A)

2.1 Background
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent human pathogen
attributed to sporadic cases and large outbreaks of bloody diarrhea (hemorrhagic colitis) (Rangel
et al., 2005). In 2006, an outbreak in the United States of O157:H7 due to the consumption of
tainted spinach was associated with unusually high rates of hospitalization and life-threatening
sequelae (i.e. hemolytic uremic syndrome) (Manning et al., 2008). Phylogenetic analysis of over
five hundred clinical O157:H7 isolates, suggested that the strain which caused this outbreak,
TW14359, belongs to a discrete genetic group referred to as clade 8, the members of which are
highly virulent (Manning et al., 2008). Consistent with this hypothesis, DNA sequencing of this
strain has revealed the presence of virulence factors that are absent in the reference genomes of
sequenced O157:H7 strains Sakai (1996 Japan) and EDL933 (1982 USA) (Kulasekara et al.,
2009; Manning et al., 2008). In addition, a virulence expression phenotype has been described
for strain TW14359 characterized by increased basal transcription of locus of enterocyte
effacement (LEE) genes, as well as Shiga toxin 2 genes (stx2AB) and Stx2 protein relative to
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other O157:H7 strains (Abu-Ali et al., 2010a; Abu-Ali et al., 2010b; Neupane et al., 2011).
Elevated basal LEE expression in TW14359 has further been correlated to increased adherence
to bovine epithelial cells (Abu-Ali et al., 2010b).
The LEE is a 35.6-kb pathogenicity island that encodes a type III secretion apparatus
required for competitive colonization of the intestine and attaching/effacing (A/E) lesion
formation in EHEC and enteropathogenic E. coli (EPEC) (Elliott et al., 1998; McDaniel and
Kaper, 1997; Perna et al., 1998), and in the mouse pathogen Citrobacter rodentium (Schauer and
Falkow, 1993). Regulation of LEE expression has been intensively studied (Mellies et al., 2007;
Tree et al., 2009), but is still not fully understood. Four LEE-encoded proteins are currently
known to control its expression: Ler (LEE encoded regulator), Mcp (multiple point controller),
GrlR (global regulator of LEE repressor) and GrlA (global regulator of LEE activator). ler is the
first gene of the LEE1 operon, and is a master regulator of the LEE, activating transcription from
all five LEE operons (Elliott et al., 1998; Sperandio et al., 1999). Mcp, when overexpressed,
down-regulates LEE expression through interaction with Ler, and GrlA directly activates ler
transcription (and thus the LEE), whereas GrlR represses ler transcription through interactions
with GrlA (Creasey et al., 2003; Deng et al., 2004; Huang and Syu, 2008; Lio and Syu, 2004). In
addition, a myriad of non-LEE encoded regulators modulate LEE expression through ler in
response to environmental cues such as growth phase, bicarbonate, stress, and others (Abe et al.,
1997; Abe et al., 2002; Bergholz et al., 2007a; Friedberg et al., 1999; Grant et al., 2003; Kenny et
al., 1997a; Shin et al., 2001; Sperandio et al., 1999; Tobe et al., 2005; Umanski et al., 2002).
In this study, the role for RcsB, a response regulator of the Rcs phosphorelay system, in
the virulence expression phenotype of strain TW14359 was examined. In particular, the
importance of RcsB to enhanced LEE expression and adherence characteristic of this strain was
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investigated. In addition, the study sought to define the regulatory contribution of RcsB to
bicarbonate-dependent activation of the LEE and LEE-dependent repression of motility.

2.2 Methods…
2.2.1 Bacterial strains and culture conditions
The strains and plasmids used in this study are listed in Table 2. Strains were stocked at 80°C in glycerol diluted (15% v/v final) in Luria Broth (LB), and were maintained in LB or on
LB with 1.5 % agar (LBA). Unless otherwise noted, overnight (18-20 h) cultures grown in LB
were used to inoculate fresh LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or
fresh Dulbecco’s Modified Eagle’s Medium (DMEM) (4 g l-1 glucose, 4 mM glutamine, 44 mM
NaHCO3, pH 7) to a final optical density 600 nm (OD600) of 0.05. Cultures were grown at 37°C
in a rotary shaker (200 RPM) using a 1:10 media-to-flask volume. The growth of strains was
monitored by taking OD600 readings at 1 h intervals for 11 h. Antibiotics (Sigma-Aldrich, St.
Louis, MO) were added to cultures when required. For maximum expression from the PBAD
promoter of pBAD22 (Guzman et al., 1995), cultures were grown in DMEM containing Larabinose (0.5% w/v) and glycerol (0.4% v/v).

2.2.2 Genetic manipulations and chromosomal FLAG-fusion construction
Primers used for the genetic manipulation of TW14359 and Sakai are provided in Table
3. Gene deletion and kanamycin (Kan) replacement mutants were constructed using the λ Red
recombinase-assisted approach (Murphy and Campellone, 2003) and as described (Riordan et al.,
2010). To make a TW14359 grlA overexpression strain, an EcoRI/XbaI digested 413-bp PCR
fragment containing the promoterless grlA ORF was cloned into similarly digested pBAD22
32

(Guzman et al., 1995) to yield pRJM-15, which was then transformed by electroporation into
TW14359 as described (Riordan et al., 2010). For rcsB complementation, a BamHI/XhoI
digested 3,424-bp PCR fragment, containing the rcsB ORF and native promoters, was cloned
into similarly digested pACYC177 to yield pRJM20, which was then transformed into
TW14359ΔrcsB. To construct FLAG fusions to rcsB and tir, the approach of Uzzau et al. (Uzzau
et al., 2001) was used. Primers FLAG-F and P2 used to amplify the FLAG epitope and Kan
resistance cassette from pSU312 (Uzzau et al., 2001) were constructed with 40-bp
oligonucleotide 5’ extensions with homology to a 3’ region of the target ORF and a downstream
intergenic region, respectively. Homologous recombination of this product using λ Red
recombinase replaces the native stop codon with the FLAG sequence in-frame with the target
ORF. When expressed, the fusion protein contains a seven amino acid C-terminal epitope
(FLAG) that can be detected by western blots using anti-FLAG mAbs (Uzzau et al., 2001). All
genetic constructs were validated using a combination of PCR and restriction mapping, qRTPCR, and DNA sequencing (Eurofins MWG Operon, Huntsville, AL). DNA was purified using
the QIAquick PCR Purification kit (Qiagen).

2.2.3 Protein extraction, SDS-PAGE and western blots
Protein extraction, purification and western blots were performed as described previously
(Mitra et al., 2012). To extract and purify secreted proteins, mid-exponential phase (OD600=0.5)
cultures were centrifuged at 5,000 x g for 5 minutes and supernatants were passed through sterile
0.22 μm Millex-GV syringe filters (Millipore, Billerica, MA). Filtrates were precipitated
overnight (18-20 h) in 15% (v/v) trichloroacetic acid at 4°C and then centrifuged at 15,000 x g
for 30 minutes at 4°C. Protein pellets were washed twice with 100% ice cold acetone before re-
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suspension in 1M triethyl ammonium bicarbonate (TEAB). The amount of protein loaded on
SDS-PAGE gels for western blots was measured by a Bradford protein assay standard curve, and
equal loading was validated by western blots for GroEL using anti-GroEL mAbs (Bio-Rad,
Hercules, CA). Monoclonal antibodies against FLAG (Sigma-Aldrich) were also used. Each
experiment was repeated a minimum of three times in independent trials. Densitometry was used
to estimate differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging
System and Image Lab 3.0 (BioRad).

2.2.4 Proteomic analysis
Isobaric tag for relative and absolute quantitation (iTRAQ)-based mass spectrometry of
strains TW14359 and Sakai followed a previously described protocol (Rivera et al., 2012).
DMEM cultures (n=4 for cytosolic; n=3 for secreted) of TW14359 and Sakai were grown to
OD600=0.5 (2.5 to 3 h) before sampling for protein extraction (see above Methods). Peptide
labeling with isobaric tags 114 and 116 (strain Sakai) and 115 and 117 (strain TW14359) for
iTRAQ was performed using the iTRAQ™ Reagents 4-plex reaction kit (Applied Biosystems)
following the manufacturer’s instructions. Spectra data files (.RAW) were searched using
Mascot

Daemon

ver.

2.3

against

a

Uniprot

TW14359

protein

database

(http://www.uniprot.org/taxonomy/544404) downloaded on April 18th, 2011, containing 10,510
total sequences (forward and reverse) using the Mascot search algorithm (Matrix Science). Data
analysis for proteomics experiments followed a previously described procedure (Rivera et al.,
2012). Raw data files (.dat and .RAW) have been deposited in ProteomeXchange through the
Proteomics Identification Database (PRIDE) (Vizcaino et al., 2009) (accession #PXD000023).
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2.2.5 RNA purification and quantitative real-time PCR (qRT-PCR)
Primers for qRT-PCR are provided in Table S1. RNA purification, cDNA synthesis,
qRT-PCR cycling conditions and data analysis followed previously described protocols (Riordan
et al., 2010). For ler mRNA stability, cultures were growth to mid-exponential phase
(OD600=0.4) before addition of a sub-inhibitory concentration of the transcription inhibitor
rifampin (300 µg/ml final). Sampling for RNA extraction was performed immediately before
addition of rifampin (Rif), and at 4 min intervals thereafter for 12 min. qRT-PCR was performed
using a Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsA
(16S rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary
transcript expression levels using 2-ΔCt /10-6 as described (Livak and Schmittgen, 2001; Riordan
et al., 2010). Expression levels were compared using the appropriate t-test or by Tukey’s HSD
following a significant F-test (n≥3, α=0.05) (R. ver. 2.13.0).

2.2.6 Construction of lacZ transcriptional promoter fusions and β-galactosidase assays
The construction of lacZ reporter transcriptional fusions to the promoters of ler, rcsB,
rcsD, and flhD, followed a previously described protocol using vector pRS551 (Simons et al.,
1987). For lerP905-lacZ, a 904-bp BamHI/EcoRI-digested PCR fragment generated using primers
ler-905/EcoRI and ler-1/BamHI was cloned into similarly digested pRS551 using T4 DNA ligase
(Fisher Scientific) to produce pRJM-2. Similarly, rcsB, rcsD, and flhD promoter fragments were
cloned into pRS551 following BamHI/EcoRI digestion using primers rcsB-1/BamHI and rcsB1000/EcoRI (rcsBP1000-lacZ), rcsD-501/EcoRI and rcsD-1/BamHI (rcsDP501-lacZ), and flhD1/BamHI and flhD-1000/EcoRI (flhDP1000-lacZ).

ler-, rcsB-, rcsD-, and flhD- lacZ

transcriptional fusion plasmids were transformed into WT and derivative backgrounds of strains
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TW14359 and Sakai. All lacZ fusion constructs were confirmed by PCR and sequencing
(Eurofins MWG Operon). β-galactosidase activity (Miller Units) was measured as previously
described and compared between strains using a Student’s t-test or by Tukey’s HSD following a
significant F-test (n≥3, α=0.05) (R) (Miller, 1972; Mitra et al., 2012).

2.2.7 Adherence assays
Adherence to epithelial cells was determined following the method of Abe et al. (Abe et
al., 2002). Briefly, human HT-29 (ATCC HTB-38, Manassas, VA) colonic epithelial cells were
grown to confluence on polylysine-treated glass coverslips placed within the wells of 24 well
culture plates at 37°C with 5% CO2. Overnight DMEM cultures were diluted 1:40 (v/v) in fresh
DMEM and 0.05 ml of this dilution was used to inoculate each well which already contained
0.45 ml of sterile DMEM. Culture plates were then gently centrifuged (1000 x g) for 5 min and
incubated as above. After 3 h, plate wells were washed five times with PBS (137 mM NaCl, 2.7
mM KCl, 10 mM Na2HPO4, pH 7) to remove non-adherent bacteria from the coverslips, and
fresh DMEM was then added before incubating for an additional 3 h. Plate wells were
subsequently washed three times in PBS, and then fixed with ice cold (−20°C) 100% methanol
for 10 min before staining with Giemsa diluted in PBS 1:20 (v/v) for 20 min. Giemsa stain was
aspirated from the wells, and each stained coverslip was then examined at 1000X magnification
by oil immersion bright field microscopy using a binocular microscope (Fisher Scientific).
Microcolonies, defined as a pattern of localized adherence (McKee and O'Brien, 1995; Nataro
and Kaper, 1998), were scored as discrete clusters of five or more bacterial cells as previously
defined (Abe et al., 2002; Iyoda and Watanabe, 2004). For each sample, a minimum of ten
viewing frames were observed and the average number of microcolonies was reported per 80
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HT-29 cells. Microcolony counts were compared between strains by Tukey’s HSD following a
significant F-test (n≥3, α=0.05) (R).

2.2.8 Motility assays
Overnight LB cultures were diluted in fresh LB to OD600=0.5 and 2 μl samples were inoculated
onto LB plates containing 0.25% (w/v) agar following a previous method (Krin et al., 2010).
Plates were incubated upright for 5 hours at 37°C before the diameter of lateral growth on the
agar surface was examined for each strain. Experiments were repeated in multiple trials using at
least three biological replicates per trial.

2.3 Results......
2.3.1 The LEE expression phenotype of strain TW14359
Quantitative real-time PCR of LEE transcript levels revealed the upregulation of LEE
regulatory (ler, 3.8-fold), structural (espA, 2.3-fold), effector (tir, 2.7-fold) and effector
chaperone (cesT, 2.3-fold) genes in TW14359 when compared to strains Sakai and EDL933
during exponential growth (OD600=0.5) (p<0.05) (Fig. 8A), consistent with studies of LEE
expression in TW14359 grown in DMEM when co-cultured with bovine mammary epithelial
(MAC-T) cells (Abu-Ali et al., 2010b). Although expression of the LEE activator gene grlA was
elevated 1.6-fold in TW14359, levels did not differ significantly when compared to Sakai and
EDL933. Transcript levels for all LEE genes did not differ between Sakai and EDL933. The
expression of LEE genes decreased markedly in stationary phase (OD600=3.0) for all strains and
did not differ between them (Fig. 8A). This pattern of expression in DMEM is consistent with
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previous observations of LEE gene expression during exponential and stationary growth phases
in MOPS minimal media (Bergholz et al., 2007b).
Expression from the ler promoter, as measured by β-galactosidase activity from lerP903lacZ, increased in both the TW14359 and Sakai backgrounds during exponential growth, and
decreased as cultures transitioned into stationary phase (Fig. 8B), in agreement with qRT-PCR
data (Fig. 8A). In TW14359 however, ler expression was consistently and significantly higher
than in Sakai (p<0.05) during mid-exponential growth (between 2 and 3 h growth, corresponding
to OD600=0.3 to 0.6), indicating that increased transcription was occurring at the ler promoter.
Examination of DNA sequence for the ler ORF in TW14359 (ECSP_4703) and in Sakai
(ECs4588), as well as ler core promoters P1 and P2 and 1,200-bp upstream of the translation
initiation site revealed 100% nucleotide identity between these strains (NCBI). Adding to this,
the stability of ler mRNA during exponential growth following treatment of cultures with
rifampin did not differ between strains; the ler mRNA half-life being estimated at 2.0-min for
TW14359 and 2.1-min for Sakai (Fig. 9), which is congruent with a previous estimate (Laaberki
et al., 2006). It was therefore hypothesized that the LEE expression phenotype in TW14359 is
directed through increased transcription from the ler promoter by the influence of some transacting factor(s) during exponential growth.

2.3.2 Role for RcsB in the LEE expression and adherence phenotype of strain TW14359
Quantitative analysis of the relative differences in protein levels using iTRAQ-based
proteomics revealed a total of 116 proteins increased or decreased in abundance by at least 1.5fold in TW14359 relative to strain Sakai during exponential growth (OD600=0.5). In support of
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Figure 8 - The LEE expression phenotype of strain TW14359
(1A): Transcript levels for LEE genes are plotted for exponential (OD600=0.5) and stationary (OD600=3.0)
phase DMEM cultures of strains TW14359 (filled), Sakai (empty) and EDL933 (grey). (1B): βgalactosidase activity in Miller Units for TW14359 (squares) and Sakai (triangles) containing a lerP903lacZ fusion plotted against time during growth in DMEM. TW14359 containing an empty vector
(pRS551) control is denoted by the hatched line. Asterisks denote significant differences in transcript
levels of TW14359 compared to other strains by Tukey’s HSD following a significant F-test for 1A or
Student’s t-test for 1B (p<0.05 [*], p<0.01 [**], n≥3). Error bars denote standard deviation.
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Figure 9 - qRT-PCR for ler mRNA stability in TW14359 and Sakai.
Stability of ler mRNA in EHEC strains TW14359 (dotted line) and Sakai (solid line) was determined for
exponential phase (OD600= 0.5) DMEM cultures at 0, 2, and 4 minutes following the addition of rifampin.
Data represents the average of three independent experiments.
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previous microarray studies, a number of LEE-encoded proteins were increased in both cytosolic
and secreted protein fractions of TW14359 compared to Sakai, including the T3SS needle
protein EscF (1.94-fold), the EspA chaperone, CesA (1.72-fold), the type II secretion system
protein EtpG (2.06-fold), Ler (1.74-fold), the T3SS translocon apparatus proteins EspA (2.45fold) and EspB (2.41-fold), the translocated intimin receptor Tir (1.56-fold), and other LEEencoded proteins (Table 1). Also increased in TW14359 was the IIA subunit of Stx2 by 2.11fold and RcsB (6.86-fold), the response regulator for a multi-component regulator of capsule
synthesis (Rcs) phosphorelay system (Table 1). Importantly, when overexpressed, RcsB has
been shown to activate ler transcription and increases adherence to Caco-2 cells (Tobe et al.,
2005). It was thus of interest to determine whether the LEE expression and adherence phenotype
of TW14359 was attributable to elevated levels of RcsB.
Western blots revealed that the basal level of RcsB in TW14359 was elevated ~2.7-fold
when compared to Sakai, congruent with iTRAQ (Fig. 10A). In addition, expression of rcsB
transcript was significantly higher in TW14359 compared to Sakai (p=0.001) (Fig. 10B),
however, rcsD, which is transcribed as a dicistron with rcsB (i.e. rcsDB) from an upstream rcsDP
promoter (Krin et al., 2010; Pescaretti Mde et al., 2009), was not altered in expression between
strains (Fig. 10B). This suggests that basal levels of rcsB are intrinsically upregulated in
TW14359 in a manner which is dependent on a promoter(s) that is intracistronic to rcsD.
Consistent with a role for RcsB in the LEE expression phenotype of TW14359, ler transcript
levels were higher in TW14359 than Sakai (p=0.017), but did not differ between
TW14359ΔrcsB and SakaiΔrcsB (Fig. 11A). Complementation of TW14359ΔrcsB and
SakaiΔrcsB with rcsB did not restore differential ler expression as observed for WT strains (Fig.
11A), supporting the hypothesis that the elevated basal expression of rcsB in TW14359 relative
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Table 1 - Select list of proteins identified by iTRAQ proteomics
Fold
Protein Namea
Gene/ORFa
changeb
Intracellular
DNA-binding response regulator for Rcs phosphorelay
rcsB
6.86
Protein-export protein secB
secB
2.93
Envelope stress induced periplasmic protein
spy
2.72
Conserved metal-binding protein
yodA
2.39
Predicted DNA-binding transcriptional regulator
yheO
2.14
Type II secretion protein
etpG
2.06
Predicted DNA-binding transcriptional regulator
yhaJ
2.00
Mannonate dehydratase
uxuA
1.99
Nucleoside (Except guanosine) transporter
nupC
1.98
Conserved protein
ycaO
1.98
LEE-encoded type III secretion system component
escF
1.94
Predicted chaperone
yegD
1.86
Aminoacyl-histidine dipeptidase (Peptidase D)
pepD
1.84
AMP nucleosidase
amn
1.81
Putative uncharacterized protein; homolog of pO157p81
ECSP_6104
1.78
Isoprenoid biosynthesis protein
elbB
1.76
Locus of enterocyte effacement (LEE)-encoded regulator
ler
1.74
Bifunctional nitric oxide dioxygenase
hmp
1.73
LEE-encoded chaperone
cesA
1.72
Putative cytoplasmic membrane export protein
ECSP_0558
1.71
Selenide, water dikinase
selD
1.67
Protein assembly complex, lipoprotein component
yfgL
1.65
Malic enzyme predicted oxidoreductase
maeB
1.65
Colicin resistance and tellurite resistance protein
terE
1.64
Ferrichrome outer membrane transporter
fhuA
1.64
3-methyl-2-oxobutanoate hydroxymethyltransferase
panB
1.63
a
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF).
b

SDc
0.11
1.99
1.73
1.23
1.61
1.37
1.43
0.94
1.26
1.58
0.98
0.54
1.04
0.90
0.67
0.54
0.70
0.10
0.69
0.31
0.98
0.83
0.61
0.76
0.15
0.42

Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to
Sakai.
c

Standard deviation (SD) of the mean fold change.
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Table 1 - Select list of proteins identified by iTRAQ proteomics, continued.
Fold
Protein Namea
Gene/ORFa
changeb
10 kDa chaperonin
groS
4.57
Stress protein, member of the CspA-family
cspC
4.53
Osmotically inducible, stress-inducible membrane protein
osmC
4.42
Conserved protein
yifE
4.35
Phosphohistidinoprotein-hexose phosphotransferase
ptsH
4.34
30S ribosomal subunit protein S1
rpsA
4.08
Conserved metal-binding protein
yodA
4.05
Component of a tripartite ferrous iron transporter
efeO
3.93
Glycine cleavage system H protein
gcvH
3.80
50S ribosomal protein L24
rplX
3.71
Periplasmic chaperone
hlpA
3.70
Scaffold protein
iscU
3.64
Phosphate transporter subunit
pstS
3.61
30S ribosomal protein S14
rpsN
3.55
Glutaredoxin 3
grxC
3.51
50S ribosomal protein L9
rplI
3.38
tetrahydrodipicolinate succinylase subunit
dapD
3.29
Peptidyl-prolyl cis-trans isomerase (PPIase)
surA
3.26
High-affinity zinc uptake system periplasmic protein
znuA
3.18
Thioredoxin 1
trxA
3.12
Ecotin
eco
2.70
LEE-encoded type III secreted effector
espF
2.66
Ribosome-recycling factor
frr
2.62
Heme oxygenase
chuS
2.59
Periplasmic protein
osmY
2.58
DnaK suppressor protein
dksA
2.52
Secreted protein EspA
espA
2.45
Secreted protein EspB
espB
2.41
Catalase-peroxidase 2
katP
2.38
Conserved protein
yebT
2.31
a
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF).
b

SDc
2.92
3.24
3.83
2.52
3.07
1.96
1.31
1.05
2.02
1.73
0.85
1.79
3.59
2.53
2.27
1.73
0.72
0.74
0.88
1.59
0.74
0.65
0.51
0.43
0.70
0.75
1.98
2.04
2.39
2.74

Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to
Sakai.
c

Standard deviation (SD) of the mean fold change.
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Table 1 - Select list of proteins identified by iTRAQ proteomics, continued.
Protein Namea

Gene/ORFa

Fold
changeb

Glucose-specific enzyme IIA component of PTS
crr
2.26
Protein grpE
grpE
2.18
Serine endoprotease (Protease Do), membrane-associated
degP
2.13
Shiga toxin II subunit A
stx2A
2.11
Protein TolB
tolB
2.09
Porphobilinogen deaminase
hemC
2.03
Alkyl hydroperoxide reductase, C22 subunit
ahpC
2.00
DNA-binding transcriptional repressor
cspE
1.91
Thiol:disulfide interchange protein DsbA
dsbA
1.82
Chaperone Hsp70, co-chaperone with DnaJ
dnaK
1.80
Putative uncharacterized protein
ECSP_3241
1.79
Carbon storage regulator
csrA
1.79
50S ribosomal protein L23
rplW
1.70
Predicted uncharacterized protein
ECSP_0343
1.66
Adenylate kinase
adk
1.65
Glutamine synthetase
glnA
1.56
Translocated intimin receptor protein
tir
1.56
60 kDa chaperonin
groL
1.55
Thiosulfate:cyanide sulfurtransferase (Rhodanese)
pspE
1.54
Sorbitol-6-phosphate dehydrogenase
srlD
-1.50
Putative exoprotein-precursor
espP
-1.50
F9 fimbriae chaperone
fmlB
-1.53
Molybdate transporter subunit
modA
-1.66
Hydrogenase 2, large subunit
hybC
-1.72
Cystine transporter subunit
fliY
-1.78
Predicted protein; homolog of VT2-Sap55 in Sakai
ECSP_3238
-2.04
D-ribose transporter subunit
rbsB
-3.21
L-rhamnose isomerase
rhaA
-3.44
Oligopeptide transporter subunit
oppA
-3.49
Putative uncharacterized prophage protein
ECSP_2949
-4.21
Predicted protein
ECSP_5384
-6.07
a
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF).
b

SDc
1.16
0.90
0.14
1.51
0.13
0.38
1.10
1.30
0.56
0.31
0.48
1.39
1.13
1.03
0.43
0.26
1.20
1.49
0.36
0.02
0.68
0.17
0.69
0.25
0.75
0.14
0.06
0.01
0.21
0.21
0.22

Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to
Sakai.
c

Standard deviation (SD) of the mean fold change.
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Figure 10 - rcsB expression in Sakai and TW14359.
(2A): Representative western blot for FLAG-tagged RcsB in strains Sakai and TW14359 grown in
DMEM (OD600=0.5). Equal loading was controlled for by westerns for GroEL. (2B, top): Transcript
levels of rcsB and rcsD plotted for Sakai (filled) and TW14359 (empty) grown in DMEM. The asterisk
denotes significant differences between strains by Student’s t-test (p=0.001, n≥3). Error bars denote
standard deviation. (2B, bottom): Graphic depicts the rcsDB and rcsC open reading frames with their
respective promoters, the location of qRT-PCR priming sites, and the location of amplified promoter lacZ
fusion fragments for rcsD and rcsD in pRS551.
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to Sakai is responsible for the LEE expression phenotype. The fact that ler transcript levels were
higher in rcsB complement strains relative to WT (Fig. 11A), likely reflects expression from
pACYC177. Although this plasmid is low-copy, rcsB transcript levels were still 20-fold higher
in complement strains compared to WT (data not shown). In strain Sakai, the activation of ler by
rcsB overexpression in-trans requires an intact global regulator of virulence (grvA) gene, the
product of which activates transcription from the LEE1 promoter (Tobe et al., 2005). As such,
this study sought to determine if in TW14359, which intrinsically overexpresses rcsB, ler
activation also required grvA, or if activation was through a different pathway. Deletion of grvA
reduced ler expression to the same extent as observed for TW14359ΔrcsB when compared to
TW14359 (Fig. 11B) (p<0.05). Moreover, deletion of grvA in TW14359ΔrcsB did not further
significantly alter ler expression when compared to TW14359ΔrcsB or TW14359ΔgrvA. The
expression of ler was however slightly, but significantly higher in the TW14359ΔrcsBΔgrvA
backgrounds when compared to Sakai (p<0.05). Therefore, increased basal expression of rcsB in
TW14359 and interaction with grvA is required for the LEE expression phenotype of this strain.
This study further ascertained the contribution of intrinsic rcsB overexpression to the TW14359
adherence phenotype using the human colonic cell line HT-29. As observed for bovine MAC-T
cells (Abu-Ali et al., 2010a), adherence to HT-29 cells, as measured by microcolony formation,
was significantly higher for TW14359 than Sakai (p=0.006) (Fig. 11C). Consistent with ler
expression data, adherence did not differ between Sakai and SakaiΔrcsB, but was reduced in
TW1359ΔrcsB to a level comparable to Sakai and SakaiΔrcsB. As anticipated, the adherence of
T3SS-deficient TW14359ΔescN and SakaiΔescN strains to HT-29 cells was significantly
reduced when compared to WT and rcsB isogenic backgrounds (p<0.05), but not between escN
isogenic strains (Fig. 11C), indicating that the adherence phenotype of TW14359 is dependent
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Figure 11 - rcsB, grvA and the LEE expression and adherence phenotype of TW14359.
(3A): ler transcript levels plotted for WT, ΔrcsB , and complement ΔrcsB prcsB versions of Sakai (solid)
and TW14359 (empty) grown in DMEM (OD600=0.5). (3B): ler transcript levels plotted for WT strains
and mutant derivative strains of TW14359 during growth in DMEM. (3C): Adherence to HT-29 cells as
measured by microcolony formation plotted for WT, ΔrcsB and ΔescN versions of Sakai (solid) and
TW14359 (empty). For 3A, the asterisk denotes a significant difference between Sakai and TW14359 by
Student’s t-test (p=0.017, n≥3). For 3B and 3C, plots which differ by lower case letter, differ significantly
by Tukey’s HSD following a significant F-test (p<0.05, n≥3). Error bars denote standard deviation for all
panels.
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on intrinsic rcsB upregulation, as well as a functional T3SS.

2.3.3 Control of rcsB by the LEE-encoded regulator GrlA, and GrlA-RcsB dependent
repression of motility......
In TW14359, genes associated with motility, including structural and regulatory genes
for flagellar biosynthesis (flg and fli genes), and chemotaxis (cheB, tsr and tar) are reduced in
expression compared to Sakai (Abe et al., 2002; Abu-Ali et al., 2010a). In the present study, this
has been observed to correspond with a 30-40% reduction in the lateral growth of TW14359 on
motility plates relative to Sakai (Fig. 12A). Importantly, both RcsB and LEE-encoded activator
GrlA are known to negatively regulate motility (Francez-Charlot et al., 2003; Iyoda et al., 2006),
and both are increased in expression in TW14359. It was therefore of interest to investigate the
potential genetic interaction of rcsB and grlA, and their contribution to the regulation of motility
in TW14359.
As expected, deletion of rcsB in TW14359 enhanced the lateral growth of TW14359 on
motility plates by 30-40% (Fig. 13A), suggesting that the motility deficiency of TW14359 when
compared to Sakai is connected to intrinsic rcsB overexpression. Also, the inactivation of grlR
(strain TW14359grlR::kan) leading to grlA overexpression (Fig. 12) (Iyoda et al., 2006),
substantially impaired lateral growth on motility plates (Fig. 13A). Most importantly, deletion of
rcsB in the TW14359grlR::kan background restored lateral growth on motility plates to the level
observed for TW14359ΔrcsB, revealing that the control of motility by grlA is epistatic to rcsB.
Negative regulation of motility by RcsB has been shown to result from direct transcriptional
repression of the global regulator of motility genes flhDC (Francez-Charlot et al., 2003).
Consistent with this, expression from the flhDP promoter, as measured by β-galactosidase
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Figure 12 - qRT-PCR for ler and grlA mRNA in TW14359 and TW14359grlR::kan.
TW14359 and TW14359grlR::kan grown to mid-logarithmic phase (OD600=0.5) in LB. The asterisks
denotes significance by a Student’s t-test (p<0.05, n≥3). Error bars indicate standard deviation for both
plots.
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Figure 13 - GrlA-RcsB dependent repression of motility.
(4A): Motility as measured by lateral growth on representative motility plates for Sakai and TW14359
(top), and mutant derivatives of TW14359 (bottom); EHEC O157:H− strain 493/89 is included as a nonmotile control. (4B): β-galactosidase activity in Miller Units for TW14359 and mutant derivatives
containing an fhlDP1000-lacZ fusion during growth in DMEM. (4C): Representative western blot for
FLAG-tagged RcsB in LB plotted for TW14359 (WT) with and without 44 mM HCO3−, and for grlA
overexpression strains of TW14359 (grlA+++ and grlR::kan). Equal loading was controlled for by westerns
for GroEL. (4D): β-galactosidase activity in Miller Units plotted for TW14359 (filled) and
TW14359grlR::kan (empty) grown in LB and containing rcsDP501-lacZ, rcsBP1000-lacZ, or lerP903-lacZ
fusions. For 4B, plots which differ by lower case letter, differ significantly by Tukey’s HSD following a
significant F-test (p<0.05, n≥3). For 4D, the asterisk denotes significance by a Student’s t-test (p=0.010,
n≥3). Error bars indicate standard deviation for all panels.
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activity from flhDP1000-lacZ, was significantly increased in TW14359ΔrcsB, but decreased in
TW14359grlR::kan when compared to WT (p<0.05) (Fig. 13B). flhDP promoter expression did
not differ however between TW14359grlR::kanΔrcsB and TW14359ΔrcsB indicating that RcsBdependent repression of flhDC and motility is positively regulated by GrlA. In further support of
this, levels of RcsB were increased (~2.4-fold) in TW14359grlR::kan and in a grlA
overexpression strain compared to WT (Fig. 13C). Interestingly however, expression from rcsDP
or rcsBP promoters was not observed to be altered in TW14359grlR::kan (Fig. 13D), indicating
that control of RcsB by GrlA is at the post-transcriptional level; increased expression from the
lerP promoter was included as a positive control for grlA overexpression. Collectively, these
experiments reveal a reciprocating regulatory mechanism in which RcsB and LEE-encoded GrlA
coordinate LEE activation with repression of flhDC and motility.

2.3.4 Role for Rcs phosphorelay and grvA in bicarbonate-dependent activation of the LEE
In the preceding experiments the addition of bicarbonate to TW14359 cultures growing in
LB, and added as a positive control for LEE stimulation (Abe et al., 2002), was also observed to
increase RcsB levels ~5.4-fold (Fig. 13C). The bicarbonate ion (HCO3−) has been shown to
activate LEE expression and adherence in a dose-dependent manner in EHEC (Abe et al., 2002).
This has been reported to be through increased transcription from the grlRA promoter in C.
rodentium (Tauschek et al., 2010), however the mechanism by which bicarbonate stimulates
LEE expression in EHEC is unknown. In this study, the increase in RcsB levels with bicarbonate
was higher than that observed for grlA overexpression strains (Fig. 13C), suggesting that this
added bicarbonate stimulation of RcsB was, at least in part, independent of grlA. It was therefore
predicted that the Rcs phosphorelay system was in some way involved in bicarbonate-directed
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Figure 14 - Effect of bicarbonate on RcsB, and rcsB-dependent LEE activation.
(5A): Representative western blot for FLAG-tagged RcsB as a function of increasing bicarbonate
(HCO3−) molarity (mM) (top), and for FLAG-tagged Tir in TW14359 and TW14359ΔrcsB grown in LB
or LB with 44 mM HCO3− (OD600=0.5) (bottom). Equal loading was controlled for by westerns for
GroEL.
(4B): ler transcript levels plotted for TW14359, TW14359ΔrcsB, and complement
TW14359ΔrcsBprcsB strains grown in LB (−) or LB with 44 mM HCO3− (+) (OD600=0.5). (4C): βgalactosidase activity in Miller Units plotted for TW14359 and TW14359 containing rcsDP501-lacZ or
rcsBP1000-lacZ fusions grown in LB (−) or LB with 44 mM HCO3− (+). (4D): β-galactosidase activity in
Miller Units plotted for TW14359 (WT) and mutant derivative strains containing lerP903-lacZ and grown
in LB (−) or LB with 44 mM HCO3− (+). For 5B and 5C, the asterisks denote a significant difference
between treatments by Student’s t-test (p<0.05 [*], p<0.01 [**], n≥3). For 5D, plots which differ by
lower case letter differ significantly by Tukey’s HSD following a significant F-test (p<0.05, n≥3). Error
bars denote standard deviation for all panels.
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activation of LEE expression. In agreement with the dose-dependence of bicarbonate for LEE
stimulation, the addition of bicarbonate up to 44 mM (a physiologically relevant molarity)
(Feldman, 1983) to LB was observed to incrementally increase RcsB levels (Fig. 14A). rcsB was
shown to be required for full activation of LEE expression in response to bicarbonate, as the
levels of Tir protein were increased substantially in TW14359 grown with bicarbonate, but only
marginally increased in the TW14359ΔrcsB background (Fig. 14A). In addition, growth with
bicarbonate increased ler transcript levels 5-fold in the WT (p=0.001) compared to only 1.24fold in TW14359ΔrcsB (Fig. 14B). Bicarbonate stimulation of ler was restored in complement
strain TW14359ΔrcsB prcsB.
Expression from both rcsDP and rcsBP promoters was significantly increased in the
presence of bicarbonate (p<0.05) (Fig. 14C), revealing that bicarbonate is stimulating
transcription of rcsDB from the rcsDP promoter, as well as rcsB alone from at least one of two
mapped promoters intracistronic to rcsD. Expression from the lerP promoter was expectedly
increased with bicarbonate addition for TW14359 (p<0.05), but not for TW14359ΔrcsB (Fig.
14D). In addition, deletion of the Rcs phosphorelay sensor kinase rcsC significantly reduced
bicarbonate stimulation of lerP promoter activity compared to WT (p<0.05). And consistent with
an RcsB-GrvA dependent pathway of LEE activation, lerP promoter expression with bicarbonate
addition was reduced in TW14359ΔgrvA and TW14359ΔrcsBΔgrvA when compared to WT
(p<0.05), but not compared to TW14359ΔrcsB or TW14359ΔrcsC (Fig. 14D). Collectively, this
reveals that bicarbonate-dependent stimulation of LEE expression in EHEC is at least partly
dependent on components of the Rcs phosphorelay system, and on the RcsB-GrvA pathway of
LEE activation.

53

2.4 Discussion
It is predicted that rcsB, encoding the response regulator of the Rcs system, is
intrinsically upregulated in TW14359, and that this is responsible for the enhanced LEE
expression and adherence phenotype of this strain. It is not yet clear why rcsB is upregulated in
TW14359. rcsB is co-transcribed as the second gene of a dicistron with rcsD (Krin et al., 2010)
and yet rcsD transcript levels by qRT-PCR (Fig. 10) and protein levels by iTRAQ proteomics
did not differ in TW14359 when compared to Sakai. This is consistent with the observation that
rcsB overexpression can upregulate the LEE independent of rcsD (Tobe et al., 2005).
Alternatively, rcsB can be expressed as a monocistron from at least two promoters which are
intracistronic to rcsD (i.e. rcsBP1 and rcsBP2) (Krin et al., 2010), but upstream of the priming
sites used for qRT-PCR in this study. Since there are no differences in the sequence of these
promoters between TW14359 and Sakai, it is predicted that intrinsic upregulation of rcsB is
therefore dependent on some trans-factor(s) acting on the rcsBP1 and/or rcsBP2 promoters.
Unfortunately, how these promoters are expressed and regulated is unknown, and needs to be
further examined. A genetic polymorphism unique to strain TW14359 was initially hypothesized
in this study to be important for the rcsB expression phenotype of this strain. Kulasekara et al.
(Kulasekara et al., 2009) had described a 90-bp insertion in the ORF of tolA, the product of
which is an inner membrane component of the Tol-Pal envelope complex involved in
maintaining cell envelope integrity (Bernadac et al., 1998; Cascales et al., 2000). Importantly,
mutations in tolA have been reported to substantially upregulate rcsB (Clavel et al., 1996).
Indeed, rcsB expression in strains TW14359tolA::kan and SakaitolA::kan was increased
compared to their WT counterparts. However, the level of rcsB transcript was still
proportionately increased in TW14359tolA::kan relative to SakaitolA::kan (p=0.016), suggesting
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that the tolA polymorphism is not responsible for increased basal expression of rcsB in
TW14359.
The results also indicated that deletion of rcsB had no effect on ler expression or HT-29
adherence in strain Sakai. This latter finding is inconsistent with a study demonstrating that both
the overexpression and deletion of rcsB in Sakai can lead to increased LEE expression and
adherence through independent regulatory pathways: RcsB was predicated to upregulate the LEE
through activation of grvA, and downregulate LEE expression through repression of pchA, a
positive regulator of the LEE (Tobe et al., 2005). The reason for this disparity in results is not yet
known. However, the direction and magnitude at which RcsB regulates LEE expression is likely
to be sensitive to differences in growth phase, nutrient availability, as well as signals which
activate Rcs phosphorelay. In this study, the influence of RcsB on ler expression was only
examined in mid-exponential cultures (OD600=0.5), and may differ substantially with even a
subtle change in the phase of growth or experimental condition. For example, in Tobe et al (Tobe
et al., 2005) Caco-2 cells were used for adherence studies, whereas this study utilized HT-29
cells.
The RcsB-dependent LEE expression phenotype of strain TW14359 was further shown to
require an intact global regulator of virulence grvA gene. The mechanism by which RcsB
controls grvA, and how RcsB-GrvA regulate ler is unknown. Tobe et al. (Tobe et al., 2005)
observed increased expression of grvA in response to rcsB overexpression and described RcsB
boxes in the predicted grvA promoter region with some homology to the RcsB consensus
(Wehland and Bernhard, 2000), suggesting direct regulation of grvA transcription. Alternatively,
RcsB may interact with GrvA to directly activate the expression of ler and other genes. There is
precedent for this, as RcsB has been shown to regulate transcription as a heterodimer with RcsA
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(Francez-Charlot et al., 2003; Stout et al., 1991), GadE (Castanie-Cornet et al., 2010), and BglJ
(Venkatesh et al., 2010). If RcsB-GrvA activate ler transcription as a heterodimer, they likely
bind upstream of the core promoter region (i.e. upstream of -35) as is typical for RcsB promoter
activation (Boulanger et al., 2005; Castanie-Cornet et al., 2010; Sturny et al., 2003; Venkatesh et
al., 2010). However, there is no RcsB binding site upstream of and including the ler P1 and P2
promoters.
The results of this study suggest that RcsB is involved in the inverse regulation of genes
that control motility (i.e. flhDC) and those for intimate colonization (i.e. the LEE) in EHEC.
This opposing relationship between colonization and motility may be important for the
establishment of E. coli in the gut. For example, constitutive expression of FlhDC regulon in
EHEC markedly reduced adherence to HeLa cells (Iyoda et al., 2006), whereas the deletion of
flhDC and lack of motility in K12 increased colonization in a murine model (Gauger et al., 2007;
Leatham et al., 2005). It is important to note however that FlhDC also controls the expression of
genes which serve no direct role in motility but which could contribute in some way to
colonization. In EHEC, the LEE encoded activator GrlA indirectly downregulates transcription
of flhDC leading to reduced motility (Iyoda et al., 2006). This study has revealed that mutation
of rcsB masks the negative regulatory effect of GrlA on motility and flhDC transcription, and
that the overexpression of grlA increases RcsB levels. This suggests that RcsB and GrvA are
members of a reciprocating regulatory mechanism in EHEC which, at a minimum, coordinates
the upregulation of LEE genes with a downregulation of the flhDC flagellar regulon. Activation
of RcsB by GrlA appears to be at the post-transcriptional level, as increased protein levels did
not correspond with increased transcription from promoters driving expression of rcsDB or rcsB.
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In EHEC, bicarbonate has been shown to stimulate LEE transcription through ler, and to
increase adherence to Caco-2 cells in a pH-independent manner (Abe et al., 2002). It has been
hypothesized that bicarbonate produced naturally in the small bowel to neutralize gastric acid
may serve as a biological cue for T3SS-dependent colonization (Abe et al., 1997; Abe et al.,
2002). In C. rodentium bicarbonate interacts with the AraC-type regulator RegA to directly
upregulate grlA expression (Tauschek et al., 2010). In EHEC and EPEC however, there are no
homologs of RegA, and the genetic determinant(s) which regulate bicarbonate-dependent
induction of the LEE in these pathogens is unknown. This study has shown that Rcs
phosphorelay components RcsB and RcsC and the global regulator of virulence GrvA are
required for full stimulation of the LEE in response to bicarbonate in EHEC. Despite the
interplay of GrlA and RcsB in the control of flhDC and motility, there is no evidence that grlA is
important for bicarbonate dependent LEE expression through this pathway. For instance,
overexpression of grlA did not increase rcsB transcription, whereas bicarbonate addition did
enhance rcsB transcription (Figs. 13D and 14C). Furthermore, the level of RcsB induction was
markedly higher in WT cells grown with bicarbonate than in strains which overexpress grlA
alone (Fig. 13C). Therefore in EHEC it is predicted that bicarbonate stimulates LEE expression
through an RcsB-GrvA-Ler activation pathway.
To conclude, the LEE expression phenotype of TW14359 is hypothesized to result from
intrinsically increased basal levels of the response regulator RcsB, activating LEE expression
through a GrvA-Ler pathway. In addition, increased adherence of strain TW14359 to intestinal
cells was shown to be dependent on elevated rcsB expression and a functional T3SS. Whether or
not this dysregulated pathway is responsible for the severe disease attributed to infections with
this strain is not yet clear. Furthermore, the LEE-encoded activator GrlA was determined to
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require rcsB for repression of the flhDC flagellar regulon, suggesting that GrlA and RcsB work
together to coordinate the activation of genes for colonization with the repression of genes for
motility. Finally, bicarbonate was proposed to be a physiological signal for an Rcs phosphorelayand GrvA-directed pathway activating LEE expression and colonization in EHEC.
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Table 2 - Strains and plasmids used in Chapter 2

Strain/plasmid Relevant characteristics

Reference

Nucleotidea
Position

Strain name:
DH5α

Vector propagation, recA1 endA1

Sakai

WT 1996 outbreak, Osaka Japan

Michino, 1999
Manning, 2008

EDL933

WT 2006 outbreak, western U.S.A.
WT 1982 outbreak, MI and OR,
U.S.A.

EcRJM-1

TW14359∆escN

This study

4665071-4666029

EcRJM-2

Sakai∆escN

This study

4605926-4606884

EcRJM-3

TW14359∆sepD

This study

4670066-4670518

EcRJM-5

TW08264∆rcsB

This study

3049164-3049814

EcRJM-6

TW14359∆rcsB

This study

3045397-3046047

EcRJM-7

TW14359∆rcsC

This study

3046247-3049096

EcRJM-8

TW08264rcsB-FLAG::kan

This study

3049812-3049864

TW14359

Riley, 1983

EcRJM-9

TW14359rcsB-FLAG::kan

This study

3046045-3046097

EcRJM-10

TW14359rcsB-FLAG

This study

3046045-3046097

EcRJM-11

TW14359∆grvA

This study

1282113-1282867

EcRJM-12

TW14359∆rcsB ∆grvA

This study

EcRJM-13

TW14359tir-FLAG

This study

4659012-4659077

EcRJM-14

TW08264tir-FLAG

This study

4599867-4599932

EcRJM-15

TW14359∆rcsB tir-FLAG

This study

EcRJM-16

TW08264∆rcsB tir-FLAG

This study

EcRJM-22

Sakai pRJM-2

This study

EcRJM-23

TW14359 pRJM-2

This study

EcRJM-29

TW14359 pRJM-7

This study

EcRJM-34

TW14359 pRJM-8

This study

EcRJM-35

TW14359∆grlR::kan

This study

EcRJM-36

TW14359∆grlR::kan pRJM-2

This study

EcRJM-37

TW14359∆grlR::kan pRJM-8

This study

EcRJM-38

TW14359∆grlR::kan pRJM-7

This study

EcRJM-39

TW14359∆rcsB pRJM-2

This study

EcRJM-40

TW14359∆rcsC pRJM-2

This study

4673380-4673731

EcRJM-55
TW14359 pRJM-15
This study
Nucleotide positions based on the published Sakai (NC_002695) and TW14359 (NC_013008)
genome sequences (NCBI)
a
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Table 2

Strains and plasmids used in Chapter 2,
continued.

Strain/plasmid Relevant characteristics

Nucleotidea
Position

Reference

Strain name:
EcRJM-59

TW14359∆rcsB ∆grlR::kan

This study

EcRJM-60

This study

EcRJM-61

TW14359∆grlR::kan pRJM-17
TW14359∆rcsB ∆grlR::kan pRJM17

EcRJM-62

TW14359∆rcsB pRJM-17

This study

EcRJM-63

TW14359∆rcsC pRJM-17

This study

EcRJM-64

TW14359∆grvA pRJM-17

This study

EcRJM-65

TW14359∆rcsB ∆grvA pRJM-17

This study

EcRJM-66

TW14359∆escN ∆sepD

This study

EcRJM-67

TW14359∆escN ∆sepD pRJM-10

This study

EcRJM-68

Sakai∆tolA::kan

This study

860848-862032

EcRJM-69

TW14359∆tolA::kan

This study

865712-866986

EcRJM-70

Sakai∆tolA::kan pRJM-19

This study

EcRJM-71

TW14359∆tolA::kan pRJM-18

This study

Low copy cloning vector, AmpR
KanR
Ara inducible expression vector,
AmpR

Chang, 1978

This study

Plasmid name:
pACYC177
pBAD22

R

R

Guzman, 1995
+

pRS551

lac fusion vector, Amp Kan lacZ

pCP20

Flp recombinase expression vector

Datsenko, 2000

pKD4

Template plasmid for Kan cassette

Datsenko, 2000

pKM208

Red-recombinase expression vector

Datsenko, 2000
Invitrogen

pSU312

Ara inducible expression vector
FLAG epitope template, Amp R,
KanR

pRJM-2

pRS551 containing lerP905-lacZ

This study

4680206-4679303

pRJM-7

pRS551 containing rcsBP1000-lacZ

This study

3044397-3045396

pRJM-8

pRS551 containing rcsDP501-lacZ

This study

3042208-3042707

pRJM-15

pBAD22 containing grlA

This study

4672912-4673325

pRJM-17

pRS551 containing flhDP1000-lacZ

This study

2485401-2486400

pRJM-18

pACYC177-tolA (Sakai)

This study

860790-862067

pBAD-TOPO®

Simons, 1987

Uzzau, 2001

pRJM-19
pACYC177-tolA (TW14359)
This study
865654-867021
a
Nucleotide positions based on the published Sakai (NC_002695) and TW14359 (NC_013008)
genome sequences
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Table 3 - Primers used in Chapter 2

Primer name

Sequence (5'→ 3')

Function/Ref.

FLAG-F

gactacaaagatgacgacga

Uzzau, 2001

P1

gtgtaggctggagctgcttc

Datsenko, 2000

P2

catatgaatatcctccttag

Datsenko, 2000

RcsB+609/Fla
g-F

TTATCTCTCTTCAGTAACGTTAAGTCCGGCAGATAAAGACgactacaaag
atgacgacga

FLAG fusion

RcsB+741/P2

CGTAGGACGGATAAGGCGTTTACGCCGCATCCGGCAATCGcatatgaat
atcctccttag

RcsB+585

CGAGAACGATATCGCCCTGC

RcsB+831

CCGCATCTGGCATTCAGTGC

FLAG fusion
FLAG fusion
validation
FLAG fusion
validation

Tir-1635/FlagF

TTCGAATAACCCACCAGCGCCGGGATCCCATCGTTTCGTCgactacaaag
atgacgacga

FLAG fusion

Tir-1741/P2

AGCTCAAGAGTTGCCCATCCTGCAGCAATGTTATTCCCTGcatatgaatat
cctccttag

Tir+1613

GGAGTAATAGCGCTGTGAAT

Tir+1968

AATTTCCCACAGACACCATA

FLAG fusion
FLAG fusion
validation
FLAG fusion
validation

EspD+1083/Fl
ag-F

TTCAGCACGGGTAAATAGTCGTATTGTTAGTGGCCGAATTgactacaaa
gatgacgacga

FLAG fusion

EspD+1136/P2

CGTTACTTGAGTATTATCAATAGTATTCATAATAAAATTCcatatgaatat
cctccttag

EspD+1042

CAGGCGAGCTATTTACAAAG

EspD+1198

CTCTCCGAAGCGGAATTAAC

FLAG fusion
FLAG fusion
validation
FLAG fusion
validation

EscN+0/P1

ATGATTTCAGAGCATGATTCTGTATTGGAAAAATACCCAC
gtgtaggctggagctgcttc

Deletion
primer

EscN+1338/P2

GGCAACCACTTTGAATAGGCTTTCAATCGTTTTTTCGTAAcatatgaatat
cctccttag

EscN-45

GGAGGTTGGGAATAATATCG

EscN+1405

CCATTGATTCTCTCAATCGG

Deletion
primer
Deletion
validation
Deletion
validation

RcsB-41/P1

AGTTATGTCAAGAGCTTGCTGTAGCAAGGTAGCCTATTACgtgtaggctg
gagctgcttc

Deletion
primer

RcsB+691/P2

CAGATAAGACACTAACGCGTCTTATCTGGCCTACAGATGAcatatgaata
tcctccttag

RcsB-95

CTGATTCGTGAGAAGGATGT

Deletion
primer
Deletion
validation

a

Restriction sites indicated by bolded and underlined nucleotides
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Table 3
Primer
name

Primers used in Chapter 2, cont.

RcsB+880

GAGAGGGTCAGGAAATCGCG

Function/Ref.
Deletion
validation

GrlR-41/P1

AAATTGAAAGGAGTGAGGTTAGTATGAAACTGAGTGAGTTgtgtaggct
ggagctgcttc

Deletion primer

GrlR+412/P
2

TTATTTGATAAATAAATCGACATAAAAAACATACATAAAAcatatgaata
tcctccttag

Deletion primer

GrlR-78

GGTCTCCATTATTCTTGATATTGCTTATGG

Deletion
validation

GrlR+472

CTGAGTCAGGAATTACATAGTCGCCATTTT

Deletion
validation

RcsC-41 /P1

ACCACACTCCATCGGTCACCTGAGGCGGAGCTTCGCCCCTgtgtaggctg
gagctgcttc

Deletion primer

RcsC+2890/
P2

ACCACACTCCATCGGTCACCTGAGGCGGAGCTTCGCCCCTcatatgaatat
cctccttag

RcsC-207

GGATATAACCATTAACAAGC

RcsC+2974

CTTATCCGTCCTACGATTCC

Deletion primer
Deletion
validation
Deletion
validation

TolA+1/P1

GTGTCAAAGGCAACCGAACAAAACGACAAGCTCAAGCGGGgtgtaggc
tggagctgcttc

Deletion primer

TolA+1185/
P2

TTACGGTTTGAAGTCCAATGGCGCGTTTTTGAACACTTCAcatatgaatatc
ctccttag

TolA-93

GGTTGGTTTAATGACGCAGC

TolA+1346

CCAAATGCTACTCGTAATGC

Deletion primer
Deletion
validation
Deletion
validation

GrvA-41/P1

AATACTGGATTTGTAATACACAACTAAGGTATAAAATGTAgtgtaggctg
gagctgcttc

Deletion primer

GrvA+795/P
2
GrvA-115/FVal
GrvA+959/R
-Val

Sequence (5'→ 3')

GAGAGAGTTGCAATTATTTGGTGATTCAGAGTTTAACATCcatatgaatat
cctccttag

CGGTGAAATTAATAACATGG

Deletion primer
Deletion
validation
Deletion
validation

Ler905/EcoRI

CGGAATTCTCTTTATAGAGGGGCGCATT

lacZ promoter
fusion

Ler1/BamHI

CGGGATCCAATAAATAATCTCCGCATGC

pRS551 lacZ
fusion

a

CAGATAATTCAGATTTGCAT

Restriction sites indicated by bolded and underlined nucleotides
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Table 3

Primers used in Chapter 2, cont.

Primer name

Sequence (5'→ 3')

RcsB1,000/EcoRI

CGCGGAATTCCGCGGCGATCGCGATGCATTACGACGTATT

pRS551 lacZ
fusion

RcsB1/BamHI

CGCGGGATCCGTAATAGGCTACCTTGCTACAGCAAGCTCT

pRS551 lacZ
fusion

RcsD501/EcoRI

CGCGGAATTCATAATAATTCAAGGTTAAAATCAATAACTT

pRS551 lacZ
fusion

RcsD1/BamHI

CGCGGGATCCTCGTGTTTATGACCTGTTAAAACTTCGCGA

pRS551 lacZ
fusion

GrlA+1/EcoR
I

CGGAATTCATGGAATCTAAAAATAAAAATGGCGACTAT

pBAD22
cloning

GrlA+414/Xb
aI

GCTCTAGATTATTTTAAATAAACTTGTG

pBAD22
cloning

ECSP_3286+
1

GAGGAATAATAAATGACCACTATAACCGATAA

pBAD-TOPO
cloning

ECSP_3286+
504

TCAGTGGTGGTGGTGGTGGTGCAGTAGAGATGCATGGTGTAAC

pBAD-TOPO
cloning

ECSP_0242+
1

GAGGAATAATAAATGGAGGAAGCCAATGGGGGGGAG

pBAD-TOPO
cloning

ECSP_0242+
747

TCAGTGGTGGTGGTGGTGGTGTTCAGAAACATGAGAAATATAAC
C

pBAD-TOPO
cloning

ECSP_1773+
1

GAGGAATAATAAATGAAAATAATATCCACTGTTATTCAAACAC

pBAD-TOPO
cloning

ECSP_1773+
588

TCAGTGGTGGTGGTGGTGGTGTAAATATTTTCTGTTTAATAATGA
ATAAAAATC

pBAD-TOPO
cloning

a

Function/Ref.

Restriction sites indicated by bolded and underlined nucleotides

63

Chapter 3: Function and regulation of the RcsB-GrvA pathway controlling virulence and
fitness factors in enterohemorrhagic Escherichia coli
3.1 Background
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent intestinal pathogen,
attributed to food-borne outbreaks of bloody diarrhea (hemorrhagic colitis) and the lifethreatening kidney disease hemolytic uremic syndrome (HUS) (Nataro and Kaper, 1998; Rangel
et al., 2005). Intimate attachment of this pathogen to the intestine requires a functional type III
secretion system (T3SS) and is characterized by the formation of attaching and effacing (A/E)
lesions (Kaper et al., 2004). This T3SS is encoded on a 36-kb pathogenicity island referred to as
the locus of enterocyte effacement (LEE) containing 41 genes organized into five operons
(LEE1-LEE5) (McDaniel et al., 1995). The master LEE regulator Ler, encoded as the first gene
of the LEE1 operon, positively stimulates LEE gene transcription by relieving H-NS mediated
repression while negatively regulating its own transcription. Ler is also able to stimulate
production of other LEE encoded regulators including GrlA and GrlR, which activate and repress
ler transcription, respectively (Berdichevsky et al., 2005; Deng et al., 2004; Elliott et al., 2000;
Haack et al., 2003; Islam et al., 2011; Sperandio et al., 2000). The genes grlA and grlR are
encoded as a discistron from an H-NS/Ler regulated promoter (Barba et al., 2005), and GrlA
binds directly to the LEE1 promoter region (Huang and Syu, 2008); Further regulation of LEE
gene transcription is mediated by numerous non-LEE encoded factors that converge on the ler
and grlA promoters to direct the proper spatio-temporal production of the T3SS (Flockhart et al.,
2012; Hansen and Kaper, 2009; Iyoda and Watanabe, 2004; Kendall et al., 2010; Leverton and
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Kaper, 2005; Luzader et al., 2013; Nakanishi et al., 2006; Russell et al., 2007; Sharp and
Sperandio, 2007; Zhang et al., 2004).
One such regulator, RcsB, has been shown to both activate and repress LEE transcription,
and more recently to be required for upregulation of the LEE in response to the bicarbonate ion
(Morgan et al., 2013; Tobe et al., 2005). RcsB is the response regulator of the Rcs phosphorelay
system, a multi-component signaling pathway including RcsC (sensor kinase), RcsD (histidine
phosphotransferase) and RcsB, which is activated by cell envelope stresses (Brill et al., 1988;
Gottesman and Stout, 1991; Huang et al., 2006; Stout and Gottesman, 1990). Upon
phosphorylation, RcsB can bind to target promoters as either a homodimer or as a heterodimer in
conjunction with other regulatory proteins, such as BglJ, GadE, or RcsA (Gottesman et al., 1985;
Johnson et al., 2011; Venkatesh et al., 2010). Binding occurs at specific RcsB consensus sites
(Francez-Charlot et al., 2003; Wehland and Bernhard, 2000), and the location of binding relative
to the -35 consensus sequence can dictate whether RcsB positively or negatively affects
transcription (Majdalani and Gottesman, 2005). RcsB mediated regulation of the LEE requires
LEE transcriptional regulators PchA and GrvA. In one study, overexpression of RcsB was
observed to repress LEE transcription through down-regulation of LEE activator, PchA, while
positive stimulation of the LEE by RcsB overexpression occurs through transcriptional activation
of grvA (Tobe et al., 2005). In agreement with this mechanism, a strain that intrinsically
overexpressed RcsB is characterized by grvA-dependent increased LEE expression (Morgan et
al., 2013).
EHEC contains a number of horizontally acquired, multi-genic, elements termed Oislands that contribute roughly 1.3 Mb of genomic content that is not present in K-12 (Hayashi et
al., 2001). The genes contained within O-islands (OI) are diverse in function, and play a
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significant role in EHEC fitness and virulence. The OI-47 locus, containing grvAB, is inserted
between the ycdU and ycdT K-12 backbone genes, and is only present within the O157:H7 and
O55:H7 pathogenic E. coli serotypes. GrvA is a predicted ToxR family membrane-bound
transcriptional regulator. Analysis of the amino acid sequence, using the TMHMM v2.0 analysis
program (http://www.cbs.dtu.dk/services/TMHMM/) (Krogh et al., 2001), suggests that GrvA
contains a single transmembrane domain, similar to ToxR of Vibrio cholera encoded on the
toxRS operon. The downstream gene, grvB, encodes a product with a single transmembrane
domain, and may serve to allow GrvA to dimerize and form an active transcriptional complex, as
is the case with ToxR and ToxS (DiRita and Mekalanos, 1991). While grvAB is found in EPEC
O55:H7 and EHEC O157:H7 serotypes, another ToxR homolog, YqeI, is encoded within the
defunct ETT2 type III secretion system found in pathogenic and some non-pathogenic E. coli
strains (Ren et al., 2004). The gene downstream of yqeI also encodes a protein with a single
transmembrane domain, similar to that of ToxS (Vibrio), GrvB (EHEC), and FidL (Salmonella).
The ToxR family of regulators identified in E. coli contain significant amino acid sequence
diversity compared between each other and homologues found in Salmonella. YqeI from EHEC
and MarT from Salmonella share 41.5% amino acid homology, whereas GrvA and MarT share
only 28.3% homology. Interestingly, GrvA and YqeI share only 29.5% amino acid sequence
homology, suggesting divergent functions even within the strain.
While GrvA homologues were not identified through BLASTp search, several
homologues for YqeI were identified among Escherichia, Yersinia, Serratia, and
Pseudoalteromonas strains. The ToxR homolog identified in Pseudoalteromonas tunicata,
WmpR, has been shown to regulate genes associated with biofilm, virulence, and survival in low
iron media (Stelzer et al., 2006). Additionally, VttRA and VttRB are ToxRS homologues of non-
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O1/non-O139 serogroup strains of V. cholera that regulate bile-dependent TTSS activation,
stress responses, and motility (Alam et al., 2010; Chaand and Dziejman, 2013). The ToxR
family of regulators is diverse in function and, to-date, have been largely associated with
virulence and fitness gene regulation.
The specific factors that function at the grvA promoter are not presently known and,
although a putative RcsB consensus sequence upstream of grvA was identified, direct
transcriptional control at the grvA promoter by RcsB has not been shown. Importantly,
overproduction of RcsB cannot activate transcription from the ler promoter in K-12 without coexpression of grvA (Tobe et al., 2005). While the RcsB-GrvA-Ler regulatory pathway has been
previously shown, the contribution of GrvA to the virulence of O157 strains and the specific
mechanism through which GrvA regulates LEE gene transcription have not yet been described.
The goals of this study were to explore the RcsB-GrvA mechanism of LEE gene activation,
characterize the GrvA regulon in EHEC O157:H7, and explore its significance in virulence and
stress fitness. As such, the transcriptome of GrvA was determined by RNA sequencing, and
increased stress fitness was observed for the grvA isogenic mutant. This study further expands
the role of GrvA in virulence of EHEC, and reveals a novel pathway for LEE gene regulation by
GrvA, through the acid resistance regulator gadE.

3.2 Methods……..……
3.2.1 Bacterial strains and culture conditions
The strains and plasmids used in this study are listed in Table 6. Strains were stocked at 80°C in glycerol diluted (15% v/v final) in Luria Broth (LB), and were maintained in LB or on
LB with 1.5% agar (LBA). Unless otherwise noted, overnight (18-20 h) cultures grown in LB
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were used to inoculate fresh LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or
fresh Dulbecco’s Modified Eagle’s Medium (DMEM) (4 g/l glucose, 4 mM glutamine, 44 mM
NaHCO3, pH 7.4) to a final optical density 600 nm (OD600) of 0.05. Cultures were grown at 37°C
in a rotary shaker (200 RPM) using a 1:10 media-to-flask volume. Antibiotics (Sigma-Aldrich,
St. Louis, MO) were added to cultures when required.

3.2.2 Genetic manipulations and complementation
Primers used for genetic manipulation and complementation are listed in Table 7. For
construction of deletion mutants and chromosomal FLAG-epitope fusions the λ-Red assisted
one-step deletion method, adapted for EHEC, was used as described (Datsenko and Wanner,
2000; Lippolis et al., 2009; Morgan et al., 2013). A previously published approach was used to
construct FLAG fusions to rcsB, tir, and zinT (Morgan et al., 2013) based on the method of
Uzzau et al. (Uzzau et al., 2001). When expressed, the fusion protein contains a seven amino
acid C-terminal epitope (FLAG) that can be detected by western immunoblots using anti-FLAG
mAbs (Sigma-Aldrich. St. Louis, MO). Confirmation of genetic constructs was done using a
combination of BccI (NEB) restriction mapping and DNA sequencing (MWG Operon,
Huntsville, AL).
Complementation of rcsB was performed using vector pRJM-20, as previously described
(Morgan et al., 2013). Additionally, a fragment containing the entire rcsDB operon, including
the

rcsD

promoter

region

(nucleotide

positions

3041665-3046191,

GenBank

Ref#

NC_013008.1), was cloned into BamHI/XbaI-digested low-copy expression vector pMPM-K3
(KanR) (Mayer, 1995) using primers RcsB-3732/BamHI and RcsB+794/XbaI, to produce pRJM21. To complement grvA, a PCR product corresponding to the grvA ORF and including a 267-bp
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upstream region of grvA containing the predicted promoter (nucleotide positions 12819841283134, GenBank Ref# NC_013008.1), was produced using primers GrvA-268/XhoI and
GrvA+884/BamHI, and cloned into XhoI/BamHI digested low-copy expression vector pMPMA2 (AmpR) (Mayer, 1995), creating pRJM-22. To create a vector expressing a C-terminal 6xHIS
tagged variant of GrvA under the control of the native grvA promoter, a PCR product including
the grvA ORF and a region extending 267-bp upstream and 810-bp downstream of the
translational start site (including the predicted promoter but not the native stop codon)
(nucleotide positions 1282059-1283134, GenBank Ref# NC_013008.1), was produced using
primers GrvA-268/XbaI and GrvA+810/EcoRI-6xHIS, with the reverse primer containing the
nucleotide sequence for the 6xHIS epitope. This PCR product was cloned into XbaI/EcoRI
digested pUC19 to create pRJM-32.
To complement gadE, a PCR product corresponding to the gadE ORF and 762-bp
upstream of gadE (containing the native promoters) (nucleotide positions 4458857-4460195,
GenBank

Ref#

NC_013008.1)

was

produced

using

primers

GadE-763/XbaI

and

GadE+577/BamHI, and cloned into the XbaI/BamHI digested vector pMPM-A2, to create pRJM30.

3.2.3 Protein extraction, SDS-PAGE and western immunoblots
Protein extraction, purification and western immunoblots were performed as described
previously (Mitra et al., 2012). The amount of protein loaded on SDS-PAGE gels for western
blots was measured by a Bradford protein assay standard curve, and equal loading was validated
by western blots for GroEL using anti-GroEL mAbs (Bio-Rad, Hercules, CA). Monoclonal
antibodies against FLAG (Sigma-Aldrich, St. Louis, MO) were also used. Each experiment was
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repeated a minimum of three times in independent trials. Densitometry was used to estimate
differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging System
and Image Lab 3.0 (BioRad).

3.2.4 RNA purification and quantitative real-time PCR (qRT-PCR)
Primers for qRT-PCR are provided in Table 7 in supplemental materials. RNA
purification, cDNA synthesis, qRT-PCR cycling conditions and data analysis followed
previously described protocols (Riordan et al., 2010). qRT-PCR was performed using a
Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsH (16S
rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary transcript
expression levels using 2-ΔCt /10-6 as described (Livak and Schmittgen, 2001; Mitra et al., 2012).
Expression levels were compared statistically using the appropriate t-test or by Tukey’s HSD
following a significant F-test (n≥3, α=0.05) (R. ver. 3.1.0).

3.2.5 Construction of single copy luxE operon fusions
Strains containing single-copy chromosome-plasmid luxE reporter fusions were
constructed using a protocol adapted from Shimizu et. al. (Shimizu et al., 2011). To make rcsDBluxE and grvAB-luxE fusions, the kan cassette and flanking FRT sites were amplified from
pKD4

(Datsenko

and

Wanner,

2000)

using

primers

pKD4forward/SacI

and

pKD4reverse/BamHI. This product was SacI/BamHI-digested and cloned into the BamHI/SacI
site of pMPM-T3 (Mayer, 1995) to produce pMPM-T3-kan. An XhoI/BamHI-digested PCR
product containing the luxE gene and native RBS was amplified from placlux8 (Shimizu et al.,
2011) using primers LuxE-18/XhoI and LuxE+1,450/BamHI and cloned into the XhoI/BamHI
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site of similarly digested pMPM-T3-kan to create pMPM-T3-luxE-kan. For rcsDB-luxE, a luxEkan PCR product amplified from pMPM-T3-luxE-kan using primers RcsB+625/LuxE and
RcsB+838/P2 and Phusion© High-Fidelity DNA Polymerase (NEB) was fused to a region 13-bp
downstream of the rcsB ORF, and 53-bp downstream of the convergently-transcribed rcsC ORF
(nucleotide position in TW14359) using λ Red assisted homologous recombination (Datsenko
and Wanner, 2000). A similar approach was used to construct grvAB-luxE using primers
GrvA+1,283/LuxE and GrvA+1,431/P2. Kanamycin resistance cassettes were removed using
FLP recombinase as described (Datsenko and Wanner, 2000), and luxE fusion constructs were
validated using a combination of restriction mapping and DNA sequencing (MWG Operon). lux
operon genes luxCDAB were constitutively expressed in trans in TW14359rcsDB-luxE and
TW14359grvAB-luxE backgrounds from pluxCDAB3 (Shimizu et al., 2011; Shimizu et al.,
2012).

3.2.6 Luciferase plate assays
Overnight cultures grown in either LB or DMEM were used to inoculate fresh LB
containing 44 mM NaHCO3, or DMEM with 44 mM NaHCO3 and ampicillin (100 µg/ml) to an
OD600=0.05. Cultures (0.2 ml) were inoculated into 96-well, clear bottom white-walled plates
(Greiner Bio-One 655098) and incubated at 37°C in a rotary shaker (200 RPM). Luciferase and
OD600 measurements were taken every hour for 10 hours using a Biotek Synergy 2 plate reader
(1 sec integration) pre-warmed to 37°C. Assays were performed in quadruplicate (n=4), and
mean luciferase activity was compared using the appropriate t-test (n=4, α=0.05) (R. ver. 3.1.0).
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3.2.7 Electrophoretic mobility shift assay (EMSA)
EMSA experiments were performed as previously described (Mitra et al. 2014). Briefly,
the forward primer used to PCR amplify rcsB from TW14359 DNA contained a new start codon
and a 6xHis epitope tag, and the PCR product was cloned into the NcoI/XhoI sites of similarly
digested vector pET-24d, to create pRJM-27. N-terminal 6xHis-RcsB fusion proteins have wildtype RcsB activity (Carballes et al., 1999). N-terminal 6xHis tagged RcsB was purified from
strain BL21(DE3)pLysS using Ni-NTA Spin Columns (Qiagen) according to the manufacturer’s
protocol. Briefly, overnight cultures grown in LB (supplemented with 1 mM IPTG and Kan (50
µg/ml), at 18°C and 200 rpm) were pelleted and re-suspended in 1.5 ml of Lysis Buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by sonication for 3 min (50 %
amplitude, 10 sec interval, 30 sec pause) while chilled on ice. The lysate was centrifuged at
21,000 x g to remove insoluble cellular debris, and the supernatant was used for column
purification, and subsequently eluted with Elution Buffer (50 mM NaH2PO4, 300 mM NaCl, 500
mM imidazole, pH 8.0). Purified 6xHis-RcsB protein was quantified using a Bradford protein
assay. 5’-biotin labeled primers (IDT Oligos) were used to amplify the grvA promoter region
containing the RcsB consensus binding site. An additional fragment, with no predicted RcsB
consensus sequence, was amplified and used as a negative binding control. Amplified biotin
labeled probes were gel purified (QIAquick Gel Extraction Kit), and diluted to a concentration of
0.5 ng/μl. All EMSA experiments were performed using the LightShift Chemiluminescent
EMSA Kit (Thermo Pierce) according to the manufacturer’s specifications. Prior to
electrophoresis, purified 6xHis-RcsB and biotin labeled fragments were co-incubated for 40 min
in Binding Buffer (1x binding buffer, 50 ng/μl sheared salmon sperm DNA, 2.5% glycerol,
0.05% NP-40, 5 mM MgCl2, 50 mM KCl, and 1 mM EDTA) at room temperature. Samples were
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loaded into a pre-run and cooled, 8% native polyacrylamide gel, and run at 20 V/cm for 1 hour.
Following electrophoresis, biotin labeled DNA was transferred (25V for 20 minutes) to a
Biodyne B Pre-Cut Modified Nylon Membrane (Thermo Pierce) and UV crosslinked for 60 sec.
Biotin labeled DNA fragments were detected using Streptavidin-HRP conjugated antibodies
(1:300) in blocking buffer, and membranes were washed, equilibrated, and subsequently detected
using luminol/enhancer solutions in a ChemiDoc XRS+ Imaging System and Image Lab 3.0
(BioRad).

3.2.8 Construction of lacZ transcriptional promoter fusions and β-galactosidase assays
Construction of the grvAP-lacZ reporter transcriptional fusion followed a previously
described protocol using vector pRS551 (Morgan et al., 2013). Briefly, a 306-bp PCR product
containing the predicted grvA promoter was amplified from TW14359 genomic DNA using
primers GrvA-268/EcoRI and GrvA+38/BamHI, BamHI/EcoRI digested, and cloned into the
similarly digested pRS551, resulting in pRJM-31. Four different gadEP-lacZ promoter fusions
were created by cloning BamHI/EcoRI-digested PCR products into similarly digested pRS551
using primers GadE-320/EcoRI and GadE-1/BamHI, GadE-276/EcoRI and GadE-516/BamHI,
GadE-773/EcoRI and GadE-497/BamHI, and GadE-773/EcoRI and GadE-1/BamHI. βgalactosidase activity (Miller Units) was measured as previously described and compared
between strains using the appropriate t-test or by Tukey’s HSD following a significant F-test
(n≥3, α=0.05) (R ver. 3.1.0) (Miller, 1972; Mitra et al., 2012).
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3.2.9 RNA-seq and data analysis
RNA sequencing experiments were performed as previously described (Weiss et al.,
2014). RNA extractions were performed as described for qRT-PCR, except residual genomic
DNA was digested using TURBO™ DNase (Ambion, cat. AM2238) following the
manufacturers' protocol. Three independent RNA samples for each strain (TW14359,
TW14359∆grvA, and TW14359∆rcsB∆grvA) were mixed in a 1:1:1 ratio to account for intersample variability, and rRNA was removed using the MICROBExpress™ Bacterial mRNA
Enrichment Kit (Ambion, cat. AM1905) according to instructions. The integrity and
concentration of purified and enriched mRNA was determined using an Agilent 2100
Bioanalyzer (Agilent Technologies). mRNA was converted to strand specific cDNA using the
Ion Total RNA-Seq Kit v2 (Ion Torrent™, cat. 4475936) and samples were sequenced using an
Ion Personal Genome Machine® (PGM™) System (Ion Torrent™). Sequence mapping and data
analysis was performed using CLC Main Workbench 6 (CLC bio). Subsequent RPKM (reads per
kilobase per million mapped reads) values were converted to fold change relative to wild-type
TW14359 for both TW14359∆grvA and TW14359∆rcsB∆grvA. Genes of interest with an RPKM
below the 1-RPKM cut-off were individually examined for significance between samples.
Circular plots were created using Circos v0.65 (http://www.circos.ca) (Krzywinski et al., 2009).

3.2.10 Adherence assays
The maintenance and culture of HT-29 colonic intestinal cells was performed as
previously described (Morgan et al., 2013). Adherence competition indexes were determined
using the method of Gabbianelli et al. (Gabbianelli et al., 2011). Briefly, overnight DMEM
cultures were used to inoculate fresh DMEM to OD600=0.05, and were incubated for 3 hours at
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37°C with shaking (200 RPM). Cultures were then diluted to an OD600 = 0.5 and mixed in a 1:1
ratio (test strain:control strain), and 200 μl of each was used to inoculate HT-29 cells in 6-well
culture plates. For the control strain, the entire lacZ ORF was deleted in TW14359 to produce a
strain incapable of utilizing lactose, for use in differential selection in competition assays. Each
plate was gently mixed before centrifugation at 500 x g for 5 min and then incubated as above.
Following 3 h of incubation, each well was washed four times using sterile PBS to remove nonadherent cells and adherent cells were removed using 500 μl of 0.1% Triton X-100. Cells were
enumerated (CFU/ml) by serial dilution in PBS and plating onto MacConkey agar, which is a
differential media used to indicate lactose utilization. After overnight growth on MacConkey
agar, pink colonies (Lac+) were scored as test strain CFU/ml, whereas white colonies (Lac-)
were scored as TW14359ΔlacZ CFU/ml. The competitive index was derived by dividing
CFU/ml of the test strain by the CFU/ml of TW14359∆lacZ, and was compared statistically
using the appropriate t-test (n≥3, α=0.05) (R ver. 3.1.0).

3.2.11 Acid resistance assays
Acid resistance by the glutamate-dependent system was measured as described (Riordan
et al., 2010) with slight adaptations. Mid-exponential phase (OD600=0.5) DMEM cultures were
inoculated to 106 CFU/ml final cell density in E minimal glucose (EG) media with or without 5.7
mM L-glutamate at pH 7 (control) or acidified with HCl (pH 2). For cell counts (CFU/ml) and
percent survival determinations, samples were serially-diluted in PBS (pH 7), plated to LBA and
incubated overnight at 37°C.
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3.3 Results…….
3.3.1 Expression profiles of the rcsDB and grvAB operons, and molecular basis for grvA
activation by RcsB
Previous work has shown RcsB to be an activator of grvA, and that both factors are
required for bicarbonate-dependent upregulation of the LEE-encoded regulator, Ler, and
subsequent stimulation of LEE expression in EHEC (Tobe et al; Morgan et al 2013). RcsB is
predicted to act upstream of grvA in the regulation of ler, yet the mechanism underlying the
control of grvA by RcsB is as yet unknown. In addition, the expression profile for both rcsDB
and grvAB operons under LEE-inducing conditions has not been determined
In both DMEM and LB, expression of rcsDB was highest during exponential phase
growth as measured by luciferase activity (Fig. 15A). For DMEM, rcsDB expression declined
during transition into stationary phase (after 3 h growth), but for LB, expression declined earlier
(after 1 h growth) and during exponential phase. For both DMEM and LB, rcsDB expression
continued to decline into stationary phase. The expression of rcsDB was significantly higher (2to -4-fold) in DMEM over the course of the first 6 h of growth compared to LB (p<0.05) (Fig.
15A). Addition of bicarbonate to LB increased rcsDB expression during early exponential
growth (1 h) (p=0.001), however levels were still significantly less than that observed for
DMEM at the same time point (p<0.001 and Fig. 15A). Furthermore, during the later stages of
growth (5–10 h), rcsDB expression in LB with bicarbonate was significantly lower than LB. This
suggests that, while bicarbonate is able to stimulate rcsDB transcription, growth in DMEM leads
to markedly higher levels of rcsDB transcription during early stages of growth. Finally, this data
indicates that bicarbonate stimulation of rcsDB expression in LB is dependent on growth-phase.
Like rcsDB, grvAB expression was growth-phase dependent. In both DMEM and LB,
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Figure 15 - Temporal expression of rcsDB and grvAB operons in TW14359
Analysis of rcsB promoter activity and temporal expression of the rcsDB and grvAB operons in
TW14359. Luciferase activity of (A) rcsDB-luxE and (B) grvAB-luxE strains containing plasmid
pluxCDAB3, measured over 10 hours, in DMEM with 44 mM bicarbonate (triangle), LB (diamond), and
LB with 44 mM bicarbonate (square). RLU values are a function of total luciferase activity divided by
OD600 measurements at each time point. The OD600 valuse of all cultures are indicated by dashed lines.
The means at each time point varied by less than 10% for each sample. (C) Representative western blot
for RcsB-FLAG grown to mid-exponential phase (OD600=0.5) in LB, LB supplemented with 44 mM
bicarbonate, and DMEM. Non-specific binding was used as to control for loading. (D) Schematic diagram
for the construction of chromosomal rcsDB- and grvAB-luxE fusions in TW14359.
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expression peaked during early exponential phase, declining rapidly between 1-2 h growth to
substantially lower levels of expression for the remaining course of the experiment (2-10 h) (Fig.
15B). As for rcsDB, grvAB expression was significantly higher (1.5- to 3.5-fold) in DMEM
compared with LB up until transition to stationary phase (0-4 h) (p<0.05). Bicarbonate addition
to LB increased grvAB expression slightly during early exponential growth, however for
stationary-phase cultures, levels were significantly less in LB with bicarbonate (p<0.05, 5-10 h)
(Fig. 15B). The patterns of rcsDB and grvAB expression were consistent with cytosolic levels of
RcsB during exponential (OD600=0.5, or 2 h) growth, with higher levels of proteins observed in
LB with HCO3, and substantially higher levels during growth in DMEM (Fig. 15D). This data
indicates that GrvA controls several genes, including those involved in colonization and acid
resistance, but also includes a number of genes which are not associated with virulence directly.
While RcsB has been shown to upregulate grvA (Tobe et al., 2005), the mode of
activation is not known. Overexpression of rcsDB in trans in a grvAB-luxE reporter background
(strain EcRJM105) substantially increased RLUs of luciferase (Fig. 16A), suggesting that RcsB
is working directly on the promoter of grvAB for activation. Consistent with this, two putative
RcsB boxes were identified in tandem and proximal to a predicted -35 site (nucleotides 12829681282982 in TW14359) of the grvA promoter (grvAP) (Wehland and Bernhard, 2000) (Tobe et al.,
2005) (Fig. 16B). To test this hypothesis, purified RcsB was co-incubated with a fragment of the
core grvAP element including the putative RcsB boxes and analyzed using electrophoretic
mobility shift assays (EMSA). As anticipated, the 235-bp grvAP fragment was visibly shifted
with the addition of increasing amounts (1-12 μg) of purified RcsB, while no shift was observed
for the control fragment (Fig. 16C). Based on these findings, it is predicted that RcsB is a direct
transcriptional activator of grvA and that activation occurs at the grvA promoter region
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Figure 16 - Direct transcriptional regulation of grvA by RcsB
(A) Luminesence was visualized from strain TW14359 grvAB-luxE pluxCDAB3 with empty vector
pMPM-K3 or vector pMPM-rcsDB. Empty vector and rcsDB expressing strains were streaked onto an
LBA plate and incubated at 37°C for 8 hours before detection. (B) Genomic DNA sequence upstream of
grvA ORF containing the putative sigma-70 promoter (grey fill), RcsB consensus binding sites
(unerlined), and grvA translational start site (bold italics) (C) Electrophoretic mobility shift assay for
biotinylated grvA promoter fragments containing an (bottom left) RcsB consensus sequence and (bottom
right) no consensus sequence. RcsB concentration was increased from 1 to 12 μg for the fragment
containing the RcsB consensus binding site, and at 12 μg for the fragment with no consensus binding
site. The arrow indicates location of the shifted grvA sequence.
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containing at least one RcsB box.

3.3.2 The GrvA regulon of EHEC
While GrvA clearly contributes to the regulation of Ler (Tobe et al 2005; Morgan et al 2013), the
precise mechanism by which it upregulates the LEE and the breadth of genes controlled by GrvA
is unknown. To determine this, the transcriptome of EHEC O157:H7 strain TW14359 and its
grvA isogenic derivative (TW14359ΔgrvA) was measured by RNA-seq analysis during
exponential growth (OD600=0.5) in DMEM. As RcsB is a direct activator of grvA (above) and
required for GrvA-dependent control of the LEE (Tobe et al; Morgan et al), the transcriptome of
TW14359ΔrcsBΔgrvA was measured in parallel.
In TW14359ΔgrvA, 765 genes were altered in expression >2-fold above the RPKM
cutoff when compared to TW14359 (Fig. 17A and 17B); of these, 264 were upregulated and 501
were downregulated. Gene ontologies were determined based on known and predicted gene
product function and included 31% as cellular and metabolic roles (74 up; 162 down), 9% as
known or predicted regulators (23 up; 45 down), and 8% involved in transport (18 up; 42 down)
(Table 4). For those genes in which GrvA is dependent on rcsB for regulation, it was expected
that the direction and magnitude of expression would not differ between TW14359ΔgrvA and
TW14359ΔgrvAΔrcsB backgrounds. Of the genes differentially expressed in TW14359ΔgrvA,
33% (250/765) were similarly altered in expression for TW14359ΔgrvAΔrcsB (Table 4; Fig.
17A and 17B). However, while 63% (485/765) of genes altered in TW14359ΔgrvA were
unchanged in TW14359ΔgrvAΔrcsB, 4% (30/765) were altered in the opposite direction.
Specifically, 13 genes which were upregulated in TW14359ΔgrvA were down in

80

Figure 17 - Circular plot of RNA-Seq in EHEC strain TW14359 and mutant derivatives
(A) Circular plots represent data from RNA sequencing of strains TW14359, TW14359∆grvA, and
TW14359∆grvA∆rcsB. Plots represent data and information as follows: (outer, black) Numeric genomic
location based on nucleotide position. Heatmaps of fold change in expression for TW14359∆grvA (outer)
and TW14359∆grvA∆rcsB (inner), with select key locations indicated with black arrows; fold changes
represented as the wild type RPKM divided by the mutant derivative RPKM value for each gene. The
inner three histograms represent the RPKM of TW14359 (black), TW14359∆grvA (red), and
TW14359∆grvA∆rcsB (blue). Circular plots created using Circos v0.65 (http://www.circos.ca). (B) Venn
diagram representing the number of genes up- or down-regulated by at least 2-fold between TW14359
(blue), TW14359∆grvA (grey), and TW14359∆grvA∆rcsB (red). (C) Ontological grouping of genes
influenced by GrvA in TW14359. A total of 765 genes showed at least 2-fold alteration up (red) or down
(blue) in expression, and genes are grouped by their known or predicted ontologies.
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Table 4 - RNA-seq transcriptome data

Fold Change b
LEE PAI genes, and non-LEE encoded effectors
∆grvA ∆grvArcsB

ECSP IDa
ECSP_4665

Gene

Description

espF

-3.08

-1.18

LEE-encoded type III secreted effector

ECSP_4666

orf29

-3.36

-5.13

LEE-encoded predicted type III secretion system factor

ECSP_4667

escF

-5.79

-5.06

LEE-encoded type III secretion system component

ECSP_4668

cesD2

-8.31

-5.08

predicted chaperone

ECSP_4669

espB

-6.55

-5.82

secreted protein EspB

ECSP_4670

espD

-4.49

-3.85

secreted protein EspD

ECSP_4671

espA

-4.39

-4.31

secreted protein EspA

ECSP_4672

sepL

-4.53

-5.69

LEE-encoded type III secretion system component

ECSP_4673

escD

-4.03

-3.36

LEE-encoded type III secretion system component

ECSP_4674

eae

-4.76

-2.91

intimin adherence protein

ECSP_4675

cesT

-5.95

-3.98

molecular chaperone

ECSP_4676

tir

-4.01

-3.10

translocated intimin receptor protein

ECSP_4677

map

-4.42

-3.48

type III secreted effector protein

ECSP_4678

cesF

ND (-)

-1.08

chaperone for type III secretion of EspF

ECSP_4679

espH

-4.79

-5.49

LEE-encoded type III secreted effector

ECSP_4680

escQ

-1.91

-2.79

LEE-encoded type III secretion system factor

ECSP_4681

orf16

-8.06

-6.16

LEE-encoded predicted type III secretion system factor

ECSP_4682

orf15

-1.21

-6.16

LEE-encoded predicted type III secretion system factor

ECSP_4683

escN

-2.70

-1.69

LEE-encoded type III secretion system factor

ECSP_4684

escV

-2.29

-3.59

LEE-encoded type III secretion system factor

ECSP_4685

orf12

-1.26

ND (-)

ECSP_4686

espZ

-3.48

-1.85

translocated effector protein

ECSP_4687

escI

-1.28

1.09

LEE-encoded predicted type III secretion system component

ECSP_4688

escJ

-2.80

-4.53

LEE-encoded type III secretion system factor

ECSP_4689

sepD

-1.26

-1.93

LEE-encoded type III secretion system component

ECSP_4690

escC

-1.73

-2.38

type III needle complex subunit

ECSP_4691

cesD

-1.08

-5.78

LEE-encoded type III secretion system factor

ECSP_4692

grlA

-1.11

-4.62

LEE-encoded positive regulator of transcription

ECSP_4693

grlR

-1.93

-2.72

LEE-encoded negative regulator of transcription

LEE-encoded predicted type III secretion system factor
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Table 4 - RNA-seqtTranscriptome data, continued.
ECSP_4694

etgA

-1.51

ND (-)

predicted lytic transglycosylase

ECSP_4695

escU

ND (+)

1.02

LEE-encoded type III secretion system factor

ECSP_4696

escT

ND (-)

-2.70

LEE-encoded type III secretion system factor

ECSP_4697

escS

3.97

-1.54

LEE-encoded type III secretion system factor

ECSP_4698

escR

-1.64

ND (-)

LEE-encoded type III secretion system factor

ECSP_4699

escL

-2.94

-3.85

LEE-encoded predicted type III secretion system factor

ECSP_4700

orf4

-1.83

-4.47

LEE-encoded type III secretion system factor

ECSP_4701

cesA

-1.01

1.14

LEE-encoded chaperone

ECSP_4702

escE

-1.13

-2.60

LEE-encoded type III secretion system factor

ECSP_4703

ler

-2.45

-2.33

locus of enterocyte effacement (LEE)-encoded regulator

ECSP_4704

espG

-3.69

-1.61

LEE-encoded type III secreted effector

ECSP_4705

rorf1

-1.01

ND (-)

ECSP_0061

espY1

1.98

3.25

non-LEE-encoded type III secreted effector

ECSP_0866

nleC

-2.27

-3.08

non-LEE-encoded type III secreted effector

ECSP_0868

nleD

-1.66

-1.97

non-LEE-encoded type III secreted effector

ECSP_1702

nleA

-4.03

-2.46

non-LEE-encoded type III secreted effector

ECSP_1704

nleH2

2.25

1.21

non-LEE-encoded type III secreted effector

ECSP_1705

nleF

-3.69

-3.99

non-LEE-encoded type III secreted effector

ECSP_3954

nleE

-4.03

-4.11

non-LEE-encoded type III secreted effector

LEE-encoded type III secretion system factor

Metabolism and Acid Resistance
∆grvA ∆grvArcsB

ECSP ID

Gene

ECSP_0704

gltL

-3.89

-4.56

ECSP_0705

gltK

-3.02

-3.29

ECSP_0706

gltJ

-2.49

-2.99

ECSP_0707

gltI

-2.98

-2.39

ECSP_0906

glnQ

-2.35

-2.06

Description
glutamate and aspartate transporter subunit, ATP-binding
component of ABC superfamily
glutamate and aspartate transporter subunit, membrane
component of ABC superfamily
glutamate and aspartate transporter subunit, membrane
component of ABC superfamily
glutamate and aspartate transporter subunit, periplasmicbinding component of ABC superfamily
glutamine transporter subunit; ATP-binding component of
ABC superfamily
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Table 4 - RNA-seq transcriptome data, continued.
ECSP_0907

glnP

-2.33

-1.24

glutamine transporter subunit; membrane component of
ABC superfamily
glutamine transporter subunit; periplasmic binding
component of ABC superfamily

ECSP_0908

glnH

-1.51

-1.36

ECSP_1977

gadC

15.63

1.79

predicted glutamate:gamma-aminobutyric acid antiporter

ECSP_1978

gadB

14.58

1.30

glutamate decarboxylase B, PLP-dependent

ECSP_2312

astE

-4.03

-2.93

succinylglutamate desuccinylase

ECSP_2313

astB

-5.95

-5.34

succinylarginine dihydrolase

ECSP_2314

astD

-9.07

-5.74

succinylglutamic semialdehyde dehydrogenase

ECSP_2315

astA

ND (+)

-11.87

arginine succinyltransferase

ECSP_2316

astC

-66.00

-11.40

succinylornithine transaminase, PLP-dependent

ECSP_2329

gdhA

-1.84

-2.32

glutamate dehydrogenase

ECSP_3185

argT

-3.53

-1.78

lysine/arginine/ornithine transporter subunit, periplasmicbinding component of ABC superfamily

ECSP_4065

uxaA

1.69

4.10

altronate hydrolase

ECSP_4066

uxaC

1.76

4.91

uronate isomerase

ECSP_4486

slp

1.98

3.56

outer membrane lipoprotein

ECSP_4498

hdeB

ND (+)

1.00

acid-resistance protein

ECSP_4499

hdeA

ND (+)

ND (+)

stress response protein acid-resistance protein

ECSP_4500

hdeD

ND (+)

ND (+)

acid-resistance membrane protein

ECSP_4501

gadE

ND (+)

ND (+)

ECSP_4502

mdtE

ND (+)

ND (+)

acid-induced positive regulator of glutamate-dependent acid
resistance
multidrug resistance efflux transporter

ECSP_4503

mdtF

ND (+)

ND (+)

multidrug transporter, RpoS-dependent

ECSP_4504

gadW

ND (+)

ND (+)

DNA-binding transcriptional activator
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Table 4 - RNA-seq transcriptome data, continued.
ECSP_4505

-

1.00

1.00

hypothetical protein

ECSP_4506

gadX

ND (+)

ND (+)

DNA-binding transcriptional dual regulator

ECSP_4507

gadA

ND (+)

ND (+)

glutamate decarboxylase A, PLP-dependent

ECSP_4508

yhjA

1.00

ND (+)

predicted cytochrome C peroxidase

ECSP_4509

treF

ND (+)

ND (+)

cytoplasmic trehalase

ECSP_4510

yhjB

1.00

ND (+)

ECSP_4511

yhjC

ND (+)

ND (+)

predicted DNA-binding response regulator in twocomponent regulatory system
predicted DNA-binding transcriptional regulator

ECSP_4512

yhjD

ND (+)

ND (+)

conserved inner membrane protein

ECSP_4513

yhjE

87.33

159.09

predicted transporter

ECSP_4921

-

ND

ND (+)

hypothetical protein

ECSP_4922

-

-1.06

1.44

hypothetical protein

ECSP_4923

glnG

-3.74

-5.30

ECSP_4924

glnL

-3.71

-7.85

ECSP_4925

glnA

-4.32

-6.22

fused DNA-binding response regulator in two-component
regulatory system
sensory histidine kinase in two-component regulatory
system with GlnG
glutamine synthetase

ECSP_0518

glnK

ND (+)

ND (+)

ECSP_0519

amtB

-74.77

-69.89

nitrogen assimilation regulatory protein for GlnL, GlnE, and
AmtB
ammonium transporter

ECSP_4793

asnC

-2.02

-4.62

DNA-binding transcriptional dual regulator

ECSP_4794

asnA

-4.97

-6.59

asparagine synthetase A

ECSP_0721

asnB

-7.58

-6.67

asparagine synthetase B

ECSP_2651

cbl

-4.79

-10.97

DNA-binding transcriptional activator of cysteine
biosynthesis
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Table 4 - RNA-seq transcriptome data, continued.
ECSP_2652

nac

-63.48

-21.56

DNA-binding transcriptional dual regulator of nitrogen
assimilation

ECSP_3790

galR

-2.05

1.20

DNA-binding transcriptional repressor

ECSP_3791

lysA

-4.28

-3.59

diaminopimelate decarboxylase, PLP-binding

ECSP_3792

lysR

-2.77

1.65

DNA-binding transcriptional dual regulator

Metal Stress Response and Import/Export
ECSP ID

Gene

∆grvA ∆grvArcsB

ECSP_0334

yk gL

ND (+)

ECSP_0335

rpmJ

ECSP_0336

rpmE2

ECSP_0622

Description

ND (+)

predicted protein

170.69

438.30

putative second copy of 50S ribosomal protein L36

565.67

1205.82

Zn(II)-responsive ribosomal protein

cusS

-1.30

-1.61

ECSP_0623

cusR

1.07

-1.79

ECSP_0624

cusC

-1.04

-1.67

sensory histidine kinase in two-component regulatory
system with CusR, senses copper ions
DNA-binding response regulator in two-component
regulatory system with CusS
copper/silver efflux system, outer membrane component

ECSP_0625

cusF

-1.79

-5.08

periplasmic copper-binding protein

ECSP_0626

cusB

-1.35

-5.78

copper/silver efflux system, membrane fusion protein

ECSP_0627

cusA

-1.41

-6.60

copper/silver efflux system, membrane component

ECSP_0731

fur

1.69

6.09

DNA-binding transcriptional dual regulator of siderophore
biosynthesis and transport

ECSP_2430

yebA

4.47

11.31

predicted peptidase

ECSP_2431

znuA

17.68

39.94

High-affinity zinc uptake system periplasmic protein

ECSP_2432

znuC

2.48

6.41

High-affinity zinc uptake system ATP-binding protein

ECSP_2433

znuB

4.23

9.00

High-affinity zinc uptake system membrane protein
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conserved metal-binding protein

ECSP_2579

zinT

163.75

484.95

ECSP_4263

zntR

-1.15

-1.17

DNA-binding transcriptional activator in response to Zn(II)

ECSP_4425

zntA

-1.39

-3.45

zinc, cobalt and lead efflux system

Other Functions
∆grvA ∆grvArcsB

ECSP ID

Gene

ECSP_1968

ddpF

1.10

1.80

ECSP_1969

ddpD

1.49

1.62

ECSP_1970

ddpC

1.59

-1.93

ECSP_1971

ddpB

-6.55

-20.02

ECSP_1972

ddpA

-28.72

-6.75

Description
D-ala-D-ala transporter subunit, ATP-binding component of
ABC superfamily
D-ala-D-ala transporter subunit, ATP-binding component of
ABC superfamily
D-ala-D-ala transporter subunit, membrane component of
ABC superfamily
D-ala-D-ala transporter subunit, membrane component of
ABC superfamily
D-ala-D-a la transporter subunit, periplasmic-binding
component of ABC superfamily

ECSP_1973

ddpX

ND (-)

-15.40

D-ala-D-ala dipeptidase, Zn-dependent

ECSP_2574

yedV

-1.82

-1.78

ECSP_2575

yedW

1.00

-5.56

predicted sensory kinase in two-component regulatory
system with YedW
predicted DNA-binding response regulator in twocomponent system with YedV

ECSP_5434

yjiA

2.78

1.91

predicted GTPase

ECSP_5435

yjiX

27.79

25.32

conserved protein

ECSP_5436

yjiY

3.81

3.00

predicted inner membrane protein

ECSP_2492

-

-2.36

-16.79

hypothetical protein

ECSP_4094

-

-1.87

-25.76

hypothetical protein

a

Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359
#XXX, NCBI) and K-12 strain MG1655 (EcoCyc, REF).
b

(accession

fold change calculated as either wild-type RPKM value divided by the mutant strain RPKM value.

c

RPKM denotes Reads Per Kilobase per Million mapped reads
For inclusion, genes were selected with a fold change greater than 2 in either the single or double mutant strains.
Additionally, genes that are part of an operon were included, with their respective fold change and RPKM data,
if a component gene was notably altered in expression.
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TW14359ΔgrvAΔrcsB, and 17 were downregulated in TW14359ΔgrvA were upregulated in
TW14359ΔgrvAΔrcsB.
In agreement with the role of GrvA in ler activation, 21 LEE-encoded genes were
downregulated in TW14359ΔgrvA, including ler, the translocon genes espA, espB and espD,
eaeA (intimin) and tir (translocated intimin receptor) (Table 4; Fig. 17). As anticipated, LEE
expression was also decreased in TW14359ΔrcsBΔgrvA compared to TW14359, but was not
further decreased when compared to TW14359ΔgrvA. Decreased transcription of ler in
TW14359ΔgrvA and TW14359ΔrcsBΔgrvA was validated by qRT-PCR, and complementation
of grvA was shown to restore ler expression to wild-type levels (Table 5).
Interestingly, genes encoded within the 15 kb genomic acid fitness island (AFI), the
products of which are required for survival at low pH (Foster, 2004), were upregulated in
TW14359ΔgrvA when compared to TW14359, in which the expression of AFI genes was barely
detectable (Fig. 17; Table 4). Most notably, genes of the glutamate-dependent acid resistance
(GDAR) system were upregulated, including gadA, gadE, gadW, gadX, and the non-AFI
encoded gadCB operon. Increased transcription of gadE, encoding the central regulator of
GDAR, was validated through qRT-PCR, and complementation with grvA was shown to restore
gadE expression to levels observed for TW14359 (Table 5). While there was no difference in
gadE and gadW expression between TW14359ΔgrvA and TW14359ΔrcsBΔgrvA, the expression
of gadA, gadBC, and hde genes was markedly reduced in TW14359ΔrcsBΔgrvA compared to
TW14359ΔgrvA (Table 4). This observation likely reflects the fact that RcsB directly activates
transcription from the promoters of these genes as a heterodimer with GadE (Castanie-Cornet et
al., 2010; Johnson et al., 2011), and suggests that the effect of grvA deletion on the expression of
GDAR genes is independent of rcsB.
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Table 5 - qRT-PCR validation of RNA-seq data
Strain
Geneb:

Expression Unitsa
ler

gadE

astC

znuA

1054.77 (51.81)

0.18 (0.06)

111.56 (1.55)

8.02 (2.34)

∆grvA

78.28 (21.68)

61.11 (8.22)

1.21 (0.67)

551.15 (150.90)

∆rcsB∆grvA

127.97 (33.65)

87.87 (4.10)

2.5 (1.49)

622.03 (46.05)

∆grvA pgrvA

556.98 (180.36)

12.94 (0.81)

6.87 (2.24)

20.46 (8.28)

TW14359

a

Expression units for each gene were calculated relative to rrsH expression, and
standard deviation is in parentheses.
b

Gene names IDs based on EHEC strain TW14359 (accession #NC_013008.1, NCBI)

Table 5: qRT-PCR validation of RNA-seq data
Select genes (ler, gadE, astC, and znuA) were validated through qRT-PCR from exponential phase
(OD600=0.5) DMEM cultures. Numbers represent the expression units for each gene in the noted strain,
with the standard deviation listed adjacently in parentheses. Each value represents the average of three
independent experiments (n=3).
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Genes for zinc binding, transport and resistance to zinc and other metals including znuA, znuCB,
zinT (formerly yodA), rpmE2, rpmJ, ykgL, and yebA (Ferianc et al., 1998; Hensley et al., 2012;
Kershaw et al., 2007) were upregulated in TW14359∆grvA and TW14359ΔrcsBΔgrvA compared
to TW14359 (Fig. 17, Table 4); for rpmE2, expression was increased by >500-fold in
TW14359∆grvA and TW14359ΔrcsBΔgrvA. Increased expression of znuC, encoding a high
affinity zinc uptake protein, was validated by qRT-PCR, and expression was restored with
complementation (Table 5). This data indicates that GrvA controls several genes, including
those involved in colonization and acid resistance, but also includes a number of genes which are
not associated with virulence directly.

3.3.3 GrvA/GadE control of ler and adherence to HT-29 colonic epithelial cells
RNAseq analysis revealed that deletion of grvA leads to the de-repression of gadE, a recognized
transcriptional repressor of the LEE-encoded regulator, ler (Kailasan Vanaja et al., 2009). It was
thus of interest to determine if this interaction between grvA and gadE was the underlying
mechanism by which GrvA controls LEE expression and influences adherence. In
TW14359∆grvA, ler expression was observed to be significantly reduced compared to TW14359
and

TW14359∆gadE

(p<0.05),

but

was

increased

to

near

wild-type

levels

in

TW14359∆grvA∆gadE (Fig. 18A). In addition, complementation of TW14359∆grvA∆gadE with
gadE constitutively expressed restored ler transcript levels to that observed for TW14359∆grvA.
These findings are in agreement with GadE dependent repression of ler, and support a hypothesis
in which GrvA activation of ler is directed through the repression of gadE.
The effect of grvA and gadE interaction on in-vitro adherence was determined by a
competition assay. Strains were co-incubated in a 1:1 ratio with HT-29 intestinal cells, followed
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Figure 18 - Analysis of the gadE dependent GrvA regulation of ler and competitive adherence to
HT-29 colonic epithelial cells
(A) ler transcript levels plotted for TW14359, TW14359ΔgrvA, TW14359ΔgadE,
TW14359ΔgrvAΔgadE, complement strain TW14359ΔgadE pgadE,
and complement strain
TW14359ΔgrvAΔgadE pgadE grown in DMEM (OD600=0.5). Plots which differ by lower case letter,
differ significantly by Tukey’s HSD following a significant F-test (p<0.05, n≥3). Error bars denote
standard deviation. (B) Competitive adherence to confluent monolayers of HT-29 colonic epithelial cells
was determined for each strain; adherence was assessed for cultures following 3 hours of co-incubation
with HT-29 cells and EHEC strains mixed in a 1:1 ratio with TW14359∆lacZ. Bars represent the ratio of
CFU/ml recovered for the strain indicated divided by the CFU/ml of TW14359∆lacZ, as determined by
serial dilution and enumeration on MacConkey agar. Asterisks denote significance compared with
TW14359, as determined using the Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001); Error bars
denote standard deviation.
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by plating and enumeration on MacConkey differential media. The control strain
(TW14359∆lacZ) was Lac-, and thus colonies on MacConkey were white, whereas test strains
(TW14359 and mutant derivatives) were Lac+, and colonies were thus pink. An adherence index
was determined for each test strain from plate counts as the ratio of CFU/ml for the test strain
relative to TW14359∆lacZ.
Consistent with the effect of grvA and gadE interaction on LEE expression, the adherence
index of TW14359∆grvA was significantly decreased when compared to TW14359,
TW14359∆gadE, and grvA complemented strain TW14359∆grvA pgrvA (p<0.05) (Fig. 18B). In
strains where gadE was expressed constitutively in-trans (plasmid pgadE), the adherence index
was uniformly reduced to levels lower than in all other strains, including TTSS-defective strain
TW14359∆escN (p<0.001) (Fig. 18B). These experiments reveal that GrvA-dependent
regulation of ler and adherence to intestinal cells is dependent on an intact gadE gene and are in
agreement with a hypothesis in which control of the LEE and LEE-dependent adherence by
GrvA is directed through the repression of gadE.

3.3.4 Effect of grvA mutation on gadE promoter activity
GadE is a negative regulator of LEE expression, acting directly on the LEE1 promoter to repress
ler transcription (Kailasan Vanaja et al., 2009; Tree et al., 2011). Since GrvA requires gadE for
LEE activation, it was of interest to define cis elements of the gadE promoter region, which
encompasses over 1-kb of DNA upstream of the ORF, needed for this control. To determine this,
transcription from four different gadE promoter lacZ reporter constructs (Fig. 19A bottom) in
TW14359 and TW14359ΔgrvA were compared during exponential and stationary phase growth
in DMEM. During exponential growth, transcription from gadEP1-P3-lacZ containing
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Figure 19 - Investigating the individual contribution of gadE promoters using promoter lacZ
fusions
β-galactosidase activity in Miller Units for TW14359 and mutant derivatives containing a gadEP-lacZ
fusion during growth in DMEM. (A) (top) Activity measured at an OD600=0.5 (exponential phase) and
OD600=2 (stationary phase) for TW14359 and TW14359∆grvA. (bottom) Relative location of amplified
P1, P2, P3, and P1P2P3 gadE promoter fragments, with location of individual promoters indicated with
black arrows; relative location of mapped RNA-seq transcripts are aligned roughly with their relative
position in the above gadE promoter diagram. (B and C) Activity measured at an OD600=0.5 (exponential
phase) for TW14359, TW14359∆grvA, and TW14359∆grvA∆gadE with a gadE promoter fusion
containing the P1 and P3 fragments, respectively. Asterisks denote significance by a Student’s t-test
(p<0.05, n≥3). Error bars indicate standard deviation for all panels.
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all three (P1 though P3) gadE promoters was significantly increased in TW14359∆grvA
compared to TW14359 (p=0.002) (Fig. 19A). Promoter activity from fragments containing the
P1 (gadEP1-lacZ) or P3 (gadEP3-lacZ) promoters alone were also significantly higher in
TW14359∆grvA (p<0.05), while activity from the fragment containing only the P2 promoter
(gadEP2-lacZ) did not differ between TW14359∆grvA and TW14359. As anticipated, promoter
activity from all fragments increased significantly during stationary growth for TW14359
(p<0.001), however only slightly for P2 (p<0.001) (Fig. 19A). For TW14359∆grvA, promoter
activity only further increased from P1 during stationary phase (p=0.015), and was higher than
P1 activity in TW14359. This latter observation was predicted to be due to auto-activation of the
P1 promoter by GadE, as previously shown (Ma et al., 2004). Indeed, the deletion of gadE in
TW14359∆grvA completely abrogated P1 activation during exponential growth, but had no
effect on P3 activity (Fig. 19B and 19C). Based on these findings it is predicted that GrvAdependent repression of gadE transcription is directed solely through the P3 promoter.
Transcription from the gadE P3 promoter is directly controlled by the AFI encoded
regulators GadX and GadW (Sayed et al., 2007), and RNAseq analysis of TW14359∆grvA
revealed both genes to be elevated in expression when compared to TW14359 (Table 5). It was
thus suspected that repression of P3 by GrvA was mediated through one or both of these
regulators. To test this, the effect of gadX and gadW deletion in TW14359∆grvA on P3 activity
during exponential growth (OD600=0.5) in DMEM was measured. Only the deletion of gadW was
observed to reduce transcription from P3. Activity from P3 in TW14359∆gadW and
TW14359∆grvA∆gadW was reduced significantly compared to TW14359∆grvA (p=0.01 and
0.03, respectively), but not when compared to TW14359 (Fig. 20). Conversely, P3 activity was
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Figure 20 - Investigating the contribution of GadX and GadW to increased gadE promoter activity
β-galactosidase activity in Miller Units for TW14359 and mutant derivatives containing a gadEP3-lacZ
fusion during growth in DMEM. Activity measured at an OD600=0.5 (exponential phase) for either (A)
TW14359, TW14359∆grvA, TW14359∆grvA∆gadX, and TW14359∆grvA∆gadW or (B) TW14359,
TW14359∆grvA, TW14359∆grvA∆gadW, and TW14359∆gadW with a gadE promoter fusion containing
the P3 fragment. Plots which differ by lower case letter, differ significantly by Tukey’s HSD following a
significant F-test (p<0.05, n=3). Error bars denote standard deviation.
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slightly but significantly increased in TW14359∆grvA∆gadX when compared to TW14359∆grvA
(p=0.01) (Fig. 20). Taken together, this data indicates that GrvA indirectly represses
transcription from the gadE P3 promoter during exponential growth in a manner that is
dependent on gadW.

3.3.5 Acid Resistance experiments in TW14359 and grvA mutant strains
The expression of glutamate-dependent acid resistance (GDAR) genes is growth phase
dependent; it is low during exponential growth and increases markedly as cells transition into
stationary phase (Castanie-Cornet et al., 1999). Correspondingly, exponential phase cultures are
generally acid susceptible, while stationary phase cultures are acid resistant. Since deletion of
grvA was shown to de-repress the GadW pathway activating gadE during exponential growth
(Table 4), the contribution of GrvA to the GDAR was determined for exponential cultures and
was compared to that of the GDAR phenotype of stationary phase cultures.
As expected, no colonies of wild-type TW14359 could be recovered on LBA after a 1 h
exposure of exponential cultures to acidified EG media (pH 2) (Fig.21A). However for strain
TW14359∆grvA, in which GDAR genes are de-repressed during exponential growth, 400
CFU/ml were recovered, representing 9% of the original inoculum. Complementation of
TW14359∆grvA with grvA restored wild-type levels of acid sensitivity (Fig. 21A). While GDAR
genes are upregulated in TW14359∆grvA during exponential growth, the deletion of rcsB in
TW14359∆grvA counteracts this effect for GDAR structural genes gadA and gadBC (Fig. 17).
Decreased expression of these genes in TW14359∆grvA∆rcsB was shown to correspond with a
complete loss of the GDAR phenotype during exponential growth in DMEM (Fig. 21A).
Complementation with rcsB expressed from a low-copy vector and under the control of
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Figure 21 - GrvA dependent exponential phase acid resistance phenotype
Representative experiments for acid resistance in TW14359 and mutant derivative strains during
exponential (top) and stationary (bottom) growth. Each plate represents 10-fold microdilutions of control
or acid challenged (pH 2.0) samples for each strain before and after acid challenge for 1 hour.
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its native promoters restored GDAR in TW14359∆grvA∆rcsB, but not in TW14359∆rcsB,
suggesting that expression of the phenotype requires an rcsB+ grvA¯ background. During
stationary phase, deletion and complementation of grvA had no effect on survival in acid with
100% of the initial inoculum being recovered following a 1 h challenge, suggesting that
regulation of GDAR genes by GrvA is relegated to exponential phase (Fig. 21B). For
TW14359∆rcsB and TW14359∆grvA∆rcsB however, no colonies were recovered following acid
challenge, while complementation of these mutants with rcsB restored wild-type levels of
GDAR. This effect of rcsB deletion on acid resistance is consistent with its role as an activator of
GDAR in both exponential and stationary phase cultures (Johnson et al., 2011). Interestingly
however, overexpression of rcsB has also been determined to indirectly repress GDAR genes
gadE, gadX and gadW (Castanie-Coronet et al 2010). Since rcsB overexpression also leads to
grvA upregulation (Tobe et al., 2005), it is plausible that this negative regulation of GDAR
requires the interaction of RcsB and GrvA.

3.4 Discussion
In this study, we examined the TW14359 transcriptome and defined the RcsB-GrvA
transcriptome using RNA sequencing, and identified a novel pathway for LEE gene regulation in
EHEC. RNA sequencing has been performed with E. coli strains in the past, with the commensal
MG1655 and the pathogenic EHEC O157:H7 strain Xuzhou21 (Haas et al., 2012; Zhao et al.,
2013). Both previous studies were from cultures grown LB media, which is not ideal for
examination of LEE gene transcription. In this study, cultures were grown in DMEM
supplemented with sodium bicarbonate, conditions known to induce LEE gene expression. And,
in agreement with previous accounts of differential gene expression in LB and DMEM (Iyoda et
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al., 2006; Tobe et al., 2011), flagellin (fliC) was among the most abundant transcripts detected
for LB cultures in the aforementioned studies, while motility associated genes were barely
detected in our analysis of exponentially growing cultures in DMEM. This observation is
congruent with previous work demonstrating increased transcription of genes promoting
colonization in DMEM, such as those encoding the E. coli common pilus (ECP) and long-polar
fimbriae (LPF) (Rendon et al., 2007; Torres et al., 2002). Thus, the results of this study provide
insight into the regulatory interplay of the RcsB-GrvA-GadE pathway in conditions which favor
colonization, and importantly, transcription of the LEE pathogenicity island.
Transcription of the rcsDB and grvAB operons was shown to be maximal during growth
in DMEM containing 44 mM bicarbonate. grvAB is growth phase dependent, indicating tight
transcriptional regulation. Previous reports, and our own analyses, have demonstrated that RcsB
activates grvA transcription from cultures grown at 37°C (Morgan et al., 2013; Tobe et al.,
2005). However, a recent report on curli variants in a 1993 hamburger-associated EHEC
outbreak strain demonstrated decreased transcription of grvA following the repair of a strain
specific rcsB deletion mutation (Carter et al., 2012). Possible explanations for this disparity may
include differences in the experimental conditions employed, specifically growth at 28°C. In
support of this, in EHEC strain Sakai, grvAB transcription was reported to be decreased
following transition to growth at both 25°C and 14°C compared to growth at 35°C
(Kocharunchitt et al., 2012). These observations suggest that regulation of grvAB at low
temperatures may be different from that at physiological temperatures. Importantly, the predicted
grvAB promoter contains putative RcsAB binding sites upstream of the -35 site, indicating direct
transcriptional regulation by at least RcsB. Indeed, purified RcsB was able to shift the grvA
promoter fragment containing the predicted consensus sequences, validating direct
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transcriptional regulation of grvA by RcsB alone. It is therefore possible that, during low
temperature growth conditions which do not favor Lon-dependent RcsA proteolysis (TorresCabassa and Gottesman, 1987), an RcsAB heterodimer may bind at the grvA promoter to repress
transcription, but at physiological growth temperatures RcsB alone acts as a transcriptional
activator. Such a model of transcriptional regulation exists for RcsAB potentiated repression of
the flhDC promoter (Francez-Charlot et al., 2003). However future work is required to define
the specific regulatory factors functioning at the predicted grvAB promoter.
Importantly, our data revealed substantially increased transcription of genes involved in
acid fitness and metal stress in mutants for strains TW14359∆grvA and TW14359∆rcsB∆grvA.
Interestingly, transcription of genes involved in zinc import and acquisition, such as znuA and
zinT, was substantially higher in both mutant strains. Modulation of zinc fitness was of particular
interest as zinc has been shown to have a negative effect on type III secretion in EPEC and
EHEC (Mellies et al., 2012) and, importantly, to inhibit Stx production (Crane et al., 2011).
Previous reports have revealed ZinT as being required for curli production in zinc limiting
conditions (Lim et al., 2011), and EHEC znuA mutants were deficient in adherence to Caco-2
cells, where a zinT mutation alone did not result in decreased adherence (Gabbianelli et al.,
2011). Thus, it is clear that alterations in zinc acquisition and export can have pleiotropic effects
on EHEC adherence, through direct or indirect means. One possibility is that GrvA effects basal
levels of zinc through a metabolic pathway and indirectly contributes to cytosolic zinc transport
and export. In such a model, GrvA could indirectly regulate the transcription of Zur-dependent
genes, and subsequently alter colonization and pathogenesis through subtle changes in cytosolic
zinc concentrations. Interestingly, the Rcs phosphorelay has been shown to be activated by the
presence of 1 mM ZnCl2 (Hagiwara et al., 2003), suggesting an even more complex regulatory
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relationship between RcsB, GrvA, and the zinc stress response in EHEC. However, this potential
regulatory relationship was not examined in this study.
The RNA-seq data also revealed increased transcription of genes encoded within the AR2
acid fitness island, including the transcriptional regulator gadE that activates the glutamatedependent acid resistance (GDAR) system. Importantly, GadE has been shown to repress LEE1
transcription following overproduction (Kailasan Vanaja et al., 2009), and is able to bind directly
to the LEE1 and LEE2/3 promoters in-vitro (Tree et al., 2011). This is particularly salient in light
of recent studies identifying three EHEC specific prophage encoded regulators (PsrA/ PsrB, and
PatE) that activate transcription of gadE and hdeA to direct repression of both the LEE1 and
LEE2/3 operons and modulate acid fitness (Bender et al., 2012; Tree et al., 2011). Conversely, a
recent study has suggested that GadE and GadX both negatively regulate the LEE indirectly
following exposure to nitric oxide stress (Branchu et al., 2014). Our data suggests that GrvA
plays an antagonistic role in regulating the LEE, through gadE, to promote transcription of the
LEE during early exponential growth. A report in Salmonella described a reverse phenotype
following expression of mart-fidL (a grvAB operon homolog) from S. typhimurium in S. typhi,
which lacks the mart-fidL genes, where expressing the marT-fidL operon in S. typhi reduced acid
resistance (Retamal et al., 2010). In this study, mutation of grvA resulted in increased glutamatedependent acid resistance (GDAR), but was completely dependent on an intact rcsB gene. This
finding is markedly consistent with previous accounts of RcsB-dependent activation of several
key GadE regulated GDAR genes (Johnson et al., 2011). Thus, while GrvA mediated regulation
of exponential phase glutamate-dependent acid resistance through is wholly dependent on RcsB,
GrvA regulation of the LEE is independent of RcsB.
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Based on the results of this study it is predicted that the gadEP3 promoter is likely the
target for transcriptional repression by GrvA, either direct or indirect. Indeed, the mapped reads
from TW14359∆grvA RNA sequencing correlate well with the mapped location of the gadEP3
promoter. This finding was of interest as the previously identified AraC-family prophage
encoded regulators PsrA and PsrB bind directly to the gadEP3 promoter region to stimulate
transcription of gadE following attachment (Tree et al., 2011). The 750-bp region upstream of
gadE contains 3 mapped promoters (P1, P2, and P3) and has been termed a sensory integration
region (Sayed and Foster, 2009). Indeed, there exists a complex cascade of regulatory factors
that collapse at one or more of the gadE promoters to modulate acid resistance in response to
growth phase and nutritional availability (Aiso et al., 2011; Ma et al., 2004; Sayed et al., 2007).
In this study, during exponential growth, wild-type transcription arising from the gadEP3
promoter is repressed activated following deletion of grvA. Thus, our results extend the temporal
regulation of this region during exponential growth, and further validate GadE auto-regulation at
the gadEP1 promoter. However, attempts to validate direct binding of GrvA at the gadE promoter
were unsuccessful (data not shown), suggest that its regulatory effects are indirect.
While both gadX and gadW were more highly transcribed in TW14359∆grvA, gadX
transcription in TW14359∆grvA∆rcsB was lower than the isogenic grvA mutant alone, but still
higher than wild type TW14359. This observation is agreement with RcsB mediated
transcriptional activation of the gadE independent gadX promoter (Johnson et al., 2011). Loss of
gadW abrogated the increased gadEP3 promoter activity observed in TW14359∆grvA, while
activity in TW14359∆gadX was not similarly reduced. Therefore, it is proposed that GrvA
mediated regulation of acid resistance genes occurs through a GadW-GadE pathway.
Transcription of gadW can arise from one of two mapped promoters (Tramonti et al., 2008),
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though our RNA sequencing data suggests that in TW14359∆grvA, during exponential growth,
only the gadWP1 promoter is actively transcribed. This is not surprising, as the gadX and gadW
promoters are under complex transcriptional and post-transcriptional regulation (Giangrossi et
al., 2005; Sayed et al., 2007; Tramonti et al., 2008). Further analysis is required to determine if
GrvA regulation of gadW transcription is direct, or if it is functioning through an additional
factor to influence transcriptional repression of gadW. Because increased grvAB transcription
was observed during lag and early exponential growth, it is possible that GrvA is required for
full repression of gadE transcription through gadW following transition from stationary to active
growth. Such a regulatory pathway would ensure that AFI encoded regulators, such as GadE, are
efficiently repressed during periods when adherence is advantageous.
We further went on to show that GrvA mediated activation of ler transcription is at least
partly dependent on an intact gadE gene, establishing a pathway for LEE gene regulation. The
possibility remains that one or more additional factors are controlling LEE gene repressing in the
absence of GrvA, such as cytosolic zinc levels (discussed above). Competitive adherence assays
revealed a dependence on gadE for grvA mediated regulation of adherence to HT-29 epithelial
cells. Interestingly, attempts to complement and express gadE ectopically resulted in adherence
that was reduced to levels lower even than the TTSS deficient strain TW14359∆escN. One
explanation for this observation is that, while loss of escN abrogates type III secretion, LEE
encoded regulatory genes remain intact. It is possible that some adhesin, under the control of ler,
is transcriptionally altered by overexpression of gadE. Indeed, lpf genes, encoding long polar
fimbriae, are known to be positively regulated by ler (Torres et al., 2007), and could partially
account for the disparity.
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The 32-kb O-island (OI-47) encoding the grvAB operon remains largely uncharacterized.
The vmpA gene immediately downstream of grvAB, encoded in the opposite direction, was
recently characterized and encodes a c-di-GMP phosphodiesterase that contributes to biofilm
formation and motility in EHEC strain EDL933 (Branchu et al., 2013).

Mutation or

overexpression of grvA was not observed to effect motility in TW14359 (data not shown). The
remaining OI-47 genes are functionally diverse, encoding a predicted pilus, adhesin, and usher
protein (sharing amino acid homology to the Klebsiella Mrk pilus proteins), a predicted
hemolysin-like protein, and proteins predicted to be involved in fatty-acid biosynthesis. A
CDART search (NCBI) (Geer et al., 2002) of GrvA identified an N-terminal DNA-binding
winged HTH-domain and a predicted C-terminal methylenetetrahydrofolate reductase (MTHFR)
domain, including a predicted FAD binding domain. The N-terminal domain is predicted to be
localized to the periplasmic space, and the C-terminal, DNA-binding domain, is predicted to be
located in the cytoplasm. Whether any or all of the OI-47 component genes share regulatory cues
or biological functions, or if they are independent of one another, remains to be explored. It is
interesting to speculate on the potential for periplasmic FAD activation of GrvA. Additionally,
while GrvB shares homology with ToxS, its contribution to GrvA regulation and potential
dimerization requires further analysis.
To conclude, we propose a model where, following gastric passage, bicarbonate
stimulates activation of the Rcs phosphorelay and transcription of rcsB. Subsequent high levels
of RcsB directly positively regulate transcription of the grvAB operon. As GrvA is activated,
transcription of genes associated with acid resistance and gastric passage are down-regulated,
and subsequent LEE gene transcription is stimulated to promote colonization. Work remains to
be done to establish whether GrvA is indeed a membrane bound regulator and if it binds directly
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to the gadW promoter. It is also of interest to explore the contribution, if any, of YqeI to
virulence and fitness gene regulation in EHEC and other pathogenic E. coli strains.
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Table 6 - Strains and plasmids used in Chapter 3

Strain/plasmid
Strain name:
DH5α
BL21(DE3)pLysS
MG1655
E2348/69
3256-97
TW14359
EcRJM-1
EcRJM-6
EcRJM-10
EcRJM-11
EcRJM-12
EcRJM-13
EcRJM-35
EcRJM-72
EcRJM-73
EcRJM-74
EcRJM-75
EcRJM-76
EcRJM-77
EcRJM-78

Relevant characteristics

EcRJM-79

TW14359∆grvA pRJM-24

This study

EcRJM-80

TW14359∆grvA pRJM-25

This study

Vector propagation, recA1 endA1
BL21 with IPTG inducible T7 polymerase
F-, lambda-, rph-1
Escherichia coli O127:H6; (typical EPEC)
Escherichia coli O55:H7; (atypical EPEC)
WT 2006 outbreak, western U.S.A.
TW14359∆escN
TW14359∆rcsB
TW14359rcsB-FLAG
TW14359∆grvA
TW14359∆rcsB ∆grvA
TW14359tir-FLAG
TW14359∆grlR::kan
TW14359∆rcsB pRJM20
TW14359∆lacZ
TW14359 pRJM-23
TW14359 pRJM-24
TW14359 pRJM-25
TW14359 pRJM-26
TW14359∆grvA pRJM-23

Reference

Pan, 2000
Iguchi, 2009
Zhou, 2010
Manning, 2008
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2013
This study
This study
This study
This study
This study
This study

EcRJM-81
TW14359∆grvA pRJM-26
This study
EcRJM-82
TW14359∆grvA∆gadE::kan pRJM-24
This study
EcRJM-110
TW14359∆grvA∆gadE::kan pRJM-26
This study
EcRJM-83
TW14359∆grvA pRJM-22
This study
EcRJM-84
TW14359∆rcsB∆grvA pRJM-22
This study
EcRJM-85
TW14359∆rcsB∆grvA pRJM-20
This study
EcRJM-86
TW14359 rcsDB-luxE
This study
EcRJM-87
TW14359 grvAB-luxE
This study
EcRJM-88
TW14359 rcsDB-luxE pluxCDAB3
This study
EcRJM-89
TW14359 grvAB-luxE pluxCDAB3
This study
EcRJM-90
TW14359∆gadE::kan
This study
EcRJM-91
TW14359∆grvA∆gadE::kan
This study
EcRJM-92
TW14359∆gadE::kan pRJM30
This study
EcRJM-93
TW14359∆grvA∆gadE::kan pRJM30
This study
EcRJM-94
TW14359zinT-FLAG::kan
This study
EcRJM-95
TW14359∆grvA zinT-FLAG::kan
This study
EcRJM-96
TW14359 pRJM-31
This study
EcRJM-97
EPEC E2348/69 pRJM-31
This study
EcRJM-98
MG1655 pRJM-31
This study
a
Nucleotide positions based on the published TW14359 (NC_013008) genome sequences
(NCBI)
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Table 6

Strains and plasmids used in Chapter 3, continued.

Strain/plasmid
EcRJM-99
EcRJM-100
EcRJM-101
EcRJM-102
EcRJM-103
EcRJM-104
EcRJM-105
EcRJM-106

Relevant characteristics
DH5α pRJM-31
TW14359 pRJM-32
EPEC E2348/69 pRJM-32
MG1655 pRJM-32
DH5α pRJM-32
TW14359 rcsDB-luxE pluxCDAB3 pRJM-21
TW14359 grvAB-luxE pluxCDAB3 pRJM-21
TW14359∆grvA pRJM-23

Reference
This study
This study
This study
This study
This study
This study
This study
This study

EcRJM-107

TW14359∆grvA pRJM-24

This study

EcRJM-108

TW14359∆grvA pRJM-25

This study

EcRJM-109
Plasmid name:

TW14359∆grvA pRJM-26

This study

pACYC177
pBAD22
pMPM-A2
pMPM-K3
pMPM-T3
pUC19

Low copy cloning vector, AmpR KanR P15A
R

Ara inducible expression vector, Amp M13
R

Low copy cloning vector, Amp pMB1/f1
R

Low copy cloning vector, Kan p15A/f1
R

Low copy cloning vector, Tet p15A/f1
R

High copy cloning vector, Amp pMB1
R

R

+

pRS551
pCP20
pKD4
pKM208

lac fusion vector, Amp Kan lacZ ColE1
Flp recombinase expression vector
Template plasmid for Kan cassette
Red-recombinase expression vector

pET-24d

T7 promoter, His tag vector, KanR f1, pBR322

pSU312
pRJM-20

R

R

FLAG epitope template, Amp , Kan , R6K
pACYC177-rcsB

Chang, 1978
Guzman, 1995
Mayer, 1995
Mayer, 1995
Mayer, 1995
Yanisch-Perron, 1985
Simons, 1987
Datsenko, 2000
Datsenko, 2000
Datsenko, 2000
Novagen
Uzzau, 2001
Morgan, 2013

pRJM-33
pACYC177-grvAB
This study
pRJM-21
pMPM-K3-rcsDB
This study
pRJM-22
pMPM-A2-grvA
This study
pRJM-23
pRS551-gadEp(-773,-1)
This study
pRJM-24
pRS551-gadEp(-320,-1)
This study
pRJM-25
pRS551-gadEp(-516,-276)
This study
pRJM-26
pRS551-gadEp(-773,-497)
This study
pRJM-27
pET-24d-6xHis-rcsB
This study
pRJM-28
pMPM-T3-kan
This study
pRJM-29
pMPM-T3-luxE-kan
This study
pRJM-30
pMPM-A2-gadE
This study
pRJM-31
pRS551-grvAp(-268,+38)
This study
pRJM-32
pUC-grvA-6xHIS
This study
placlux8
placlux8
Shimizu, 2011
pLuxCDAB3
pLuxCDAB3
Shimizu, 2011
a
Nucleotide positions based on the published TW14359 (NC_013008) genome sequences
(NCBI)
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Table 7 - Primers used in Chapter 3
Primers used in this study.
Primer name
FLAG-F
P1
P2
Ler+109
Ler+214
GadE +309
GadE +419
ZnuA+218
ZnuA+309
AstC+419
AstC+519
GadE-320/EcoRI
GadE-1/BamHI
GadE-276/EcoRI
GadE-516/BamHI
GadE-773/EcoRI
GadE-497/BamHI
GrvA-268/EcoRI
GrvA+38/BamHI
LuxE-18/XhoI
LuxE+1450/BamHI
pKD4For/SacI
pKD4Rev/BamHI
GrvA+1283/LuxE

a

Sequence (5'→ 3')a
gactacaaagatgacgacga
gtgtaggctggagctgcttc
catatgaatatcctccttag
CGAGAGCAGGAAGTTCAA
GTCCATCATCAGGCACAT
TGGTAAACACTTGCCCCATA
AGCGTCGACGTGATATTGCT
AGAACGCGGACTTAGTCGT
CGTTACCTGCTTCGCTTCT
GTCGCACGCTGTTTACTGT
GCATGACGGATATCTGGTG
CGCGGAATTCTCGGATTACTTTTTAACT
TT
CGCGGGATCCAACTTGCTCCTTAGCCGTT
A
CGCGGAATTCGGTTAAATAAGTAATCCG
GG
CGCGGGATCCGTTTGTGATCTCTGAAGA
AT
CGCGGAATTCGTCACTTGATGTGACTAT
GA
CGCGGGATCCGCAATGTAATCAACGCCA
GT
CGCGGAATTCGGAGGATGCGTCCCGTTCT
T
CGCGGGATCCGAGTTGAATCTTACTTCA
TC
CCGACTCGAGGGAGGGGTAAAACAGGT
CCGAGGATCCTGAGAATTTCCCTCAAAT
TT
GCGGAGCTCGTGTGTAGGCTGGAGCTGCT
TC
CCGAGGATCCCATATGAATATCCTCCTT
AG
CCACGCTTCATATGTATTTCCCACTAAC
AGCATTGTTGCTGGAGGGGTAAAACAGG
T

Restriction sites indicated by bolded nucleotides
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Function/Reference
(Uzzau, 2001)
(Datsenko, 2000)
(Datsenko, 2000)
qRT-PCR Primer/(Mitra, 2012)
qRT-PCR Primer/(Mitra, 2012)
qRT-PCR Primer/(Mitra, 2012)
qRT-PCR Primer/(Mitra, 2012)
qRT-PCR Primer
qRT-PCR Primer
qRT-PCR Primer
qRT-PCR Primer
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
pRS551 lacZ promoter fusion
luxE cloning primer
luxE cloning primer
k an from pKD4 primer
k an from pKD4 primer
grvAB, luxE insertion primer

Table 7

Primers used in this study, continued.

Primer name

Sequence (5'→ 3')a
CAATGGTATGTAAACAGATAAATAATT
AACCAATATTGGAGTGTAGGCTGGAGCT
GCTTC
ACGTTAAGTCCGGCAGATAAAGACTAA
TCATCTGTAGGCCGGAGGGGTAAAACAG
GT
GTTTACGCCGCATCTGGCATTCAGTGCA
AATGCCAGATGCGTGTAGGCTGGAGCTG
CTTC
GAAATTGTGAGCGGATAACAATTTCAC
ACAGGATACAGCTGTGTAGGCTGGAGCT
GCTTC
TTACACGAAATACGGGCAGACATGGCCT
GCCCGGTTATTACATATGAATATCCTCC
TTAG
CGATTCATTAATGCAGCTGG
CCCGTATCACTTTTGCTGAT
GCATTTATTGCTGTAGGAGAAAACTGAT
TGTTCAGGAAATGTGTAGGCTGGAGCTG
CTTC
CTGTACTACTCTGCTCAAGGGGACGTGA
TTCACTGACATTCATATGAATATCCTCC
TTAG
GGCGCAGCAGATAATGAAGC
GTGTCCTCCATGCAGAACAC
TACAGGGCTTTTGGCAGTTGAAAGATAA
TCACGAAATGATCATATGAATATCCTC
CTTAG
TAAGATGTGATACCCAGGGTGACGATGT
CGCTCATACGTCGTGTAGGCTGGAGCTGC
TTC
CAACGATTCGGACAAGGATG
ATGAAATCAGCATCTGCATC
CCGATCTAGAGTGACTATGATCCGATTA
ATACTCTCTCCG
CCGAGGATCCCTGCATCCCTCGTCATGCC
AGCCATCAATT
CCGAGGATCCCTATTTCACAAATAATT
AACATCAGCATAA
CCGATCTAGACTGACGCGTCTTATCTGGC
CTACTTTAATG
CCGAGGATCCTGCTCCTTATGAGTAAGT
AATATTTAAGGG

GrvA+1431/P2

RcsB+625/LuxE

RcsB+838/P2

LacZ-1/P1

LacZ+3115/P2

LacZ-178/FVal
LacZ+3,263/RVal
EtpD-43/P1

EtpD+1,993/P2

EtpD-122/FVal
EtpD+2,077/RVal
GadE+35/P2

GadE+521/P1

GadE-74/FVal
GadE+590/RVal
GadE-763/XbaI
GadE+577/BamHI
RcsB-3732/BamHI
RcsB+794/XbaI
GrvAB-679/BamHI
a

Restriction sites indicated by bolded nucleotides
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Function/Reference
grvAB, luxE insertion primer

rcsDB, luxE insertion primer

rcsDB, luxE insertion primer

Deletion primer

Deletion primer

Deletion validation
Deletion validation
Deletion primer

Deletion primer

Deletion validation
Deletion validation
Deletion primer

Deletion primer

Deletion validation
Deletion validation
pMPM-A2 cloning primer
pMPM-A2 cloning primer
pMPM-K3 cloning primer
pMPM-K3 cloning primer
pACYC177 cloning primer

Table 7

Primers used in this study, continued.

Primer name

Sequence (5'→ 3')a
CCGAGGATCCCTGCATCCCTCGTCATGCC
AGCCATCAATT
CCGAGGATCCCTATTTCACAAATAATT
AACATCAGCATAA
CCGATCTAGACTGACGCGTCTTATCTGGC
CTACTTTAATG
CCGAGGATCCTGCTCCTTATGAGTAAGT
AATATTTAAGGG
CCGACTCGAGCAGATAAATAATTAACC
AATATTGGAATGG
CCGACTCGAGGGAGGATGCGTCCCGTTCT
T
CCGAGGATCCGGCTCAGAATTGCTGCAA
TA
CCGATCTAGAGGAGGATGCGTCCCGTTCT
T
CCGAGAATTCTCAGTGGTGGTGGTGGT
GGTG CTCCGCTTTATAATAGAGAGAG
CGGATAAAAGACAGTACCGG
CGTTATAGGGAAAGAACGGG
GGATACGCAGTTTTTATCAG
TACATTTTATACCTTAGTTG

GadE+577/BamHI
RcsB-3732/BamHI
RcsB+794/XbaI
GrvAB-679/BamHI
GrvAB+1417 /XhoI
GrvA-268/XhoI
GrvA+884/BamHI
GrvA-268/XbaI
GrvA+810-6xHis
GrvA-365/BtFor
GrvA-238/BtRev
GrvA-236/BtFor
GrvA-1/BtRev
a

Restriction sites indicated by bolded nucleotides
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Function/Reference
pMPM-A2 cloning primer
pMPM-K3 cloning primer
pMPM-K3 cloning primer
pACYC177 cloning primer
pACYC177 cloning primer
pMPM-A2 cloning primer
pMPM-A2 cloning primer
pUC19 cloning primer
pUC19 cloning primer (6xHIS)
EMSA
EMSA
EMSA
EMSA

primer
primer
primer
primer

Chapter 4: A novel promoter drives transcription of the Escherichia coli common pilus in
the 2006 EHEC O157:H7 spinach outbreak strain TW14359
4.1 Background
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent pathotype of the
gram negative commensal bacteria, Escherichia coli. Following host colonization, pathogenesis
of EHEC is largely attributed to the production of the Shiga-like toxin (Stx), which damages the
kidney vasculature and can lead to the life-threatening hemolytic uremic syndrome (HUS) (Eaton
et al., 2008). EHEC adherence to epithelial cells, and subsequent host colonization, is enhanced
by a common pilus structure observed almost ubiquitously across E. coli strains, the E. coli
common pilus (ECP) (Rendon et al., 2007). The E. coli common pilus is a chaperone-usher
fimbrial adhesin, composed of a 21-kDa subunit encoded by the gene ecpA, and its production
plays a role in early-stage biofilm development for commensal and pathogenic E. coli and
Klebsiella pneumonia strains (Alcantar-Curiel et al., 2013; Garnett et al., 2012; Lehti et al., 2010;
Wurpel et al., 2013).
The ecp operon contains the gene ecpR, encoding a transcriptional regulator of the
common pilus operon. In pathogenic and non-pathogenic E. coli, the regulator EcpR positively
stimulates ecp transcription through the ecpR promoter, aided by integration host factor (IHF)
and RcsB to relieve H-NS mediated repression (Lehti et al., 2012b; Martinez-Santos et al.,
2012). Binding of EcpR occurs at a consensus site (TTCCT-N17-TTCCT) located upstream of
ecpR, and is believed to bind as a homodimer (Martinez-Santos et al., 2012). High levels of
promoter architecture variation have been described for the ecpR (matA) promoter sequence in E.
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coli strains and a phylogenetic organizational model has been previously proposed, with EHEC
strains belonging to group E (Lehti et al., 2013a). Within this model, production of ECP varies
between groups. For example, E. coli strain MG1655, while possessing a functional ecp operon,
is unable to counteract H-NS mediated repression of the ecp promoter and direct production of
ECP (Lehti et al., 2013a). Detailed sequence analyses have been performed for the ecpR
promoter in EHEC (Martinez-Santos et al., 2012), however no reports to-date have identified
promotable elements within the ecpR ORF, upstream of ecpA. Indeed, only the presence of
putative temperature sensitive regulatory elements downstream of ecpR has been observed from
the ecpA upstream region (Lehti et al., 2013a).
The remaining products of the ecpRABCDE operon include EcpA (the major fimbrial
subunit), EcpB (a predicted chaperone), EcpC (a putative usher protein), EcpD (the ECP tip
adhesin), and EcpE (a putative chaperone). In meningitic E. coli (NMEC) and EHEC strain
EDL933, EcpA (MatA in NMEC) is required for efficient biofilm formation (Garnett et al.,
2012; Lehti et al., 2010), indicating that successful ECP pilus formation is thus required for
attachment and biofilm production in diverse E. coli pathotypes. While a number of adhesins
produced by Shiga toxin-producing E. coli have been identified (reviewed in (Farfan and Torres,
2012)), the specific targets recognized by each adhesin and their contribution to virulence in-vivo
requires further exploration. ECP production is temperature and oxygen dependent, and
increased ecp transcription has been observed for cultures grown in DMEM, acetate, and acidic
conditions (Lehti et al., 2013a; Rendon et al., 2007). Further, for cultures grown DMEM with 5%
CO2, the addition of ethanolamine was recently shown to significantly increase transcription of
ecp, and other E. coli fimbrial adhesins, in a EutR dependent manner (Gonyar and Kendall,
2013).

112

Among divergent EHEC O157:H7 lineages, strain TW14359 has been previously
reported as having a robust LEE gene expression and adherence phenotype (Abu-Ali et al.,
2010a; Abu-Ali et al., 2010b), which is dependent on intrinsically up-regulated rcsB
transcription, and an intact type III secretion system (Morgan et al., 2013). However, factors that
contribute to increased rcsB transcription have not yet been characterized. In this study, a novel
promotable element within the ecpR open reading frame was identified that is able to drive
transcription of ecpA, and is dependent on a polymorphism specific to the EHEC O157:H7 strain
TW14359. Finally, the ECP directed regulation of type III secretion through the response
regulator RcsB is explored, and establishes a novel mechanism for co-regulation of adherence
factors by distinct and distally encoded adherence factors.

4.2 Methods……
4.2.1 Bacterial and mammalian tissue culture
The strains and plasmids used in this study are listed in Table 7 in the supplemental
material. Strains were stocked at -80°C in glycerol diluted (15% v/v final) in Lysogeny Broth
(LB), and were maintained in LB or on LB with 1.5% agar (LBA). Unless otherwise noted,
overnight (18-20 h) cultures grown in LB were used to inoculate fresh LB or LB buffered with
sodium bicarbonate (44 mM NaHCO3) or fresh Dulbecco’s Modified Eagle’s Medium (DMEM)
(4 g/l glucose, 4 mM glutamine, 44 mM NaHCO3, pH 7.4) to a final optical density 600 nm
(OD600) of 0.05. Cultures were grown at 37°C in a rotary shaker (200 RPM) using a 1:10 mediato-flask volume. Antibiotics (Sigma-Aldrich, St. Louis, MO) were added to cultures when
required.
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Maintenance and culture of Caco-2 and HT-29 colonic intestinal cells was performed as
previously described (Morgan et al., 2013). Briefly, Caco-2 or HT-29 cells were grown to
confluency in multi-well plates at 37°C with 5% CO2. Prior to infection with bacterial strains,
media was aspirated and each well was washed once and replaced with DMEM without FBS.
For adherence experiments, bacterial cultures were grown to mid-logarithmic phase (OD600 of
0.5) in DMEM, and 200 μl of culture was added to each well of a 6-well plate. Following 3 hours
of incubation, each well was washed four times using sterile PBS to remove non-adherent cells,
and adherent cells were removed using 500 μl of 0.1% Triton X-100. Finally, cells were
enumerated through serial dilution and plating on LBA agar. Each experiment was performed at
least 3 times.

4.2.2 Mutagenesis and vector construction
Primers used for the genetic manipulation are provided in Table 8. For construction of
isogenic deletion mutants and chromosomal FLAG-epitope fusion construction, the λ-Red
assisted one-step inactivation method was used, adapted for enterohemorrhagic Escherichia coli
(Lippolis et al., 2009), and as described (Mitra et al., 2012; Morgan et al., 2013). A previously
published approach was used to construct FLAG fusions to ecpA, rcsB, and tir (Morgan et al.,
2013) based on the method of Uzzau et al. (Uzzau et al., 2001). When expressed, the fusion
protein contains a seven amino acid C-terminal epitope (FLAG) that can be detected by western
immunoblots using anti-FLAG mAbs (Sigma-Aldrich. St. Louis, MO). Confirmation of genetic
constructs was done using a combination of BccI (NEB) restriction mapping and DNA
sequencing (MWG Operon, Huntsville, AL)
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Deletion of the ecpR promoter region was performed as described above using primers
EcpR-388/P2 and EcpR+40/P1. Complementation of ecpR was performed by cloning a fragment
containing the entire ecpR open reading frame, and upstream promoter region, into the
BamHI/XhoI digested low copy vector pMPM-A2 (Mayer, 1995) using primers EcpR-404/XhoI
and EcpR+637/BamHI. To express ecpR under the control of the inducible pBAD promoter, the
ecpR ORF was cloned into the pBAD-TOPO (Invitrogen) expression vector using primers EcpR1/FpBAD and EcpR+637/RpBAD. A vector expressing the ecpABCDE operon, under the control
of the TW14359 specific ecpA promoter, was created by amplifying the ecpABDCE operon
using primers EcpA-666/SacI and EcpA+6,220/XbaI, followed by SacI/XbaI digestion and
ligation into the similarly digested vector pUC19.

4.2.3 RNA purification and quantitative real-time PCR (qRT-PCR)
Primers for qRT-PCR are provided in Table 8 in supplemental materials. RNA
purification, cDNA synthesis, qRT-PCR cycling conditions and data analysis followed
previously described protocols (Riordan et al., 2010). qRT-PCR was performed using a
Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsH (16S
rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary transcript
expression levels using 2-ΔCt /10-6 as described (Livak and Schmittgen, 2001; Riordan et al.,
2010). Expression levels were compared using the appropriate t-test or by Tukey’s HSD
following a significant F-test (n≥3, α=0.05) (R. ver. 2.13.0).
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4.2.4 β-galactosidase assays
The construction of the ecpRP-lacZ reporter transcriptional fusion followed a previously
described protocol using vector pRS551 (Morgan et al., 2013). Briefly, a 306-bp fragment,
containing the ecpR promoter(s), was amplified from TW14359 genomic DNA using primers
EcpR-496/BamHI and EcpR-21/BamHI, BamHI/EcoRI digested, and cloned into the similarly
digested pRS551. To create ecpAP-lacZ fusions, fragments for regions of the ecpA promoter were
amplified with forward primers EcpA-666/EcoRI, EcpA-555/EcoRI, EcpA-496/EcoRI, EcpA387/EcoRI, EcpA-270/EcoRI, EcpA-131/EcoRI, and the reverse primer EcpA-1/BamHI from
TW14359 genomic DNA; amplified ecpA promoter fragments were digested and cloned into
similarly EcoRI/BamHI digested pRS551.
Site directed mutagenesis of the ecpA promoter nucleotide polymorphism specific to
EHEC strain TW14359 was performed by cloning the ecpA upstream region (-666 and -1
nucleotides, relative to the ecpA translational start site), using primers EcpA-666/EcoRI and
EcpA-1/BamHI, into the EcoRI/BamHI digested pUC19. Primers containing the desired C to T
mutation were designed and used to amplify the entire vector using Phusion© High-Fidelity
DNA Polymerase (NEB). The correct sequence identity of both the wild type and mutagenized
promoter fragments was confirmed through sequencing (Eurofins MWG Operon, Huntsville,
AL). The resulting fragment was digested, gel-purified, and cloned into the EcoRI/BamHI site
of pRS551. β-galactosidase activity (Miller Units) was measured as previously described and
compared between strains using the appropriate t-test or by Tukey’s HSD following a significant
F-test (n≥3, α=0.05) (R ver. 3.0.1) (Miller, 1972; Mitra et al., 2012).
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4.2.5 Protein extraction and western blotting
Protein extraction, purification and western immunoblots were performed as described
previously (Mitra et al., 2012). The amount of protein loaded on SDS-PAGE gels for western
blots was measured by a Bradford protein assay standard curve, and equal loading was validated
by western blots for GroEL using anti-GroEL mAbs (Bio-Rad, Hercules, CA). Monoclonal
antibodies against FLAG (Sigma-Aldrich, St. Louis, MO) were also used. Each experiment was
repeated a minimum of three times in independent trials. Densitometry was used to estimate
differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging System
and Image Lab 3.0 (BioRad).

4.2.6 Flow cytometry
Experiments for flow cytometry to detect relative ECP production were conducted as
previously described (Martinez-Santos et al., 2012; Morgan et al., 2013). Briefly, overnight
DMEM cultures of TW14359 or mutant derivatives co-incubated with confluent monolayers of
Caco-2 cells for 6 hours. After incubation, 106 bacteria were formalin fixed for 10 minutes and
labeled with anti-ECP antibodies overnight at 4°C. After overnight incubation, samples were
washed and labeled with goat-anti rabbit IgG Alexa Fluor 488 conjugated antibodies for 1 hour
at 4°C. Bacteria were then labeled with propidium iodide for detection using a 42-nm band pass
centered at 585 nm. Emission from Alexa Fluor fluorescence 488 was detected at a 30-nm band
pass filter centered at 530 nm. The samples were analyzed in a Becton Dickinson FACScan and
50,000 events were measured.
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4.3 Results…..
4.3.1 Promoter analysis of the ecpR and ecpA upstream regions in TW14359 identified a
novel promotable element within the ecpR open reading frame
Our previous transcriptional profiling of EHEC strain TW14359 revealed markedly
higher levels of mapped transcripts for the ecp operon (Fig. 22A) at a region upstream of ecpA,
but located within the ecpR open reading frame (Fig. 22B) (Morgan et al., 2013). The promoter
region upstream of ecpR has been well characterized in EHEC strain EDL933, and our initial
experiments in EHEC strain in TW14359, using promoter lacZ fusions, revealed significantly
higher levels of promoter activity (p<0.05) in DMEM compared with LB, in agreement with
previous reports (Fig. 22C) (Martinez-Santos et al., 2012). However, we sought to further
explore potential promotable elements capable of driving ecpA transcription, located within the
ecpR open reading frame. Cloning a fragment 666-bp upstream of the ecpA translational start
site, lacking any portion of the ecpR upstream region, into pRS551 resulted in measurable βgalactosidase activity significantly higher (p<0.05) than that of the empty vector. Activity from
the ecpAP-lacZ reporter was significantly lower than that of the ecpRP-lacZ (p<0.05), though
promoter activity of both constructs was significantly higher for cultures grown in DMEM
compared with those in LB (Fig. 22C). Maximal promoter activity of the ecpR and ecpA
promoter fragments was observed for late-log phase cultures grown in DMEM (p<0.05), and in
LB for the ecpA promoter fragment, however the ecpR promoter fragment was not altered
between mid- and late-log phase in LB (Fig. 22C). These experiments indicated that ecp
transcription in EHEC strain TW14359 could be initiated from one of two promotable elements:
(1) the promoter(s) upstream of ecpR, and (2) a promoter within the ecpR open reading frame,
and that activity from these promoters is sensitive to changes in growth phase and media.
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To identify important regions within the ecpA promoter, several lacZ fusions were
created with truncated fragments of the region upstream of the ecpA ORF, and cloned into
TW14359∆lacZ for β-galactosidase assays (Fig. 22D). The largest fragment, at 666-bp upstream
of ecpA, had the highest detectable promoter activity. Loss of the first 100-bp resulted in a
significant drop in promoter activity (p<0.05), which increased slightly following subsequent
100-bp truncation. The final fragment, at 131-bp upstream of ecpA, displayed levels which
remained significantly higher (p<0.05) than that of the empty vector, but were substantially
lower than that of the largest fragment (Fig. 22E). Collectively, these results support the
observations of transcriptional activity from an element upstream of ecpA, and reveal a region of
importance for maximal activity located upstream of the ecpA translational start site, within the
ecpR open reading frame.

4.3.2 Basal EcpA production independent of the ecpR promoter
In the previous experiments, promoter activity was observed for the region upstream of
ecpA within the ecpR open reading frame. It was thus hypothesized that, while primary ecp
transcription arises from a promoter upstream of ecpR, basal activity from a promoter located
within the ecpR ORF promoter would be sufficient to detect cytosolic EcpA production. To test
this, a strain with a chromosomally FLAG tagged ecpA gene was created. A kanamycin drug
cassette was then inserted into the region just upstream of the ecpR translational start site,
replacing the entire ecpR promoter region. Importantly, the kan cassette was inserted in a reverse
orientation from the ecp operon to prevent polar transcription from the kan promoter. For
cultures grown to mid-logarithmic phase in DMEM, EcpA was observed in the wild type strain
with an intact ecpR promoter, and EcpA production was substantially increased by
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Figure 22 – The transcriptional regulation of ecpR and ecpA
(A) The ecp operon organization with the respective location of the promoter upstream of ecpR, and the
described or predicted function of each gene. (B) Transcriptome profiling for the ecp operon. Mapped
transcripts are indicated in green (forward orientation) and red (reverse orientation). (C) β-galactosidase
activity in Miller units of ecpRP496-lacZ and ecpAP666-lacZ measured during mid log (OD600 of 0.5), late
log (OD600 of 1.0), and stationary (OD600 of 2.5) growth phases. Asterisks denote significance by a
Student’s t-test (p<0.05, n≥3). (D) Diagram indicating the relative location of ecpR and ecpA promoter
fragments for lacZ transcriptional fusions cloned into pRS551, with the ecpR and predicted ecpA
promoters denoted by a solid or hatched arrow, respectively. (E) β-galactosidase activity in Miller units
of each ecpAP-lacZ promoter fragment tested, including the empty vector (pRS551) control, in strain
TW14359∆lacZ. Plots which differ by lower case letter, differ significantly by Tukey’s HSD following a
significant F-test (p<0.05; n≥3). Error bars indicate standard deviation for all panels.
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Figure 23 - Western blot analysis of EcpA-FLAG in TW14359
Western blot for EcpA-FLAG, from cultures grown in DMEM or LB during exponential growth (OD600
of 0.5), for strains TW14359 and TW14359∆ecpRP::kan. GroEL was included as a control for equal
loading.
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ectopically expressing EcpR from its native promoter on a multi-copy vector (Fig. 23).
Following deletion of the ecpR promoter region, detectable cytosolic EcpA was similar to that of
the un-induced wild type strain, though activation of EcpA production by EcpR overproduction
was completely abrogated. This observation is in-line with the current model of EcpR mediated
transcriptional activation of ecpR, at the EcpR binding sites upstream of the ecpR promoter, and
corroborates basal production of EcpA in EHEC strain TW14359 directed through an additional
promoter within the ecpR open reading frame.

4.3.3 A single nucleotide polymorphism within the TW14359 ecpR open reading frame is
required for maximal ecpA promoter activity
An alignment of a region 666-bp upstream of the ecpA ORF from several pathogenic and
non-pathogenic E. coli strains revealed substantial sequence diversity (Fig. 24). Fragments from
several strains, representing a spectrum of sequence variation, were examined using promoter
lacZ fusions in TW14359∆lacZ. Surprisingly, only the ecpA upstream fragment from EHEC
strain TW14359 displayed β-galactosidase activity above that of the empty vector control (Fig.
25A). Further analysis of the ecpA upstream region, compared with other E. coli strains,
identified a polymorphism unique to TW14359. The most closely related sequence was that of
EHEC strain Sakai, which contained a single nucleotide difference within a region predicted,
through in-silico analysis, to contain a sigma-70 promoter. To explore the significance of this
polymorphism, the 666-bp fragment upstream of ecpA, from strain TW14395, was cloned into
vector pUC19 and the nucleotide thymine was changed to a cytosine using site-directed
mutagenesis. The resulting fragment was subsequently cloned into pRS551 assayed for promoter
activity. As expected, the T to C mutation resulted in significantly decreased promoter activity
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Figure 24 - Alignment of the ecpA upstream region from select E. coli strains
Alignment for multiple E. coli strains for the region upstream of ecpA, but not including the ecpR
upstream region. The predicted ecpA promoter is indicated with bold letters, and an asterisk indicates the
nucleotide polymorphism unique to EHEC strain TW14359.
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Figure 25 - Characterizing the TW14359 ecpA specific promoter polymorphism
(A) β-galactosidase activity in Miller units of ecpAP666-lacZ for different E. coli strains. (B) βgalactosidase activity in Miller units for the ecpA promoter of TW14359, Sakai, E2348/69 (EPEC
O127:H6), the TW14359 ecpA promoter with a site-directed mutation, and the E2348/69 ecpA promoter
with a site-directed mutation. All experiments were performed using strain TW14359∆lacZ, and the
empty vector (pRS551) was included as a negative control. Asterisks denote significance by a Student’s ttest (p<0.05; n≥3). Error bars denote standard deviation for all panels.
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(p<0.05), comparable to that of strain Sakai (Fig. 25B). Collectively these experiments reveal a
promotable region located upstream of the ecpA ORF, in EHEC strain TW14359, that is
dependent on a single nucleotide polymorphism within a predicted sigma-70 promoter region.
However, alteration of the same nucleotide from the EPEC O127:H6 ecpA upstream region did
not yield detectable promoter activity, suggesting that one or more additional nucleotide
differences contribute to ecpA promoter function.
Activity from the TW14359 ecpA promoter was observed to be weaker than that of the
ecpR promoter (Fig. 22C). Since direct binding of H-NS to the ecpR open reading frame has
been previously described, and has been shown to play an important role in regulation of ecp
transcription (Lehti et al., 2013a; Martinez-Santos et al., 2012), it was of interest to examine
whether the ecpA promoter activity observed for TW14359 was under the control of H-NS.
Indeed, mutation of hns significantly increased activity (p<0.05) from the TW14359 ecpA
promoter fragment, while only slightly increasing promoter activity from the Sakai ecpA
promoter fragment (Fig. 26). Though activation of the Sakai derived ecpA promoter was
marginal in the absence of H-NS, activity was significantly higher (p<0.05) than that of the
empty vector alone, suggesting that the fragment contains a very weak promoter which is
effectively silenced by H-NS. Taken together, this data suggests that H-NS binding actively
represses transcription of the ecpR and ecpA promoters in TW14359.

4.3.4 Adherence to epithelial cells mediated by ECP in the absence of the ecpR promoter
The positive role of the E. coli common pilus in adherence to cultured epithelial cells has
been previously described (Rendon et al., 2007; Saldana et al., 2009a). Therefore, we sought to
explore the contribution of the TW14359 specific ecpA promoter in ECP production
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Figure 26 - Regulation of the TW14359 ecpA promoter by H-NS
β-galactosidase activity in Miller units of ecpAP666-lacZ (source of cloned promoter fragment in
parentheses, strain TW14359 or Sakai) in wild type TW14359∆lacZ or TW14359∆lacZ∆hns::kan from
cultures grown to mid-exponential phase (OD600 of 0.5) in LB; The empty vector (pRS551) was included
as a negative control. Plots which differ by lower case letter, differ significantly by Tukey’s HSD
following a significant F-test (p<0.05; n≥3). Error bars indicate standard deviation for all panels.
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Figure 27 - ECP directed adherence and production of ECP by the ecpR and ecpA promoters
(left) Box plots for the level of ECP production determined by flow cytometry, in bacteria adhering to
Caco-2 cultured epithelial cells, for strains TW14359, TW14359∆ecpA::kan, and TW14359∆ecpRP::kan
with or without pecpR. (top right) CFU/ml of EHEC strain TW14359 recovered following incubation
with Caco-2 cells in different ecp mutant strains. Asterisks denote significance by a Student’s t-test (**,
p<0.01; ***, p<0.001; n≥3). Plots which differ by lower case letter, differ significantly by Tukey’s HSD
following a significant F-test (p<0.05, n≥3). (bottom right) CFU/ml of MG1655 containing pecpABCDE
or the empty vector pUC19. Asterisks denote significance by a Student’s t-test (*, p<0.05; n≥3). Error
bars indicate standard deviation for all panels.
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and adherence. As expected, overproduction of EcpR led to significantly elevated ECP
production (p<0.01), compared with wild type, and mutation of ecpA resulted in minimal
detection of ECP production (Fig. 27A). Importantly, while mutation of the ecpR promoter
region led to a substantial reduction in ECP production, detectable ECP levels were roughly 4.7fold higher than the ecpA mutant, revealing that basal activity from the remaining ecpA promoter
was able to produce low levels of ECP. In agreement with western blots for EcpA,
overproduction of EcpR did not affect basal production of ECP in strain TW14359∆ecpRP::kan.
Adherence to Caco-2 cells was observed to significantly increase following
overexpression of ecpR in wild type TW14359 (p<0.05), as expected from previous reports
(Rendon et al., 2007) and our own observations (Fig. 27B). However, adherence experiments
comparing strains TW14359∆ecpA and TW14359∆ecpRP::kan, or their respective ecpR
overexpression strains, were not significantly different from one another, suggesting that
transcription from the TW14359 specific ecpA promoter alone is not sufficient to alter
adherence, at least in the conditions tested in this study. While the preceding experiments were
unable to detect noticeable contributions to adherence from the TW14359 specific ecpA
promoter, it was hypothesized that this might be due to its low level of promoter activity, and
subsequent ecp transcription, compared with that of the fully activated ecpR promoter. To
address this, the ecpABCDE operon, excluding the entire ecpR upstream promoter region, was
cloned into a high copy vector under the control of the TW14359 ecpA promoter. Because the
ecp operon is not actively transcribed in E. coli strain MG1655, due to mutations inactivating the
ecpR promoter (Lehti et al., 2010), it was used in adherence experiments with HT-29 human
colonic epithelial cells. Indeed, expression of the ecpABCDE operon resulted in significantly
increased adherence (p<0.05), compared to MG1655 containing the empty vector alone (Fig.
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27C). Collectively, these experiments suggest that, while low levels of ECP production from the
native ecpA promoter was not able to detectably alter adherence in EHEC strain TW14359, ecp
transcription arising solely from the TW14359 ecpA promoter is able to increase adherence when
expressed from a high copy vector.

4.3.5 Overproduction of EcpR increases cytosolic RcsB and Tir protein levels
Transcription of ecpR (matA) in meningitic E. coli has been shown to require the
response regulator RcsB (Lehti et al., 2012b). However, in EHEC, the rcsB consensus binding
site was shown to be dispensable for transcription of ecpR in a study using a multi-copy reporter
system (Martinez-Santos et al., 2012). In this study, overexpression of ecpR led to significantly
higher ecpA transcription compared with wild-type (P<0.001), but did not alter transcription of
ecpA in TW14359∆rcsB or TW14359∆ecpRP::kan, in agreement with previous accounts of RcsB
and EcpR dependent ecp transcriptional (Fig. 28A) (Lehti et al., 2012b; Martinez-Santos et al.,
2012).
In EHEC strain TW14359, rcsB transcription is intrinsically up-regulated when compared
with EHEC strain Sakai (Morgan et al., 2013). However, the specific factors that contribute to
this phenotype have not yet been identified. It was therefore of interest to determine whether
increased ECP production had a role in transcriptional regulation of rcsB. To further explore the
potential co-regulation of EcpR and RcsB in EHEC strain TW14359, ecpR was cloned into a
multi-copy vector and expressed from either an arabinose inducible promoter or from the native
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Figure 28 - qRT-PCR and Western blot analysis of rcsB, ecp, and LEE gene targets
(A) Transcript levels for espA, tir, rcsB, and ecpA in wild type and derivative TW14359 strains
expressing ecpR on a multi-copy plasmid (pecpR) from its native promoter. Asterisks denote significance
by a Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001; n≥3). Error bars indicate standard deviation for
all panels. (B and C) Representative western blots for RcsB-FLAG or (D) Tir-FLAG for cultures grown
to mid-exponential phase (OD600 of 0.5) in LB or DMEM, with or without vector pBAD-ecpR, pecpR, or
prcsDB.
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ecpR promoter. Overproduction of ecpR was observed to slightly but significantly (p<0.05)
increase transcription of rcsB compared with wild-type TW14359, which was dependent upon an
intact ecpR promoter (Fig. 28A). Indeed, overproduction of EcpR, under the control of an
arabinose inducible promoter (pBAD-ecpR), or its native promoter (pecpR), resulted in visibly
increased cytosolic RcsB for cultures grown in LB, with a slight increase for cultures grown in
DMEM (Fig. 28B and 28C).
In EHEC O157:H7 strains, RcsB overproduction is able to stimulate LEE gene
transcription and subsequent type III secretion (Tobe et al., 2005). Since increased rcsB
transcription was observed following ecpR overexpression, it was hypothesized that this may
have an impact on LEE gene transcription. Therefore, transcription and cytosolic levels of the
LEE encoded protein Tir was assessed in strains overexpressing ecpR. Analysis of tir
transcription using qRT-PCR revealed significantly increased levels in TW14359 pecpR
(p<0.05), but not in TW14359∆ecpRP::kan pecpR or TW14359∆rcsB pecpR (Fig. 28A). Indeed,
overproduction of ecpR resulted in visibly increased production of cytosolic Tir during growth in
LB, but not for cultures grown in DMEM (Fig. 28D). As a positive control for LEE activation,
expression of the rcsDB operon from a multi-copy vector resulted in a similarly increased level
of cytosolic Tir during growth in LB, with a slight increase observed during growth in DMEM
(Fig. 28D). These results demonstrate that overproduction of EcpR is able to increase production
of RcsB and LEE encoded Tir. However, it was not clear whether the regulator EcpR was
directly influencing their transcription, or whether the effect was indirect.
It was thus hypothesized that production of ECP pilus was indirectly influencing
production of RcsB and Tir, rather than direct activation by EcpR. To address this, rcsB and tir
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Figure 29 - qRT-PCR and western blot analysis of rcsB, ecp, and LEE gene targets with
pecpABCDE
(A) Representative western blots for RcsB-FLAG for cultures grown to mid-exponential phase (OD600 of
0.5) in LB or DMEM, with or without vector pecpABCDE. (B) Transcript levels for tir, rcsB, and ecpA in
wild type and derivative TW14359 strains expressing pecpABCDE on a multi-copy plasmid from the
TW14359 ecpA promoter (666 bp upstream of the ecpA start codon) for exponential (OD600 of 0.5) phase
LB cultures. Asterisks denote significance by a Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001;
n≥3). Error bars indicate standard deviation for all panels.

132

transcript levels were determined in TW14359 containing a vector expressing ecpABCDE under
the control of the TW14359 specific ecpA promoter. In support of this hypothesis, significantly
higher levels of transcription (p<0.05) were observed for rcsB and tir compared to wild type
TW14359, with concomitantly elevated RcsB protein in strain TW14359 pecpABCDE (Fig. 29A
and 29B). And, consistent with the activity of the TW14359 ecpA promoter, loss of the ecpR
upstream region did not completely abrogate ecpA transcription (Fig. 29B). However, as
previously observed, TW14359∆ecpRP::kan and TW14359∆ecpRP::kan pecpABCDE did not
have significantly different levels of rcsB or tir transcription. Collectively, the results of these
experiments suggest that transcriptional activation of rcsB and tir transcription by ecpR requires
an intact ecpR promoter, and confirm that EcpR mediated transcriptional activation of the ecp
operon, in EHEC strain TW14359, requires an intact rcsB gene.

4.4 Discussion
A number of chaperone-usher fimbriae are encoded within the E. coli genome (Wurpel et al.,
2013), however their specific contribution to the colonization in the human host, or the specific
host targets recognized, remains largely unknown. The contribution of the E. coli common pilus
for adherence to cultured epithelial cells has been previously described (Rendon et al., 2007),
and a report using the commensal E. coli strain Nissile 1917 identified ecpA as being required for
colonization in an infant mouse model (Lasaro et al., 2009); more recently, virulence attenuation
was observed for avian pathogenic E. coli (APEC) following mutation of the ECP tip adhesin
gene, ecpD (Stacy et al., 2014). Though, the contribution of ECP to host colonization and
virulence for EHEC strains has yet to be definitively shown. Among pathogenic and nonpathogenic E. coli strains the ecp operon structure is highly conserved; however, a phylogenetic
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grouping has been defined based on promoter architecture of ecpR (matA), and the diverse
regulatory patterns of the ecp operon among strains are at least in part a direct result of this
promoter sequence variation (Lehti et al., 2013a). For example, transcription and production of
ECP during growth at physiological temperatures is observed for EHEC strains, but not for
NMEC (Lehti et al., 2013a). The results presented in this study identify a regulatory feature of
the ecp operon that is unique to EHEC strain TW14359, and reveal novel a pathway for ECP
mediated rcsB transcriptional activation and LEE gene regulation.
Using the mapped transcripts from previous RNA sequencing experiments (Morgan et.
al., 2014), the transcriptional profile of the ecp operon was examined. In agreement with
previous reports (Lehti et al., 2013a), transcription of the ecp operon appears to be under the
control of a transcriptional terminator (d'Aubenton Carafa et al., 1990), with levels of mapped
transcript reduced substantially near the location of the mapped terminator sequence within the
ecpA-ecpB intergenic region. Indeed, modulation of mRNA production through transcriptional
termination has been previously described in other pilus and fimbrial operons, and was proposed
to regulate stoichiometric levels of adhesin assembly machinery (He et al., 2004; Jordi et al.,
1993; Kram et al., 2008). More importantly, while the entire operon was mapped, the highest
level of mapped transcript was located within and immediately upstream of ecpA. This finding
suggested that, though the promoter(s) upstream of ecpR can drive production of ECP, another
previously cryptic element within the ecpA ORF was capable of promoting transcription. In this
study, a TW14359 specific polymorphism was characterized within the ecpR ORF that is
required for ecpRP-independent ecpA transcription. While the region upstream of ecpA in is
largely transcriptionally silent in E. coli strains, in EHEC strain TW14359 the promoter activity
was detectable. This promoter activity required a single polymorphism located near a predicted
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sigma-70 promoter region, and was negatively repressed by H-NS. One possibility is that the
polymorphism present in TW14359 alters the binding affinity of some unknown factor required
for efficient transcription from the ecpA promoter. Alternatively, it may more directly influence
the architecture of the promoter itself. A sequence analysis revealed a predicted sigma-70
promoter immediately upstream of polymorphism, and this difference might disrupt or inhibit
RNA polymerase binding. Repression by H-NS was present in EHEC strain Sakai, but promoter
activity was significantly lower than strain TW14359. It is then possible that the promoter for
ecpA transcription exists in the other strains assayed, but is cryptic in function. Future work is
aimed at determining the specific ecpA promoter sequence, and at identifying potential
regulatory elements present in TW14359 which may contribute to its distinct regulation when
compared with other E. coli strains. The results of this study thus show that, even without
repression by H-NS, ecpA promoter activity from other E. coli strains is significantly weaker
than that of TW14359.
While EcpR directly regulates transcription from the EcpR promoter, and has been shown
to weakly bind to the ecpA upstream region (Lehti et al., 2013a), loss of ecpR or its
overproduction had no effect on transcription from the ecpA promoter. This is consistent with
the fact that sequence analysis of the ecpA upstream region did not reveal any EcpR binding
consensus sites (TTCCT-N17-TTCCT) (Martinez-Santos et al., 2012) within the region 666-bp
upstream of ecpA. Overall, this data is consistent with the observation of high levels of mapped
transcripts within the ecpA ORF, and the presence of a predicted sigma-70 promoter (Huerta and
Collado-Vides, 2003). Future experiments are aimed at identifying potential factors or conditions
which act through the ecpA promoter to direct ECP production independent of primary
transcription from the promoter(s) upstream of ecpR.
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Further, this study has corroborated the contribution of ECP pilus production to cultured
epithelial cells (Garnett et al., 2012; Rendon et al., 2007), specifically to Caco-2 and HT-29
epithelial cells. E. coli strains have been shown to produce an expansive repertoire of adhesins
contributing to adherence, including intimin, curli, hemorrhagic coli pili (HCP), long polar
fimbriae (Lpf), the acid inducible YadK, and others (Avelino et al., 2010; Chingcuanco et al.,
2012; DeVinney et al., 1999; Elliott et al., 2000; Erdem et al., 2007; Fordtran and Locklear,
1966; Garnett et al., 2012; Giron et al., 2002; Gonyar and Kendall, 2013; Hernandes et al., 2013;
Hernandes et al., 2011; Kenny et al., 1997b; Saldana et al., 2009b; Torres et al., 2002;
Xicohtencatl-Cortes et al., 2007). It is therefore not difficult to rationalize the variation observed
in promoter architecture for different E. coli pathotypes, and even further promoter sequence
refinement within hemorrhagic E. coli strains, where each pathotype alters the expression of
surface expressed adhesins to suit its unique biological niche or preferred site of colonization.
This is important particularly in light of the co-regulatory nature of different EHEC adhesins,
such as Ler (LEE1 encoded, transcriptional activator of the LEE) mediated activation of Lpf
transcription (Elliott et al., 2000; Sperandio et al., 2000; Torres et al., 2007). This dynamic
extends beyond just regulation, as the localized adherence pattern of enteropathogenic
Escherichia coli was shown to be dependent on bundle-forming pili (BFP), the T3SS and ECP
working synergistically with other adhesins to coordinate adherence to host epithelial cells
(Saldana et al., 2009a). Conversely, a recent study identified factors involved in the formation
and microanatomy of E. coli strain W3110 macrocolonies, and showed that type I fimbriae and
ECP were dispensable, while flagella production played a significant role in macrocolony
morphology (Serra et al., 2013). However, for different non-pathogenic E. coli strains, such as
MG1655 and W3110, the promoter upstream of ecpR has undergone mutational attrition and is
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no longer able to facilitate active ecpR transcription (Lehti et al., 2013a). It is therefore
interesting to speculate on the potential contribution of ECP to the formation of the distinct
macrocolony structure in ECP strains producing biofilms.
Expression of ecpR from a multi-copy vector resulted in substantially increased ecpA
transcription, but was completely dependent on an intact rcsB gene. However, a previous report
using EHEC strain EDL933 found that the RcsB consensus site was dispensable for ecpR
promoter activity (Martinez-Santos et al., 2012). The reason for this disparity might be due to the
nature of the expression analysis performed, wherein the authors utilized a multi-copy vector for
their expression experiments, which might have masked subtle regulatory interactions between
RcsB and EcpR at the ecpR promoter. However, this study has corroborated the RcsB dependent
regulatory pathway for ecp transcriptional activation, through the ecpR promoter(s), at least in
EHEC strain TW14359.
Strain TW14359 has been previously shown to possess intrinsically upregulated rcsB
transcription, which was shown to be required for its increased adherence phenotype compared
with EHEC strain Sakai (Abu-Ali et al., 2010b; Morgan et al., 2013). However, the specific
factors which contribute to increased rcsB transcription remained elusive. Since transcription of
matA (ecpR) was shown to be dependent on RcsB (Lehti et al., 2012b), and our own analysis
validated this finding in EHEC strain TW14359, the potential contribution of increased ECP
biogenesis on RcsB production was explored. Where previous reports aimed at examining the
contribution of EcpR (MatA) to the transcriptional regulation of rcsB did not identify a
significant increase in rcsB transcript (Lehti et al., 2012b), this study revealed a slight but
significant increase in strain TW14359. Differences in the two strains examined, as well as the
specific growth conditions, might account for the disparity in the studies. Furthermore, and in
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agreement with RcsB regulation of type III secretion (Tobe et al., 2005), increased tir mRNA
and cytosolic Tir was detected following overproduction of ECP, specifically following
overexpression of ecpR. It is important to note that, while overproduction of EcpR did increase
cytosolic levels of RcsB, a similar increase was also observed following overexpression of the
ecp operon alone without ecpR. Therefore, one intriguing possibility is that activation of rcsB
transcription is a result of increased ECP pilus production, rather than a result of direct or
indirect activation by EcpR, such as is the case with EcpR mediated repression of motility
through the flhDC promoter (Lehti et al., 2012a). Bacterial sensing of pilus production has been
previously reported during overproduction of the type IV bundle-forming pilus, resulting in
activation of the Cpx envelope stress response system (Nevesinjac and Raivio, 2005). And, more
recently, loss of ecpD (encoding the ECP tip adhesin) was shown to decrease motility in APEC
(Stacy et al., 2014). Collectively, these findings indicate that increased production of the ECP
pilus is able to modulate transcription of rcsB, and thus indirectly effect the production of
additional, distally encoded, adherence factors in EHEC strain TW14359. As ECP production
has been found to play a critical role in E. coli biofilm formation (Lehti et al., 2010; Rendon et
al., 2007; Stacy et al., 2014), it is possible that biogenesis of the E. coli common pilus may
directly or indirectly activate the Rcs phosphorelay and transcription of genes involved in
biofilm formation.
To conclude, in EHEC strain TW14359 it was shown that transcription of ecpA is under
the control of a promoter that is repressed by H-NS. The promoter activity in TW14359 was
further shown to be dependent on a strain specific polymorphism, and that mutation of the SNP
to that of the closely related Sakai sequence reverted promoter activity to the low level observed
for other E. coli strains. Furthermore, overproduction of ECP stimulated production of RcsB and
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the LEE encoded Tir. And finally, ecp transcription, driven by the promoter upstream of ecpA,
was able to positively affect adherence to cultured epithelial cells.
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Table 8 - Strains and plasmids used in Chapter 4

Strain/plasmid
Strain name:
DH5α
MG1655
E2348/69
3256-97
TW14359
Sakai
CFT073
EAEC O42
UTI89
EcRJM-6
EcRJM-10
EcRJM-13
EcRJM-73
EcRJM-86
EcRJM-113
EcRJM-114
EcRJM-115
EcRJM-116
EcRJM-117
Plasmid name:
pACYC177
pBAD-TOPO
pMPM-K3
pUC19
pRS551
pCP20
pKD4
pKM208
pSU312
placlux8
pLuxCDAB3
pRJM-34
pRJM-35
pRJM-36
pRJM-37
pRJM-38
pRJM-39

Relevant characteristics

Reference

Vector propagation, recA1 endA1
F-, lambda-, rph-1
Escherichia coli O127:H6; (typical EPEC)
Escherichia coli O55:H7; (atypical EPEC)
WT 2006 outbreak, western U.S.A. (EHEC)
WT 1996 outbreak, Osaka, Japan (EHEC)
Escherichia coli O6:K2:H1 CFT073 (UPEC)
Wild-type Peruvian Escherichia coli O44:H18
(EAEC)
Escherichia coli O18 K1 H7 UTI89 (UPEC)
TW14359∆rcsB
TW14359rcsB-FLAG
TW14359tir-FLAG
TW14359∆lacZ
TW14359 rcsDB-luxE
TW14359∆ecpRp::kan
TW14359∆ecpA::kan
TW14359 ecpA-FLAG
TW14359∆ecpRp::kan ecpA-FLAG
TW14359∆lacZ∆hns::kan

Low copy cloning vector, AmpR KanR P15A
Ara inducible expression vector, pBR322
Low copy cloning vector, KanR p15A/f1
High copy cloning vector, AmpR pMB1
lac fusion vector, AmpR KanR lacZ+ ColE1
Flp recombinase expression vector
Template plasmid for Kan cassette
Red-recombinase expression vector
FLAG epitope template, Amp R, KanR, R6K
placlux8
pLuxCDAB3
pecpR, ecpR ORF and promoter in vector pMPMK3
pBAD-ecpR, ecpR ORF in pBAD-TOPO vector
pMPMBAD-ecpR, ecpR ORF and pBAD promoter
cloned from pRJM-35 in pMPM-K3
pecpABCDE, ecpABCDE operon cloned into pUC19
pRS551-ecpR (-496,-1), from TW14359
pRS551-ecpA (-666,-1), from TW14359

a

Iguchi, 2009
Zhou, 2010
Manning, 2008
Michino, 1998
Welch, 2002
Nataro, 1985
Chen, 2006
Morgan, 2013
Morgan, 2013
Morgan, 2013
Morgan, 2014
Morgan, 2014
This study
This study
This study
This study
This study

Chang, 1978
Invitrogen
Mayer, 1995
Yanisch-Perron, 1985
Simons, 1987
Datsenko, 2000
Datsenko, 2000
Datsenko, 2000
Uzzau, 2001
Shimizu, 2011
Shimizu, 2011
This study
This study
This study
This study
This study
This study

Nucleotide positions based on the published TW14359 (NC_013008) genome sequences
(NCBI)
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Table 7
Strain/plasmid
Plasmid name:
pRJM-40
pRJM-41
pRJM-42
pRJM-43
pRJM-44
pRJM-45
pRJM-46
pRJM-47
pRJM-48
pRJM-49
pRJM-50
pRJM-51
pRJM-52
pRJM-53
pRJM-54
pRJM-55
pRJM-56
pRJM-21

Strains and plasmids used in Chapter 3,
continued.
Relevant characteristics

Reference

pRS551-ecpA (-555,-1), from TW14359
pRS551-ecpA (-496,-1), from TW14359
pRS551-ecpA (-387,-1), from TW14359
pRS551-ecpA (-270,-1), from TW14359
pRS551-ecpA (-131,-1), from TW14359
pRS551-ecpA (-666,-1), from Sakai
pRS551-ecpA (-666,-1), from UTI89
pRS551-ecpA (-666,-1), from CFT073
pRS551-ecpA (-666,-1), from O55:H7
pRS551-ecpA (-666,-1), from O127:H6
pRS551-ecpA (-666,-1), from MG1655
pRS551-ecpA (-666,-1), from TW14359 (T to C
directed mutation)
pRS551-ecpA (-666,-1), from O127:H6 (C to T
directed mutation)
pUC19-ecpAP (-666,-1), from TW14359
pUC19-ecpAP (-666,-1), from TW14359 (T to C
directed mutation)
pUC19-ecpAP (-666,-1), from O127:H6
pUC19-ecpAP (-666,-1), from O127:H6 (C to T
directed mutation)
pMPM-K3-rcsDB

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

a

This study
This study
This study
This study
This study
This study
Morgan 2014

Nucleotide positions based on the published TW14359 (NC_013008) genome sequences
(NCBI)
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Table 9 - Primers used in Chapter 4

Primer name

Function/Reference

FLAG-F

Sequence (5'→ 3')a,b
gactacaaagatgacgacga

P1

gtgtaggctggagctgcttc

Datsenko, 2000

P2

catatgaatatcctccttag

Datsenko, 2000

Tir+664

ACTTCCAGCCTTCGTTCAGA

qRT-PCR Primer/Mitra, 2012

Tir+869

TTCTGGAACGCTTCTTTCGT

qRT-PCR Primer/Mitra, 2012

EspA+128

AGGCTGCGATTCTCATGTTT

qRT-PCR Primer/Mitra, 2012

EspA+310

GAAGTTTGGCTTTCGCATTC

qRT-PCR Primer/Mitra, 2012

RcsB+300

TCTGGATATCGAAGGGATCG

qRT-PCR Primer/Morgan, 2013

RcsB+485

AACAGGCGCAGAACTTCACT

qRT-PCR Primer/Morgan, 2013

EcpA+208

CTATTTGACGTGGCTATCG

qRT-PCR Primer

EcpA+291

CTGGGTTAATGTGTTGGTG

qRT-PCR Primer

Hns-41/P1

Hns-83/FVal

CCTCAACAAACCACCCCAATATAAGTTT Deletion Primer
GAGATTACTACAGTGTAGGCTGGAGCTGC
TTC
CGCCGATGGCGGGATTTTAAGCAAGTGCA Deletion Primer
ATCTACAAAAGCATATGAATATCCTCCT
TAG
CTGAATTTAAGGCTCTATTA
Deletion Validation

Hns+482/RVal

TGTCTTAAACCGGACAATAA

EcpR-388/P2

EcpR-496

CTTATCATTTAGACTTGTTTTTTTACTAG Deletion Primer
TCCATTACACACATATGAATATCCTCCT
TAG
CAACCTCATAGTCCCTGCTGTAATCATTT Deletion Primer
TGCCATGTCACGTGTAGGCTGGAGCTGCT
TC
GGGATGAACACCCATAACCA
Deletion Validation

EcpR+70

CAGAACGGTTTTGACATTCC

EcpA-41/P1

EcpR-496

TGGGACATCACGTCCTCAATTCAACTCGG Deletion Primer
GAAGAAATACAGTGTAGGCTGGAGCTGC
TTC
GGGATGAACACCCATAACCA
Deletion Validation

EcpR+70

CAGAACGGTTTTGACATTCC

EcpA-41/P1

TGGGACATCACGTCCTCAATTCAACTCGG Deletion Primer
GAAGAAATACAGTGTAGGCTGGAGCTGC
TTC
CCCTGCTGGTACATCAGAGAGATTAACT Deletion Primer
GGTCCAGGTCGCCATATGAATATCCTCCT
TAG

Hns+455/P2

EcpR+40/P1

EcpA+610/P2

Uzzau, 2001

Deletion Validation

Deletion Validation

Deletion Validation

a

Restriction sites indicated by bolded and underlined nucleotides

b

Nucleotides changed through site-directed mutagenesis are indicated by bold nucleotides.
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Table 8

Primers used in Chapter 4, continued.

Primer name

Function/Reference

EcpA+524

Sequence (5'→ 3')a,b
CGGCGACGTTAGCGTACAGTTCGACGCGA
CCTGGACCAGTGACTACAAAGATGACGA
CGA
GGTGCTTTTTCATAACAATTCCGTCCAGG
AATAAAGCTGGCATATGAATATCCTCCT
TAG
CTCTACCGGAAGGCATCTGG

EcpA+676

GCAGAGCGAGAAGCAGAAGG

FLAG Validation Primer

EcpR-496/BamHI

CGGGATCCGGGATGAACACCCATAACCA Fragment for pRS551

EcpR-21/BamHI

CGGGATCCTACTTTCCAAACCTGTAATT Fragment for pRS551

EcpA-666/EcoRI (1)

Fragment for pRS551

ecpAp/SDMForward

CGCGGAATTCGTGACATGGCAAAATGAT
TAC
CGCGGAATTCGGACTATCTGAACTGATTG
T
CGCGGAATTCCAGAAAAGATTTCGTGTT
TA
CGCGGAATTCGCGGCCAGAAAGTCAGAA
GC
CGCGGAATTCGGCAGGTTCCTGAGAAAA
GA
CGCGGAATTCATCGGCGTAATGCAGAGGC
C
CGCGGGATCCTGTATTTCTTCCCGAGTTG
AA
CGCGGAATTCGTGACATGGCAAAGTGAT
TAC
CGCGGGATCCTGCTTTTCTTCCCGAGTTG
AA
CGCGGGATCCTGCATTTCTTCCCGAGTTG
AA
AGTGTATACCC ATCGGCGTAA

ecpAp/SDMReverse

TTACGCCGATG GGTATACACT

Site-Directed Mutagenesis

ecpAp/SDMForward
(O127)
ecpAp/SDMReverse
(O127)

AGTGTATACCT ATCGGCGGAA

Site-Directed Mutagenesis

TTCCGCCGATA GGTATACACT

Site-Directed Mutagenesis

EcpA+546/Flag-F

EcpA+658/P2

EcpA-555/EcoRI
EcpA-496/EcoRI
EcpA-387/EcoRI
EcpA-270/EcoRI
EcpA-131/EcoRI
EcpA-1/BamHI (1)
EcpA-666/EcoRI (2)
EcpA-1/BamHI (2)
EcpA-1/BamHI (3)

FLAG Tagging Primer

FLAG Tagging Primer

FLAG Validation Primer

Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Fragment for pRS551
Site-Directed Mutagenesis

a

Restriction sites indicated by bolded and underlined nucleotides

b

Nucleotides changed through site-directed mutagenesis are indicated by bold nucleotides.
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Chapter 5: Conclusions and Future Directions
The 2006 EHEC O157:H7 outbreak strain TW14359 is characterized by increased
virulence and an increased adherence phenotype when compared with distantly related EHEC
strains (Abu-Ali et al., 2010a). Increased virulence is associated with increased LEE and stx2
gene transcription, with concomitantly increased adherence and Stx2 production compared with
the less virulent Sakai outbreak strain (Abu-Ali et al., 2010b). However, no specific factors had
been identified which could account for increased virulence gene expression in TW14359
hitherto. Here, the proteome and transcriptome of EHEC strain TW14359 was explored to
determine specific factors which contribute to increased virulence gene expression and
adherence. Our proteomic analysis identified the Rcs response regulator RcsB as being more
abundant in TW14359 when compared with EHEC strain Sakai. Indeed, loss of rcsB collapsed
the differences in LEE gene expression and adherence between Sakai and TW14359, suggesting
that it plays a role in the enhanced virulence phenotype.
The previous finding suggested that one or more factors, acting at one of the rcsB
promoters, direct hypervirulence in TW14359. It is possible that some factor is directly binding
to the rcsB promoter to influence transcriptional activation of the response regulator. Our
analysis has only shown increased rcsB and LEE gene transcription during exponential phase in
DMEM, a condition which is known to stimulate LEE gene transcription. Thus, it is possible that
the effect is specific to those conditions which mimic the host environment and promote
colonization. The production of other colonization factors, such as the E. coli common pilus
(ECP), are stimulated during growth in DMEM for EHEC (Rendon et al., 2007; Torres et al.,

144

2002; Torres et al., 2007). While no additional rcsB regulators have been identified in this study,
a few specific regulators have been previously shown to influence rcsB transcription, including
QseE and LexA (Gervais et al., 1992; Reading et al., 2010). However, neither regulator was
identified as being increased in either previous transcriptional profiles or comparative proteomic
analyses herein. It is therefore possible that another unknown factor contributes directly or
indirectly to increased rcsB transcription in EHEC strain TW14359. One additional possibility is
that RcsB is directly regulating its own transcriptional activation through the phosphorelay itself.
For example, in Salmonella the rcsDB operon is negatively regulated by RcsB through direct
binding at the rcsDB promoter upstream of rcsD (Pescaretti Mde et al., 2009). This is
particularly salient as it suggests RcsB may directly regulate its own transcription to some
degree. However, no such regulatory pathway to-date has been identified in E. coli. Moreover,
the predicted RcsB binding site upstream of rcsD present in Salmonella bears little homology to
the same site in E. coli, opening the possibility for differences in auto-regulation.
Because RcsB is more abundant in TW14359, a strain which has high levels of LEE gene
transcription, it was of interest to determine if overproduction of the LEE had a role in
transcriptional activation of rcsB. While no specific activation of rcsB was observed following
overproduction of GrlA, elevated RcsB was seen. This finding was particularly interesting since
GrlA is known to repress motility in E. coli, and this study has shown RcsB is required for GrlA
mediated repression of motility. Although increased RcsB was observed in GrlA overexpression
strains, rcsB transcriptional activation was not. This data suggests some post-translational
regulation of RcsB, either direct or indirect, by GrlA. As GrlA has been shown to interact
directly with GrlR (Padavannil et al., 2013), it is possible that GrlA interacts with RcsB in some
way to promote its stability. Alternatively, GrlA may affect some other factor that is able to post-
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translationally modulate cytosolic RcsB levels. To determine potential interactions between GrlA
and RcsB, it would be of interest to perform protein-protein interaction analyses using purified
tagged variants of both GrlA and RcsB in pull-down studies. Alternatively, a coimmunoprecipitation experiment could be performed with purified GrlA and RcsB to determine
specific protein-protein interactions. These experiments would begin to clearly determine if the
regulatory effect of GrlA on RcsB abundance is direct, or whether it is through some other
factor. In light of the latter findings, it is important to note that a previous study on
transcriptional differences between EHEC strains Sakai and TW14359 revealed differences in
LEE gene transcription, but also identified decreased transcription in genes associated with
motility (Abu-Ali et al., 2010b). This finding was of particular interest as GrlA overexpression
was also shown to negatively affect motility through the flhDC promoter, though direct
interaction has not yet been shown (Iyoda et al., 2006). The results of this study have shown that
GrlA mediated repression of motility requires an intact rcsB gene. As heterodimerization of
RcsB with a number of transcriptional regulators has been previously described (Krin et al.,
2010; Torres-Cabassa and Gottesman, 1987; Venkatesh et al., 2010), one possibility is that GrlA
and RcsB interact directly to regulate flhDC promoter activity. While a specific RcsAB binding
consensus site was identified in E. coli (Francez-Charlot et al., 2003), no current GrlA consensus
sequence has been described. Alternatively, the regulatory effects on motility by GrlA and RcsB
could be simply due to the downstream affects of increased RcsB protein levels alone.
As a positive LEE gene expression control, sodium bicarbonate was added to the growth
media to stimulate LEE gene transcription. Surprisingly, addition of bicarbonate led to
substantially increased cytosolic RcsB protein level (Fig. 31), which were elevated above that
observed following GrlA overproduction.

It was further shown that bicarbonate mediated
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transcriptional activation of the ler promoter required an intact Rcs phosphorelay, and that full
stimulation was also dependent on the EHEC specific regulator GrvA (Morgan et al., 2013; Tobe
et al., 2005). To date, numerous studies have shown that LEE gene expression is maximal
during active growth, but also in conditions which are similar to the predicted host physiology.
These include, but are not limited to, pH, osmolarity, and the availability of different nutrients
and host derived signals (Alam et al., 2010; Kendall et al., 2012; Kenny et al., 1997a; Kenny and
Finlay, 1995; Pacheco et al., 2012; Sperandio et al., 2002). While this work has demonstrated
RcsB dependent bicarbonate induction of the LEE, the method of RcsB activation by bicarbonate
remains to be determined. Experiments aimed at elucidating this mechanism could explore
factors which are dependent on the bicarbonate ion for function in E. coli that might activate the
Rcs phosphorelay. For example, the cyclopropane fatty acid synthase (Cfa) is an enzyme which
catalyzes the formation of cyclopropane groups in the non-polar region of phospholipids, a
process that has a significant role in moderate acid resistance during stationary growth (Brown et
al., 1997; Chang and Cronan, 1999). Recent studies have identified a bicarbonate molecule
within the Cfa active site, and have further shown that enzyme activity can be inhibited
following the addition of the Cfa active site competitor, borate, with a similar planar trigonal
structure (Courtois and Ploux, 2005; Iwig et al., 2005). Thus, it is possible that bicarbonate
increases enzymatic activity of the Cfa enzyme during exponential growth, when cfa
transcription is typically lower (Rosenthal et al., 2008), and promotes the addition of
cyclopropane groups to the cell membrane. Such a membrane alteration could conceivably
activate the Rcs phosphorelay and promote downstream LEE gene transcription. Initial
experiments aimed at exploring this hypothesis would be aimed at mutational analysis of cfa and
the contribution to LEE gene transcription during growth with and without bicarbonate.
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Preliminary data (not shown) has shown that addition of borate is able to quench bicarbonate
mediated rcsDB promoter activation. However, the chemical nature of this is not yet clear as
potential chemical reactions with bicarbonate and borate were not fully determined. As an
alternative to Cfa, the aminopeptidase A (PepA) catalytic domain utilizes a bicarbonate ion,
though it does not require bicarbonate for function (Strater et al., 1999). The PepA
aminipeptidase was implicated in bicarbonate mediated virulence gene regulation in Vibrio
cholera (Abuaita and Withey, 2009), though no study to-date has fully addressed the hypothesis.
Increased transcription of rcsB was observed in EHEC, and the effect was hypothesized
to be due to some factor specific to TW14359. A comparative analysis of the TW14359 genome
with other EHEC strains was performed (Kulasekara et al., 2009), and identified an insertion in
the tolA gene which was initially hypothesized to contribute to rcsB dysregulation, which would
make sense in light of the role for TolA in membrane integrity and subsequent Rcs phosphorelay
activation (Clavel et al., 1996; Levengood et al., 1991) (Fig. 30). However, while loss of tolA in
both TW14359 and Sakai EHEC strains did indeed elevate rcsB transcription, it was still
proportionally higher in TW14359. Although data towards understanding the role for the
TW14359 specific insertion in tolA did not support the initial hypothesis, further analysis into its
role in potential physiological stress response differences in TW14359 is warranted. Specifically,
variation in the E. coli tolA membrane spanning repeat domain length has recently been shown to
affect stress tolerance to 4% sodium dodecyl sulfate (SDS) (Zhou et al., 2012). Furthermore,
differences in the TolA transmembrane domain length contribute to distinct stress resistance
differences observed for Salmonella enterica subsp. enterica serovars Typhi and Typhimurium
(Lahiri et al., 2011). Thus, further examination into the direct role of TolA in EHEC virulence
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Figure 30 - Schematic model for TolQRA and the Rcs phosphorelay
The TolQRA complex is in E. coli facilitates maintenance of outer membrane integrity and has a role in
division (Lloubes et al., 2001). The TolR and TolQ proteins energize TolA by coupling the proton
motive force of the periplasmic space (Cascales et al., 2000). TolA is anchored to the inner membrane
and has an extended alpha helical which connects the terminal domain that interacts with OmpF and Pal.
Loss of TolA leads to outer membrane perturbation and strongly promotes signal transduction between
RcsF and RcsC through some unknown mechanism (Clavel et al., 1996). Activation of the Rcs
phosphorelay thus leads to transcriptional activation of capsular polysaccharide genes (cps) and is
predicted to increase LEE gene transcription through the RcsB-GrvA pathway.
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could include exploring its specific role in virulence, as observed in Salmonella (Paterson et al.,
2009), and the mechanism by which tolA mutation communicates membrane perturbation to the
inner-membrane lipoprotein RcsF (Clavel et al., 1996). As increased rcsB transcription was
observed in both Sakai and TW14359 following mutation of tolA, it is possible that potential
auto-activation of RcsB through the Rcs phosphorelay is a contributing factor. Finally, virulence
assays for tolA mutant EHEC strains could be performed to explore the significance of the
membrane spanning protein in pathogenesis and growth fitness in both bovine and mouse models
of colonization. The contribution to adherence could be ascertained through adherence assays for
EHEC on cultured epithelial cells, with either visual microcolony counts or fluorescent
microscopy with antibodies for actin to determine pedestal formation under adherent EHEC
cells. The experiment latter would permit detection of type III secretion mediated actin
accumulation, and could help to discriminate between adherent cells utilizing other important
EHEC adhesins, such as Lpf or HCP.
To identify additional factors unique to EHEC strain TW14359, a further sequence
analysis of the TW14359 genome for other factors which might directly affect rcsB transcription
was performed. Subsequent analysis of nucleotide polymorphisms specific to TW14359 revealed
a SNP located upstream of the ecp operon encoded gene ecpA. This gene, encoding the major
fimbrial subunit of the E. coli common pilus (ECP), was of particular interest as a regulatory
dynamic between RcsB and the major ecp promoter had been previously established (Lehti et al.,
2012b). A detailed mapping of the promoter, and further site-directed mutagenesis of specific
nucleotide polymorphisms, revealed that promoter activity upstream of ecpA was significantly
higher than all other E. coli ecpA promoters tested. And, perhaps more importantly, promoter
activity was significantly higher than that of EHEC strain Sakai. This finding was particularly
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salient as the only difference between the two promoters was the polymorphism identified. The
regulatory region 270-bp upstream of ecpA identified had been previously tested for promoter
activity (Martinez-Santos et al., 2012), but was performed on a strain lacking the polymorphism
unique to TW14359. Likewise, another study has explored transcriptional regulation of the ecpR
promoter and the region upstream of ecpA, specifically mediated by H-NS, and suggested that
the sequence located within the ecpR open-reading frame may contain an 'upstream regulatory
element' (Lehti et al., 2013b). This finding was congruent with our observation of H-NS control
over the TW14359 specific ecpA promoter, where mutation of hns resulted in substantially
higher ecpA promoter activity. A slight but significant increase was also seen for the promoter
fragment derived from EHEC strain Sakai, supporting a model of H-NS regulation through the
ecpA promoter in E. coli strains regardless of the promoter activity strength. Future
investigations into the regulation of the ecpA promoter could include a more detailed analysis of
the sequence differences between TW14359 and more distantly related strains, such as
enteropathogenic E. coli O127:H6 strain E2348/69. Our initial findings revealed that the
TW14359 specific SNP alone was not enough to activate transcription in E2348/69, and that one
or more of the other nucleotide sequence differences might be responsible for promoter activity
below that of strain TW14359. Identification of factors which directly regulate transcription from
the ecpA promoter, in TW14359 and other E. coli strains, would provide insight into how ECP
production is controlled in different nutritional conditions and growth phases, and provide
insight into the contribution of unique nucleotide polymorphisms found among divergent E. coli
strains.
Promoter variation for the primary ecp operon promoter, upstream of the ecp encoded
ECP regulator EcpR, has been previously explored (Lehti et al., 2013b). The latter study
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identified phylogenetic group specific variation in transcription that is associated with
differences in promoter architecture, and suggests that it may contribute to adaptation among E.
coli strains in response to different environments and growth conditions. Such a model for
promoter adaptation would make sense, in an evolutionary sense, as production of ECP in EHEC
has been associated with adherence to both mammalian and plant tissue, specifically to cultured
epithelial cells and spinach leaves, respectively (Rendon et al., 2007; Saldana et al., 2011). It is
thus possible that enhanced promoter activity of the ecpA pilin gene in EHEC strain TW14359
could provide a competitive advantage during colonization of a human or bovine host, or in
adherence to spinach leaves. The latter food matrix is particularly interesting as the 2006 EHEC
outbreak to which TW14359 was involved occurred largely through contaminated pre-packaged
spinach (Wendel et al., 2009). Whether increased ecpA promoter activity in TW14359 has a role
in adherence to mammalian or plant tissue has yet to be determined, however our analysis of
ECP production has shown that ECP is produced in TW14359 in the absence of a functional
ecpR promoter. Future analyses of TW14359 ECP production could involve experiments for
competitive mammalian and plant tissue colonization with strains lacking other major adhesins,
such as the type III secretion system, and in strains with distinct ECP expression patterns.
The primary ecp promoter upstream of ecpR is directly regulated by RcsB, as previously
observed for neuromeningitic E. coli (NMEC) (Lehti et al., 2012b) and herein observed for
EHEC. However, overproduction of EcpR in NMEC only slightly increased rcsB promoter
activity, while in EHEC strain TW14359 our experiments have shown that a significant increase
in mRNA and cytosolic RcsB is observed following expression of ecpR. This finding was quite
intriguing as it suggests the former observation of increased ecpA promoter activity in EHEC
strain TW14359 may have a role in dysregulation of rcsB when compared with other EHEC
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strains (Morgan et al., 2013). As the regulator of the ecp operon, EcpR overproduction increases
total ECP production. Thus, it is possible that increased rcsB transcription could be as a result of
significantly increased ECP protuberance. Increased fimbriae production has been observed to
activate the Cpx response in E. coli (Hung et al., 2001), in accordance with the proposed model.
The ecp operon contains all of the factors required for ECP production. Specifically, following
the chaperone-usher model of pilus biogenesis in E. coli (Thanassi et al., 1998; Waksman and
Hultgren, 2009), ECP pili require the insertion of an usher protein (EcpC) into the outermembrane through which the pilus is assembled (Volkan et al., 2013a). For ECP pili, two
predicted ecp encoded chaperones (EcpB/EcpE) direct the assembly of both the ECP tip adhesin
(EcpD) and the major ECP subunit (EcpA) (Garnett et al., 2012; Sauer et al., 1999). Since
expression of the ecp operon, excluding ecpR, resulted in a similarly increased level of rcsB
transcription, biogenesis of ECP is at least partly able to stimulate rcsB transcription (Fig. 31).
However, as EcpR has been shown to directly regulate additional genes outside of the ecp
operon, specifically flhDC (Lehti et al., 2012a), it remains a possibility that EcpR is able to
regulate rcsB production in a manner independent of the pilus. How exactly assembly of ECP is
capable of activation rcsB transcription is still unknown, however a recent study demonstrated
that loss of the ECP tip adhesin EcpD, but not the major fimbrial subunit EcpA, significantly
reduced motility in avian pathogenic E. coli (APEC) (Stacy et al., 2014). One possible
explanation for this could be that loss of the ECP tip adhesin results in either mis-assembly or
excess accumulation of EcpA in the periplasmic space, where chaperone binding capacity is
exceeded. Indeed, previous reports on the basis of pilus biogenesis indicate that pilin subunits in
the periplasm can be either chaperone-bound and awaiting assembly through the outer-
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Figure 31 - Model for ECP biogenesis and predicted stimulation of the Rcs phosphorelay
The E. coli common pilus is assembled through the chaperon-usher model of pilus biogenesis (Volkan et
al., 2013b; Wurpel et al., 2013). The ecp operon is regulated by both the ecp encoded EcpR and the
response regulator RcsB. Though two ecp promoters have been identified in TW14359, only the ecpR
promoter is directly regulated by EcpR and RcsB. ECP pilus components localize to the periplasmic space
where the EcpD and EcpE chaperones guide the major pilin subunit (EcpA) and the tip adhesin (EcpD) to
the usher protein (EcpC) for assembly. In this model, accumulation of EcpA could stimulate the Rcs
phosphorelay through RcsF, or another unknown mechanism, to promote transcription and production of
both RcsB and the LEE.

154

membrane usher, or alternatively involved OFF-pathway interactions leading to stress pathway
activation (Hung et al., 1999; Hung et al., 2001). The outer-membrane lipoprotein RcsF has been
shown to sense membrane perturbations and transmit signals to the Rcs sensor kinase (Majdalani
et al., 2005; Shiba et al., 2012), and could thus effect transcription of the rcsB gene itself.
Indeed, as previous studies have shown that mutation of tolA results in unambiguous activation
of the Rcs phosphorelay (Clavel et al., 1996), loss of tolA in TW14359 led to significantly higher
rcsB transcription (Morgan et al., 2013), in support of the proposed model of RcsB autoregulation. However, as noted previously, work remains to be done in elucidating specific autoregulation of the rcsDB operon by RcsB.
The LEE gene regulatory pathway through RcsB and GrvA had previously only been
functionally described; indeed, the grvA dependence for LEE gene transcription had only been
shown during overexpression of RcsB or through intrinsic activation of the Rcs phosphorelay
through expression of a hyper-phosphorylating variant of RcsC (Tobe et al., 2005). However, the
specific regulatory dynamic between RcsB and the grvA gene and downstream LEE gene
regulation by GrvA remained unknown. Since our work has shown that RcsB binds directly to
the grvA promoter, direct regulation through phosphorylated RcsB likely occurs at one or both of
the tandem RcsB consensus sequences located proximal to the predicted grvA sigma-70
promoter. Interestingly, the grvA promoter appears to be under tight regulation during all postlag growth phases, suggesting that some other factor may be involved in transcriptionally
regulating its activity. Even during growth in DMEM, a condition which significantly increase
rcsB transcription, grvA promoter activity eventually collapsed following transition to
exponential growth. One such possible regulator includes the capsule synthesis regulator RcsA,
which is typically under tight proteolytic degradation during growth at physiological
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temperatures (Torres-Cabassa and Gottesman, 1987). If RcsA is able to accumulate during
stationary phase, transition to growth could ultimately leave a population of the regulator able to
act of RcsA/RcsB promoters prior to its eventual degradation. In support of this, the RcsB
binding sites upstream of the grvA promoter bear high sequence similarity to that of the RcsAB
box identified upstream of flhDC (Francez-Charlot et al., 2003), a promoter which is actively
repressed during RcsA accumulation. To determine whether RcsA is indeed a bona-fide grvA
regulator, direct interaction could be determined through electrophoretic mobility shift assays or
through co-immuno precipitation with epitope tagged RcsA.
While the direct regulation of grvA by RcsB was identified, the specific role for GrvA in
the regulation of LEE gene transcription had not been shown. RNA sequencing was employed to
explore the transcriptional differences in wild type compared with grvA and rcsB mutant strains.
This aim of this approach was to determine the pathway, direct or indirect, through which GrvA
transcriptionally regulates the LEE1 promoter, and downstream type III secretion. However,
between the grvA isogenic mutant strain and the rcsB and grvA double mutant, only increased
transcription of the GAD acid fitness island (AFI) could account for decreased LEE gene
transcription. The AFI encoded transcriptional regulator GadE is a known direct repressor of
LEE gene transcription, and is under complex regulation at 3 independent promoters located
within a 750-bp sensory region upstream of the gadE ORF (Kailasan Vanaja et al., 2009; Sayed
and Foster, 2009; Tree et al., 2011). Only the gadEP3 promoter was consistently up-regulated in
the grvA mutant strain and up-regulation required an additional AFI encoded regulator, GadW
(Fig. 32).

This regulatory dynamic is of particular interest as attempts to identify GrvA

interaction at the gadEP3 promoter, while unsuccessful, revealed an additional unexpected shift
with purified membrane fractions independent of GrvA. Thus, the GAD acid fitness island may
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Figure 32 - Schematic model for RcsB-GrvA regulation of the LEE
Bicarbonate is predicted to be a signal of at least RcsC, and its activation results in phosphotransfer to
RcsD and thus RcsB. The grvA promoter is activated through direct transcriptional activation by RcsB
and, through an as of yet unknown mechanism, is predicted to represses production of the gadE positive
regulator GadW. Ultimately, de-repression of gadW leads to increased GadE production through the
gadEP3 promoter, and results in both exponential acid resistance and LEE1 promoter repression.
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interact with the inner membrane through direct binding of some factor at the gadE P3 promoter.
In this model, GrvA bound to the inner membrane could more easily interact with the AFI
encoded gadW promoter region. This mechanism of transcriptional regulation has been
extensively described for the Vibrio cholerae toxin regulator ToxR (Kolmar et al., 1995).
However, it has not been investigated whether GrvA directly binds to either of the mapped gadW
promoters, or whether its regulatory role is indirect. Although preliminary evidence does suggest
GrvA is localized to the inner membrane (unpublished data), in accordance with the location of
its predicted transmembrane domain and high amino acid homology with ToxR.
To conclude, the results presented herein have demonstrated that differences in
transcriptional regulation between two genetically distant EHEC strains is as a result of
dysregulation of the capsule synthesis regulator RcsB. In the course of experimentation, a
reciprocating regulatory loop between the LEE encoded regulator GrlA and RcsB was identified,
and bicarbonate mediated virulence gene activation in EHEC was shown to be dependent on an
intact Rcs phosphorelay. Further investigations into the genetic differences between EHEC
strains Sakai and TW14359 revealed a polymorphism upstream of the ECP major fimbrial
subunit gene encoding EcpA, and was subsequently shown to be unique to the 2006 O157:H7
EHEC spinach outbreak strain TW14359. Although increased ECP production results in rcsB
transcriptional activation, it remains a possibility that other factors contribute to intrinsic
dysregulation of the rcsB in TW14359. Finally, the RcsB-GrvA pathway was explored using
comparative RNA sequencing to elucidate the specific mechanism through which GrvA effects
LEE gene transcription, and a pathway wherein GadE, stimulated by GadW, was identified.
Taken together, the results presented significantly expand the role for RcsB in virulence gene
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regulation for EHEC, identify a novel pathway for ECP stimulated LEE gene activation, and
characterize the specific pathway for GrvA regulation of type III secretion.
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